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ABSTRACT 
ACCURACY OF PEDOMETERS AND THEIR USE IN A 
10,000 STEPS PER DAY INTERVENTION STUDY 
This dissertation was designed to assess pedometer accuracy under both 
controlled and free-living conditions and to assess the efficacy and feasibility of the 
10,000 steps per day exercise prescription in sedentary, overweight men vs. women. The 
specific aims were to 1) assess the accuracy of 10 electronic pedometers over the course 
of a 400-m walk; 2) compare the step values of multiple brands of pedometers over a 
24-hour period; 3) compare the effects on body composition, cardiovascular risk factors 
and adherence in response to a 10,000 steps per day exercise prescription in overweight 
men vs. women. 
First, the accuracy and reliability of 10 electronic pedometers was assessed over 
the course of a 400-m walk. Ten males and 10 females ranging in body mass index 
(BMI) from 19.8 to 33.6 kg·m·2 walked 400-m around an outdoor track while wearing 
two pedometers of the same model (one on the right and left sides of the body) for each 
of ten models. Four pedometers of each model were assessed in this fashion. The Kenz 
Lifecorder (KZ), New Lifestyles NL-2000 (NL), and the Yamax Digi-Walker SW-701 
(DW) were the most accurate in counting steps, displaying values that were within ±3% 
of the actual steps taken, 95% of the time. The Sportline 330 (SL330) and Omron HJ-
105 (OM) were the least accurate, displaying values that were within ±37% of the actual 
steps, 95% of the time. The reliability within a single model (Chronbach's alpha) was 
>0.80 for all pedometers with the exception of the SL330. The intra-model reliability 
was exceptionally high (>0.99) in the KZ, OM, NL, and the DW. 
lll 
Second, a comparison of 13 pedometer models was made over a 24-hour period. 
Ten males and ten females ranging in BMI from 19.8 to 35.4 kg·m·2 wore two pedometers 
for a 24-hour period. The criterion pedometer Yamax Digi-Walker SW-200 (YX200) 
was worn on the left side of the body and a comparison pedometer was worn on the right. 
Steps counted by each device were recorded at the end of the day for each of the thirteen 
pedometers. Subjects took an average of 9,244 steps·d-1• The KZ, YX200, NL, Yamax 
Digi-Walker SW-701 (YX701), and SL330 yielded mean values that were not 
significantly different from the criterion. The Freestyle Pacer Pro (FR), Accusplit 
Alliance 1510 (AC), Yamax Skeletone EM-180 (SK), Colorado on the Move (CO), and 
Sportline 345 (SL345) significantly underestimated steps (P<0.05) and the Walk4Life LS 
2525 (WL), OM, and Oregon Scientific PE316CA (OR) significantly overestimated steps 
(P<0.05) when compared to the criterion. In addition, some pedometers underestimated 
by 25% while others overestimated by 45%. 
Third, a comparison of the effects on body composition, cardiovascular risk 
factors and adherence was made in response to a 10,000 steps per day exercise 
prescription in sedentary, overweight males vs. females. Fifteen men (46 ± 7 yrs) (mean 
± SD) and twenty-four women (48 ± 5 yrs) who were overweight or obese participated in 
a 10,000 steps per day intervention for 36 weeks. Body weight, BMI, percent body fat, 
fat mass, fat-free mass, waist circumference, hip circumference, systolic blood pressure, 
diastolic blood pressure, and heart rate were determined at baseline, after 20 weeks and 
again after 36 weeks. A blood lipid profile was assessed at baseline and after 36 weeks. 
Men and women given a 10,000 steps per day exercise prescription experienced similarly 
significant improvements in body weight, BMI, percent body fat, fat mass, waist and hip 
iv 
circumferences, and HDL-C. When men and women were combined to explore the 
effect of adherence to the exercise prescription, the adherers significantly reduced body 
weight, BMI, percent body fat, fat mass, waist circumference, and hip circumference 
after 36 weeks while the non-adherers experienced little or no change in these variables. 
Thus, the 10,000 steps per day exercise prescription was effective at increasing daily 
walking volume which resulted in significant improvements in body weight and. body 
composition in overweight, sedentary, middle-aged men and women. 
V 
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Numerous prospective epidemiological studies support the belief that a physically 
active lifestyle is associated with positive health related outcomes. Several studies 
confirm the beneficial impact that physical activity can have on a variety of health 
conditions including cardiovascular disease, hypertension, obesity, type 2 diabetes, 
osteoporosis, and certain types of cancers (2). Despite the large body of evidence 
supporting the multiple benefits of physical activity, most Americans are either inactive 
or insufficiently active. According to the 1996 Surgeon General's Report, 60% of U.S. 
adults do not engage in regular leisure-time activity and about 25% report no leisure-time 
physical activity (35). More recently, the Behavioral Risk Factor Surveillance System 
(BRFSS) indicated that approximately 55% of American adults are not sufficiently active 
to achieve health benefits ( 5). Healthy People 2010 has placed physical activity among 
its leading health indicators which reflect the major public health concerns of the United 
States and were chosen based on their ability to motivate action, the availability of data to 
measure their progress, and their relevance as broad public health issues .(3 7). Two of the 
14 physical activity and fitness goals of Healthy People 2010 are to reduce the proportion 
of adults who engage irt no leisure-time physical activity and to increase the proportion of 
adults who are regularly active (3 7). 
The most recent physical activity recommendations have shifted from the 
traditional exercise prescription that focused on vigorous intensity activity for the 
attainment of cardiorespiratory benefits to one of moderate intensity activity that has been 
shown to improve health outcomes. Evidence from prospective studies in the early 
1990's showed that physical activity of lower intensity, duration, and frequency than 
required to improve cardiorespiratory fitness could produce significant improvements in 
2 
health outcomes. The current recommendation issued by the American College of Sports 
Medicine (ACSM) and the Centers for Disease Control and Prevention (CDC) in 1995, 
encourages American adults to accumulate at least 30 minutes of moderate-intensity 
physical activity on most, if not all days of the week (24). It was thought that a 
recommendation that allowed for the accumulation of moderate intensity physical activity 
through lifestyle activities may decrease the proportion of sedentary adults in the United 
States. 
As an alternative to the current ACSM/CDC physical activity recommendation, 
Dr. Hatano of Japan believes that taking 10,000 steps per day is the amount of physical 
activity needed for cardiovascular disease prevention (12). Hatano has found that 
increased ambulatory activity is associated with lower levels of blood pressure and 
subcutaneous fat (11). Hatano estimated that a 60 kg Japanese male would expend at 
least 333 kcal in walking 10,000 steps (12). Previous research indicates that this amount 
(>2000 kcals/wk) appears to be protective against heart attacks (23). In addition, 
longitudinal studies have demonstrated that walking 10,000 steps per day results in 
improvements in cardiovascular disease risk factors in sedentary, at-risk populations (20, 
31 ). This particular physical activity recommendation has been rather highly publicized 
in popular periodicals (13, 26). 
Physical activity can be viewed as a complex interaction between frequency, 
intensity, type and duration, which make it difficult to accurately measure. Thus, 
physical activity assessment has been a challenge for researchers attempting to accurately 
and objectively quantify this multifaceted behavior. Current methods for assessing 
physical activity include questionnaires, doubly labeled water, heart rate monitors, and 
3 
motion sensors. It is well documented that each method has its own advantages and 
limitations ( 4, 34, 38). 
Of the several methods that exist regarding physical activity assessment, motion 
sensors, which include accelerometers and pedometers, have some distinct advantages in 
regard to the objective measurement of physical activity. Accelerometers have the ability 
to monitor and store the actual magnitude of acceleration and deceleration of motion. 
However, although accelerometers provide a direct measure of physical activity, they are 
quite expensive and often do not provide the user with instant feedback. Pedometers are 
an additional type of motion sensor that have the benefit of being low in cost, unobtrusive 
to the subject, accurate for ambulatory activity (4, 7), and their output (steps or distance) 
is easily comprehendible. Although the early mechanical pedometers were once deemed 
unacceptable for physical activity assessment in research studies, the electronic 
pedometer has been shown to be accurate under various conditions (4). Despite the fact 
that pedometers are limited to the assessment of ambulatory activity, they have been used 
in a variety of studies, both interventional and cross-sectional in nature (20, 31-33). In 
addition to the abovementioned benefits of pedometers, they also have the potential to 
serve as a motivational tool providing immediate feedback to the user. Several electronic 
pedometers have been shown to be accurate in measuring distance walked as well as 
steps taken at various walking speeds ( 4, 7). 
Physical inactivity is one factor that has contributed to the obesity epidemic. 
Overweight and obesity are also among the leading health indicators of Healthy People 
2010.- In 2001, the U.S. Surgeon General issued a call to action, that focused on 
decreasing the growing epidemic of overweight and obesity that is currently affecting the 
4 
health of our nation (36). Recent evidence from the National Health and Nutrition 
Examination Survey (NHANES) indicates that the prevalence of overweight and obesity 
among U.S. adults is 64.5 and 30.5%, respectively (10). Compared with data from 
NHANES III (1988- 1994), NHANES (1999-2000) data show that increases in the 
prevalence of overweight and obesity have been observed among males and females and 
across all ages and racial/ethnic groups (I  0). In fact, it has been estimated that by the 
year 2008, nearly 39% of the population will be considered obese (15). 
Epidemiological studies show that overweight ( defined for adults as a body mass 
index between 25.0 and 29.9 kg/m2) and obesity (body mass index 30 kg/m2 or above) 
are associated with increases in early mortality in addition to an increased risk for 
coronary heart disease, type 2 diabetes, certain types of cancers, and various 
musculoskeletal disorders (2 1 ). An estimated 300 ,000 deaths per year ( I )  and direct 
annual health care costs of approximately 70 billion dollars (6) may be attributable to 
obesity. In 200 1, the Rand Institute reported that obese individuals have more overall 
health problems than smokers or drinkers (30). Currently, it appears that the obesity 
epidemic is progressing much faster than our understanding of the etiology of obesity and 
our ability to prevent and treat the disease ( 14). 
Research suggests that even modest reductions in body weight of 5-10% will 
significantly improve health and thus, the achievement of an optimal body weight is not 
necessary for some health benefits to be realized ( 16). It is well known that an energy 
imbalance, generally considered to be a prerequisite for weight loss to occur, can be 
created by reducing energy intake and/or increasing energy expenditure. Several studies 
provide evidence to support the beneficial effects of reducing caloric intake on weight 
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loss over the short-term (19, 28). However, an increase in energy expenditure appears to 
be an important component of long-term weight loss and/or weight maintenance (19, 28). 
Several interventional studies have demonstrated that an energy imbalance created solely 
by an increase in energy expenditure can result in a significant amount of weight loss ( 17, 
18, 25, 27-29). 
Although exercise has been shown to be an effective tool for weight management, 
its effects may be influenced by gender. A meta-analysis of 40 studies by Ballar and 
Keesey (3) provided evidence that males lost more body mass than females in response to 
run/walk exercise interventions. Additional studies that have examined the impact that 
similar exercise programs can have on body composition in males and females (17, 29, 9) 
have shown that men respond more favorably than women in regard to body weight 
changes. Interestingly, this gender effect on weight loss has also been supported in 
studies using male and female rats (8, 22). 
In 2001, the ACSM issued a Position Stand (16) that offered strategies for weight 
loss and the prevention of weight regain. It was suggested that for long-term weight loss, 
overweight and obese adults should eventually progress to 200-300 minwk· 1 of leisure­
time physical activity. If for example, a 30-minute walk added to a sedentary 
individual's normal daily walking is necessary for them to meet the 10,000 steps per day 
recommendation (39), a full week of walking this amount would require a minimum of 
21 0 minwk· 1 , which is consistent with the aforementioned guidelines issued by the 
ACSM for weight loss. Although the effects of the 10,000 steps per day recommendation 
on various cardiovascular risk factors has been assessed, no studies have compared its 
feasibility and efficacy in sedentary, overweight men vs. women. 
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Statement of the Problem 
Although electronic pedometers have been validated in a 1996 publication ( 4 ), 
many newer models have emerged on the market since then. Therefore, it necessary to 
determine which of these new models are most accurate under both controlled and free­
living conditions. Also, a popular pedometer based recommendation encourages 
individuals to accumulate 10,000 steps on a daily basis. However, few studies have 
examined the efficacy and feasibility of this recommendation as it pertains to improving 
health outcomes, and none have compared the responses of sedentary, overweight males 
vs. females to this recommendation. 
Statement of Purpose 
The purpose of this dissertation is to examine the accuracy of various pedometers 
under controlled and free-living conditions and to use one of these devices in an 
intervention aimed at comparing the adherence and cardiovascular risk factor responses 
of overweight men vs. women to the 10,000 steps per day recommendation. First, Part 
III determines the accuracy and reliability of 10 electronic pedometers over the course of 
a 400-m walk at a self-selected pace. Second, Part IV compares 13 different pedometers 
to a previously validated criterion over a 24-hour period. Finally, Part V compares the 
effects on cardiovascular risk factors and adherence in response to a 10,000 steps per day 
recommendation in overweight males vs. females. 
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Significance of these Studies 
The electronic pedometer is a device that has been previously shown to be 
accurate under a variety of conditions. However, since 1 996, no study has been done to 
assess accuracy and reliability of these devices. Therefore, it would be of significant 
benefit to the scientific community to validate the newest models of these devices under 
both controlled and free-living conditions. 
With the continued publicity of the 10,000 steps per day recommendation, it 
would also be valuable to assess both the feasibility and the efficacy of this 
recommendation, particularly as it pertains to body weight, body composition, and 
cardiovascular risk factors in overweight men and women. It would be especially 





1 .  Allison, D. B. , K. R. Fontaine, J. E. Manson, J. Stevens, and T. B. Vanltallie. 
Annual deaths attributable to obesity in the United States. JAMA. 282 :2207-2212, 
1999. 
2. American College of Sports Medicine. Benefits and risks associated with 
exercsie. In: ACSM's Guidelines for Exercise Testing and Prescription. B. A. 
Franklin (Ed.) Baltimore, MD: Lippincott Williams & Wilkins, 2000, pp. 5-7. 
3. Ballor, D. L. and R. E. Keesey. A meta-analysis of the factors affecting exercise­
induced changes in body mass, fat mass and fat-free mass in males and females. 
Int. J. Obes. 15 :7 17-726, 199 1 . 
Bassett, D.oR., B. E. Ainsworth, S. R. Leggett, et al. Accuracy of five electronic 
pedometers for measuring distance walked. Med Sci. Sports Exerc. 28 : 107 1 -
1077, 1996. 
5. Centers for Disease Control and Prevention - Morbidity and Mortality Weekly 
Report. Prevalence of Physical Activity, Including Lifestyle Activities Among 
Adults - United States, 2000-2001, 2003, pp. 764-769. 
6. Colditz, G. A. Economic costs of obesity and inactivity. Med. Sci. Sports Exerc. 
31 :S5 15-S52 1 ,  1999. 
7. Crouter, S. E., P. L. Schneider, M. Karabulut, and D. R. Bassett. Validity of 10 
electronic pedometers for measuring steps, distance, and energy cost. Med Sci. 
Sports Exerc. 35 : 1455-1460, 2003. 
9 
8. Dance, D. M., B. Bromley, R. J. Barnard, and R. A. Gorski. Sexually dimorphic 
effects of forced exercise on food intake and body weight in the rat. Physiol. 
Behav. 19: 155- 158, 1977. 
9. Donnelly, J. E., J. 0. Hill, D. J .  Jacobsen, et al. Effects of a 16-month randomized 
controlled exercise trial on body weight and composition in young, overweight 
men and women. Arch. Intern. Med. 163: 1343- 1350 , 2003. 
10. Flegal, K. M., M. D. Carroll, C. L. Ogden, and C. L. Johnson. Prevalence and 
Trends in Obesity Among U.S. Adults, 1999-2000 . JAMA. 288: 1723-1727, 2002. 
1 1. Hatano, Y. Prevalence and use of pedometer. Res. J. Walking. 1 :45-54, 1997. 
12. Hatano, Y. Use of the pedometer for promoting daily walking exercise. JCHPER 
J. 29:4-8 ,  1993. 
13. Heimrich, N. Journey to better fitness starts with 10,000 steps. USA Today. June 
29, 1999. 
14. Hill, J. 0. A new way of looking at obesity. Nutrition 17:975-976, 200o1 .  
15 . Hill, J. 0. , H. R. Wyatt, G. W. Reed, and J. C. Peters. Obesity and the 
environment: Where do we go from here? Science. 299:853-855, 2003. 
16. Jakicic, J. M., K. Clark, E. Coleman, et al. Appropriate intervention strategies for 
weight loss and prevention of weight regain for adults. Med. Sci. Sports Exerc. 
33:2 145-2 1 56, 200 1. 
17. Kirk, E. P. , · J. E. Donnelly, D. J. Jacobsen, and C. Gibson. Time-course and 
gender effects in aerobic capacity and body composition for overweight 
individuals: Midwest exercise trial (MET). Med. Sci. Sports Exerc. 34:S120 
[abstract] , 2002. 
10 
18. Leon, A. S., J. Conrad, D. B. Hunninghake, and R. Serfass. Effects of a vigorous 
walking program on body composition, and carbohydrate and lipid metabolism of 
obese young men. Am. J. Clin. Nutr. 33:1776-1787, 1979. 
19. Miller, W. C., D. M. Koceja, and E. J. Hamilton. A meta-analysis of the past 25 
years of weight loss research using diet, exercise, or diet plus exercise 
intervention. Int. J. Obes. 21 :941-94 7, 1997. 
20. Moreau, K. L., R. Degarmo, J. Langley, et al. Increasing daily walking lowers 
blood pressure in postmenopausal women. Med. Sci. Sports Exerc. 33:1825-1831, 
2001. 
21. National Institutes of Health, National Heart, Lung, and Blood Institute. Clinical 
guidelines on the identification, evaluation, and treatment of overweight and 
obesity in adults: U.S. Department of Health and Human Services, Public Health 
Service, 1998, pp. 12-19. 
22. Oscai, L. B. The role of exercise in weight control. Exerc. Sports Sci. Rev. 1 :  103-
123, 1973. 
23. Paffenbarger, R. S., A. L. Wing, and R. T. Hyde. Physical activity as an index of 
heart attack risk in college alumni. Am. J. Epidemiol. 108 :161-175, 1978. 
24. Pate, R. R., M. Pratt, S. N. Blair, et al. Physical activity and public health. A 
recommendation from the Centers for Disease Control and Prevention and the 
American College of Sports Medicine. JAMA. 273:402-407, 1995. 
25. Pollock, M. L., H. S. Miller, R. Janeway, A. C. Linnerud, B. Robertson, and V. R. 
Effects of walking on body composition and cardiovascular function of middle­
aged men. J. Appl. Physiol. 30:126-130, 1971. 
11 
26. Quittner, J. High-Tech Walking. Time. 156:77, 2000. 
27. Ross, R., D. Dagnone, P. J. H. Jones, et al. Reduction in obesity and related 
comorbid conditions after diet-induced weight loss or exercise-induced weight 
loss in men. Ann. Epidemiol. 133 :92- 103, 2000. 
28. Skender, M. L., G. K. Goodrick, D. J. DelJunco, et al. Comparison of2-year 
weight loss trends in behavioral treatments of obesity: Diet, exercise and 
combination interventions. J. Am. Diet. Assoc. 96:342-346, 1996. 
29. Snyder-Heelan, K. A., D. J. Jacobsen, J. 0. Hill, S. Johnson, and J. E. Donnelly. · 
Differences in body weight changes between males and females in response to 
exercise. Med Sci. Sports Exerc. 33 :Sl38 [abstract] , 200 1. 
30. Sturm, R. and K. B. Wells. Does obesity contribute as much to mortality as 
poverty or smoking? Public Health. 1 15 :229-235, 200 1. 
3 1. Swartz, A. M. and D. L. Thompson. Increasing daily walking improves glucose 
tolerance in overweight women. Prev. Med 37 :356-362, 2003. 
32. Thompson, D. L., J. Rakow, and S. M. Perdue. Relationship between accumulated 
walking and body composition in middle-aged women . Med Sci. Sports Exerc. 
36:91 1-9 14, 2004. 
33. Tudor-Locke, C. E., B. E. Ainsworth, M. C. Whitt, R. W. Thompson, C. L. Addy, 
and D. Jones. The relationship between pedometer-determined ambulatory 
activity and body composition variables. Int. J. Obes. 25 : 1571- 1578, 200 1. 
34. Tudor-Locke, C. E. and A. M. Myers. Challenges and opportunities for measuring 
physical activity in sedentary adults. Sports Med. 3 1 :9 1-100, 200o1. 
12 
35 . U.S. Department of Health and Human Services. Physical activity and health: a 
report of the Surgeon General. Atlanta, GA: U.S. Department of Health and 
Human Services, Centers for Disease Control and Prevention, National Center for 
Chronic Disease Prevention and Health Promotion, 1996. 
36. U.S. Department of Health and Human Services. The Surgeon General's call to 
action to prevent and decrease overweight and obesity. Rockville, MD: U.S. 
Department of Health and Human Services, Public Health Service, Office of the 
Surgeon General, 200 1, pp. 1-60 . 
37. U.S. Department of Health and Human Services. Understanding and Improving 
Health. In: Healthy People 2010 Washington, DC: U.S. Government Printing 
Office, 2000. 
38. Ward, D. S. and R. Evans. Physical activity, aerobic fitness, and obesity in 
children. Med Exerc. Nutr. Health. 4:3-16, 1995. 
39. Wilde, B. E., C. L. Sidman, and C. B. Corbin. A 10,000-Step Count as a Physical 
Activity Target for Sedentary Women. Res. Q. Exerc. Sport 72:4 1 1-4 14, 200 1. 
13 
PART II 
REVIEW OF THE LITERATURE 
14 
Physical Activity on Health 
The benefits of physical activity are well established. Several epidemiological 
and interventional studies have served to quantify the numerous health benefits 
associated with leading a physically active lifestyle. Some of these benefits include but 
are not limited to a decreased risk of cardiovascular disease (6 1, 71, 109) and all-cause 
mortality (65 , 84) along with lower incidence rates for hypertension, obesity, type 2 
diabetes, osteoporosis, anxiety, depression and certain types of cancers (2). A review of 
the physiological, epidemiological, and clinical evidence suggests that regular, moderate­
intensity physical activity can result in substantial health benefits (87). In addition, it has 
been found that even a slight increase in fitness, a byproduct of increased physical 
activity, can significantly reduce the relative risk of death from all causes ( 14). 
Physical Activity Assessment 
Despite the abundance of literature supporting the health benefits of leading a 
physically active lifestyle, our ability to accurately measure this multi-faceted behavior 
remains a challenge. Currently, various subjective and objective methods exist for 
quantifying physical activity. Physical activity questionnaires/interviews, physical 
activity diaries, and physical activity recall are among the most common subjective 
methods. Although these forms of physical activity assessment are easy to administer, 
inexpensive, and noninvasive, they are limited in their ability to assess ubiquitous, 
unstructured physical activity (1, 9 1). Objective measures of physical activity focus 
principally on body motion or physiological responses to exercise. Heart rate monitors, 
doubly labeled water, indirect calorimeters and motion sensors are some of the more 
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common means for objectively assessing physical activity. Pedometers and 
accelerometers are the two predominant forms of motions sensors. Accelerometers are 
relatively expensive devices designed to quantify vertical acceleration and deceleration of 
the body and the output is often in the form of activity counts accessible by downloading 
the data. Although accelerometers can estimate with some degree of accuracy, energy 
expended in various activities, these devices are limited in their ability to estimate energy 
expenditure during activities such as lifting or carrying objects, walking up a grade, or 
. climbing stairs. In these activities involving upper body movement, load carrying or 
changes in surface or terrain, accelerometers tend to underestimate energy expenditure (9, 
39, 120). Pedometers are also limited in their ability to estimate energy expenditure 
during non-ambulatory activity. However, these devices are much less expensive than 
accelerometers, provide the user with constant feedback on steps taken and are effective 
in measuring steps and calculating distance walked (8, 10). 
Pedometers 
The pedometer is a device designed to measure steps and estimate distance 
walked while walking or running (129). Although pedometers were originally used for 
surveying land and measuring walking distance ( 10), it wasn't until the 1960' s that these 
devices became increasingly popular for researchers interested in assessing habitual 
physical activity (115). However, these early mechanical pedometers were found to be 
unacceptable for the precision needed for research purposes primarily due to the fact that 
they were invalid and unreliable (33, 56, 129). Gayle (33) found that the validity of these 
devices varied significantly at speeds ranging from 54 to 107 m-min· 1 and that individual 
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calibrations were needed in order for mechanical pedometers to accurately measure 
distance walked. Likewise, Kemper and Vershuur (56) found two types of mechanical 
pedometers ( one German and one Russian) to be invalid at various walking and running 
speeds in adolescent boys. 
Although the earlier, mechanical pedometers were deemed unacceptable for 
research purposes, the electronic pedometer developed around 1990, offered some hope 
for these devices in assessing ambulatory activity. In 1996, Bassett et al. (8) tested five 
brands of electronic pedometers and found one model (Y amax DW-500) to have a high 
degree of accuracy and reliability. Pedometers were tested for accuracy over a 4 .88 km 
sidewalk course and at varying treadmill speeds of 54, 67, 80, 94, and 107 mmin· 1 • _o
There were significant differences in distance walked between the five pedometers over 
the 4.88 km course, with the Yamax DW-500 being one of the three most accurate 
pedometers at estimating distance. In addition, the Y amax was very consistent in 
counting steps when comparing the same model worn on both the right and left sides of 
the body. In comparing steps taken at varying treadmill speeds, it was found that the 
Yamax DW-500 was significantly more accurate than any of the models for counting 
steps and estimating distance, particularly at speeds :S 80 mmin·1 • Le Masurier et al. (63) 
also found the Y amax brand pedometer to be the most accurate of three models assessed 
under -controlled and free-living conditions. In this study, the Yamax SW-200, Omron 
HJ- 105, Sportline 330 and CSA accelerometer were all compared while walking on the 
treadmill at speeds ranging from 54 to 107 mmin· 1 and over a 24-hour period. Of the 
three pedometers tested, the Yamax SW-200 demonstrated the lowest absolute percent 
error at treadmill speeds '?:_67 m·min·1 and over 24-hours of free-living. 
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In 2003, Le Masurier and Tudor-Locke (64) compared pedometer and 
accelerometer accuracy at varying treadmill speeds and while traveling in a motorized 
vehicle. It was found that the Yamax SW-200 counted significantly fewer steps than the 
CSA (Computer Science Applications) accelerometer (75% vs. 99% of actual steps 
taken) at the slowest walking speed (54 m·min- 1) but the devices were similar at speeds 
?,.67 mmin· 1• In addition, while the CSA accelerometer counted significantly more steps 
at the slowest walking speeds, this device also detected more erroneous steps during 
motorized vehicle travel. Although no actual steps were taken during the motorized 
vehicle travel, the CSA accelerometer detected 17-fold more erroneous steps than the 
Yamax pedometer (p<0.05). Thus, this study suggests that while the Yamax pedometer 
has a higher threshold of vertical acceleration required to trigger a step as evidenced by 
counting fewer steps at the slowest walking speed, this device is also less likely to detect 
erroneous steps during non-ambulatory motion. In addition, while this study showed that 
the Y amax pedometer counted just 75% of actual steps taken at 54 m-min·1 , Hendelman 
et al. (39) pointed out that this speed is much slower than a normal walking speed and is 
unlikely to be an important source of error in field studies. 
Swartz et al. ( 1 19) assessed the effect of body mass index on pedometer accuracy. 
In this study, subjects were stratified by body mass index (BMI) into one of three tertiles: 
normal (<25 kgm-2), overweight (25-29.9 kg·m-2) and obese (?..,30 kg·m-2). Each 
participant walked on a motorized treadmill for 3-minute stages at 54, 67, 80, 94, and 107 
m·min·1 with a Yamax SW-200 brand pedometer placed in each of three locations 
(anterior midline of the thigh, mid-axillary line, posterior mid-line of the thigh) on the 
belt or waistband. It was found that neither BMI category nor pedometer placement 
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affected pedometer accuracy at any of the five walking speeds. It was also noted that 
pedometers were most accurate at walking speeds 2:80 m-min· 1 • 
From the aforementioned studies, it can be surmised that electronic pedometers 
have promise for use in assessing ambulatory physical activity. Some of these devices 
have been shown to be accurate at a variety of walking speeds and among various 
populations. In addition, pedometers appear to meet the criteria established by Freedson 
et al. (32) to denote an ideal objective instrument in that they are low in cost, easy to 
administer to large groups, unobtrusive to the subject, accurate and reliable. Evidence 
continues to mount demonstrating that pedometers are practical, accurate and acceptable 
tools for the measurement of physical activity (124) and may be the method of choice for 
physical activity assessment in epidemiological studies (7). 
ACSM/CDC Physical Activity Recommendation 
Previous physical activity guidelines from the American College of Sports 
Medicine (ACSM) emphasized the importance of vigorous-intensity, continuous aerobic 
exercise for the attainment of cardiorespiratory fitness (3). By the early l 990 's, scientific 
evidence had suggested that physical activity of lower intensity, duration, and frequency 
than that required to improve cardiorespiratory fitness could produce significant 
improvements in health outcomes. As a result of these findings, the focus of physical 
activity guidelines shifted from vigorous- to moderate-intensity exercise. The current 
recommendation issued in 1995 by the ACSM and the Centers for Disease Control and 
Prevention (CDC) encourages American adults to accumulate at least 30 minutes of 
moderate-intensity physical activity on most, if not all days of the week (87). It should 
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be noted that this recommendation is meant to complement, not supersede the previous 
recommendation that focused on improving cardiorespiratory fitness. 
The current recommendation has several unique aspects that distinguish it from 
the previous recommendations. First, the current recommendation emphasizes physical 
activity rather than exercise. Physical activity is defined as "any bodily movement 
produced by skeletal muscles that results in energy expenditure" ( 15). Conversely, 
exercise is a subset of physical activity, defined as "planned, structured, anq repetitive 
bodily movement done to improve or maintain one or more components of physical 
fitness" (15). Thus, the new recommendation extends the health benefits more generally 
to physical activity as opposed to the specific focus on exercise alone. Second, emphasis 
has been placed on moderate-intensity physical activity, which is considered to be any 
activity performed at an intensity of 3-6 METs, the equivalent of walking 3-4 mph for 
most healthy adults. It appears that the majority of the disease prevention benefits can be 
gained with moderate-intensity physical activities, which may or may not be part of a 
structured exercise routine. Third, the allowance for the accumulation of activity has 
been added in the current recommendation. This addition confers the benefits associated · 
with intermittent activity, particularly from an energy expenditure standpoint. As a 
result, activities such as gardening, lawn work, and dancing can contribute to the 30-
minute per day goal as long as the activities are performed at an intensity similar to that 
of brisk walking. 
A clear goal of this current recommendation to accumulate at least 30 minutes of 
moderate-intensity activity on most if not all days of the week was to get more 
individuals more active. Thus, an attempt was made to clearly define the minimum 
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amounts and types of physical activities needed to achieve significant health benefits. 
However, alternative recommendations have surfaced that have focused on more specific 
health outcomes. 
Institute of Medicine Recommendation 
In 2002, the Institute of Medicine (IOM) suggested that 60 minutes of exercise 
per day may be necessary for controlling body weight, a recommendation that is double 
that of the ACSM/CDC which focused on the attainment of health benefits. The IOM 
recommendation states, "to prevent weight gain as well as to accrue additional, weight­
independent health benefits of physical activity, 60 minutes of daily moderate intensity 
physical activity is recommended, in addition to the activities required by a sedentary 
lifestyle." (47). The IOM recommendation acknowledges that some health benefits can 
be achieved by adhering to the ACSM/CDC recommendation, but suggests that this 
amount is insufficient to maintain body weight in adults with a BMI ranging from 18.5 to 
25 kgm·2 and fully achieve all the identified health benefits. However, the ACSM/CDC 
recommendation clearly states that 30 minutes per day, most days of the week is the 
minimum amount of activity needed to obtain some health benefits. The ACSM/CDC 
recommendation goes on to indicate that the health benefits accrue in approximate 
proportion to the total amount of activity, and thus, those who are already meeting the 
recommendation will likely reap some additional health and fitness benefits from 
becoming more physically active, thereby acknowledging the additional benefits to be 
obtained by performing more physical activity than the recommended minimum (87). 
2 1  
Although the two recommendations are dissimilar in the amount of activity suggested, it 
should be emphasized that they were designed with two different goals in mind. 
2,000 Steps Per Day Increase 
Interestingly, an alternative recommendation that also focuses on the prevention 
of weight gain encourages American adults to take an additional 2,000 steps per d� 
This translates roughly into an extra 15 minutes of daily walking and was develor 
Dr. Hill based on the average annual weight gain of American adults. The Ion, 
CARDIA study indicated that the average 15-year weight gain was 22.5 to 3�  ds 
among adults between the ages of 18 and 30 years at baseline (68). Thus, ,, T a  
linear increase in weight over these 15 years, the average weight gain in this population is 
about 1.5 to 2.2 pounds per year. Based on this information along with the consideration 
of the efficiency of energy storage in humans, Dr. Hill believes that weight gain could be 
eliminated by some combination of increasing energy expenditure and decreasing energy 
intake by 100 kcal·d- 1 (43). Hill notes that energy expenditure can be increased by 100 
kcal ·d- 1 by walking an extra mile per day. He states that "Walking a mile, whether done 
all at once or divided up across the day, bums about 100 kcal, which would theoretically 
completely abolish the energy gap and hence weight gain for most of the population. A 
mile of walking for most people is only about 2,000 to 2,500 extra steps, and these steps 
could be accumulated throughout the day as life-style activities, for example, taking the 
stairs, parking a little farther from a destination, conducting a walking meeting" ( 43). 
Based on the above rationale, Hill has prompted the promotion of an activity 
recommendation called "America on the Move" that uses pedometers to motivate people 
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to walk an additional 2,000 steps per day. However, at this point, there is no evidence to 
support the effectiveness of this recommendation. 
10,000 Steps Per Day 
An alternative recommendation using pedometers encourages adults to take at 
least 10,000 steps per day. Dr. Yoshiro Hatano of Japan, believes that taking 10,000 
steps per day is the amount of physical activity needed for cardiovascular disease 
prevention (37). Hatano has found that increased ambulatory activity is associated with 
lower levels of blood pressure and subcutaneous fat (36). Hatano also estimated that a 60 
kg Japanese male would expend at least 333 kcal/day in walking 10,000 steps/day (37). 
Previous research by Paff enbarger et al. (85) indicates that this amount of energy 
expenditure in physical activity (>2000 kcals/wk) appears to protect against heart attacks. 
In addition, longitudinal studies have demonstrated that walking 10,000 steps/day results 
in improvements in cardiovascular disease risk factors in sedentary, at-risk populations 
(77, 121). This particular physical activity recommendation has been rather highly 
publicized in popular periodicals (38, 96). To show the relative equivalence between the 
ACSM/CDC recommendation and the 10,000 step/day recommendation, Wilde, et al. 
(131) showed that by adding a 30-minute walk to their daily routine, subjects increased 
their mean step counts from 7,220 to 10,030 steps per day. This study indicates that for 
sedentary women, walking daily for 30 minutes will generally allow them to meet both 
physical activity recommendations, suggesting that the two are roughly equivalent. 
However, Wilde et al.i(131) also noted that although the mean step count of the 
participants in this study was over 10,000 steps per day when they added a 30-minute · 
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walk to their routine, only 37.5% took at least 10,000 steps on the first day they walked 
an extra 30 minutes and just 50% took I 0,000 steps or more on the second day that 
included a 30-minute walk. Therefore, although the recommendation to walk an 
additional 30 minutes per day in addition to normal daily walking increased the mean 
steps taken day from 7,220 to just over 10,000, the 30-minute walk was not enough to get 
the majority of the participants over the 10,000 steps per day mark. 
Physical Inactivity 
Despite the abundance of literature supporting the benefits of leading a physically 
active lifestyle, most Americans are not getting a sufficient amount of activity. 
According to data collected from the CDC's Behavioral Risk Factor Surveillance System 
(BRFSS), 55% of Americans were not active enough in 2001 to meet the current physical 
activity recommendation of accumulating at least 30 minutes of any physical activity on 
five or more days per week or more than 20 minutes of vigorous physical activity on 
three or more days per week (16). Thus, although a variety of exercise recommendations 
exist, a clear goal should be to provide a recommendation that will decrease the 
prevalence of inactivity among American adults. Some factors that may potentially 
impact physical activity participation include exercise intensity, exercise frequency, 
group- vs. home-based exercise and an individual's willingness to adopt a physical 
activity program. 
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Exercise Intensity and Frequency 
Exercise intensity may have a substantial effect on adherence rates to exercise 
prescriptions. Some studies (2 1 ,  88, 100) have provided evidence that moderate-intensity 
activity programs have greater adoption and adherence rates compared with those of 
vigorous intensities. One of the suggested reasons for the decreased adherence to 
vigorous-intensity activities is an increase in injury rates (20 , 92) . 
In 1986, Sallis et al. (100) found that exercise adoption rates were higher for 
moderate- versus vigorous-intensity activities and that I -year dropout rates were greater 
for vigorous-intensity activities. Likewise, a meta-analysis of 127 interventional studies 
showed a greater increase in physical activity of low-intensity compared with that of 
moderate- or high-intensity activities (2 1 ). Also, a review by Pollock showed that 
exercise prescriptions of moderate-intensity were associated with greater adherence than 
those of vigorous-intensity (92). In 2002, Perri et al. (88) compared the adherence to 
walking based exercise prescriptions in a randomized, factorial design, with two levels of 
intensity (moderate: 45-55% HRres vs. vigorous: 65-75% HRres) crossed with two levels 
of frequency (moderate: 3-4 days per week vs. high: 5-7 days per week) for 30 minutes 
per session over 6 months in a home based setting. The results showed better relative 
adherence and a lower number of exercise-related injuries in the moderate-intensity than 
in the high-intensity conditions and equivalent adherence for the moderate and high 
frequency prescriptions. Likewise, participants in the higher intensity groups walked 
significantly fewer total minutes than did participants in the moderate-intensity groups. 
Thus, prescribing a higher frequency of exercise increased accumulation of exercise 
without a decline in adherence, whereas prescribing a higher intensity decreased 
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adherence and resulted in the completion of less exercise. However, it should be noted 
that although the vigorous intensity recommendation resulted in lower adherence, when 
exercise volume, which takes into consideration absolute intens'ity, duration and 
frequency of the activity (46), is expressed as kcalwk· 1 or MET-minwk· 1 , the higher 
intensity group may not necessarily have done "less exercise" since the increased 
intensity may offset the decrease in adherence. 
Group versus Home-Based Exercise 
Several studies have examined the effects of group- vs. home-based exercise in 
regard to a variety of factors including exercise participation, adherence, fitness, and 
weight loss. Perri et al. (89) showed that when subjects were given an exercise 
prescription similar in type, intensity, duration and frequency, those randomly assigned to 
home-based exercise experienced significantly greater improvements in exercise 
participation, treatment adherence, and weight loss during the second 6 months of a 12-
month intervention than those assigned to group-based exercise. Moreover, although 
both groups significantly improved their fitness levels in response to the 30 minutes per 
day, 5 days per week exercise prescription, attrition was significantly lower in the home­
based program compared with the group program. 
King et al. (58) also compared the effectiveness of group- vs. home-based 
exercise among healthy older adults. In this study, subjects were randomly assigned to 
higher-_intensity, group-based exercise training; higher-intensity, home-based training; 
lower-intensity, home-based training; or a control group. Regarding adherence, subjects 
in both home-based programs reported significantly greater adherence than those in the 
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group-based program. In fact, those assigned to home-based exercise had greater 
adherence rates at each measurement period throughout the 12-month intervention. Thus, 
it appears that the flexibility and convenience of a home-based exercise program appears 
to affect adherence rates over the course of a long-term intervention. 
Stages of Change 
There is a trend in physical activity research to utilize psychological theories to 
provide a framework for understanding, predicting, and changing behavior (72). An 
individual's readiness to become physically active, which can be assessed using the 
stages of change model, is clearly an important determinant of successful participation in 
physical activity (72). The stages of change model developed by Prochaska and 
DiClemente (94) is one of two different trans-theoretical models that have assisted 
researchers who are interested in understanding and predicting changes in health-related 
behaviors such as smoking, weight control, and physical activity (73). In developing the 
stages of change model, Prochaska and DiClemente (94) suggested that individuals 
engaging in a new behavior, such as physical activity move in an orderly progression 
through the stages. Marcus et al. (73) describes these stages as they relate to physical 
activity. The Precontemplation stage describes an individual who is not engaged in the 
behavior of interest (i.e., exercise) and has no intention of becoming involved in that 
behavior in the future. The Contemplation stage describes an individual who is not 
engaged in the behavior of interest but is thinking about becoming involved in the 
behavior in the near future. The Action stage describes an individual who has initiated 
some behavior change (i.e., participation in occasional exercise). The Maintenance stage 
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describes an individual who is regularly engaging in the behavior of interest (i.e . ,  
participates in the recommended amount of exercise). Exercise researchers have 
recommended that this model be applied to exercise behavior, as the exercise field shifts 
from predictive to process models to better understand behavior change as it relates to 
physical activity (73). 
Physical Activity and Cardiovascular Disease 
Among the goals of virtually any exercise recommendation should be to 
maximize adherence while improving cardiovascular disease risk factors. · It is well 
known that cardiovascular disease is the leading cause of death in the United States 
among both men and women. In addition, it is also well established that physical activity 
is an important factor involved in the prevention and treatment of cardiovascular disease. 
Hypertension, hypercholesterolemia, diabetes, and obesity are among the most 
recognized risk factors for cardiovascular disease and physical activity is known to 
positively affect each of them. Several cross-sectional and longitudinal studies have 
documented the impact that leading a physically active lifestyle can have on altering each 
of these risk factors in addition to decreasing cardiovascular disease mortality. 
Hypertension 
Hypertension or high blood pressure is among the leading causes of 
cardiovascular disease, stroke, CVD mortality, heart failure, peripheral arterial disease, 
and renal insufficiency (90). Commonly defined as a systolic blood pressure (SBP) �140 
mm Hg and/or a diastolic blood pressure (DBP) �90 mm Hg or reported use of 
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antihypertensive medications, hypertension is estimated affect 29% of American adults 
(35). The prevalence of hypertension increases with age due to a loss of arterial 
compliance and is higher among men than women at younger ages, but the reverse 
appears to be true of older individuals (90). Despite the increased ability to detect and 
treat hypertension, the prevalence of this condition remains very high (51). In addition, 
hypertension appears to cluster with hypercholesterolemia, insulin resistance, glucose 
intolerance and obesity, occurring in isolation less than 20% of the time (51). The 
aforementioned risk factors further increase the severity of this condition with respect to 
the development of cardiovascular disease. 
Physical inactivity is generally associated with an increased risk for the 
development of hypertension (85, 97). Reaven et al. (97) documented a dose response 
inverse relationship between systolic and diastolic blood pressure and increasing levels of 
physical activity. According to the American College of Sports Medicine Position Stand 
entitled "Exercise and Hypertension", there is ample evidence to support the use of 
physical activity as a means to prevent, treat, and manage hypertension (90). This 
Position Stand recommends at least 30 minutes of continuous or intermittent moderate 
intensity endurance physical activity (40-<60% of VO2Reserve) supplemented with 
resistance training on most, preferably all days of the week (90) for those with 
hypertension. There are several longitudinal, cross-sectional and interventional studies to 
support the beneficial effects of physical activity on blood pressure. 
Blair et al. ( 12) conducted a study in which normotensive men and women (SBP 
::S140 mm Hg and DBP ::S90 mm Hg) ranging in age from 20-65 years, were followed for 
up to 12 years for the development of hypertension. It was found that those with low 
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levels of physical fitness, assessed by a maximal treadmill test, had a relative risk of 1.52 
for the development of hypertension compared with those who were highly fit. In this 
study, physical fitness was significantly associated with hypertension after adjusting for 
potential confounding factors such as age, BMI, sex, and baseline blood pressure. 
Similarly, Sawada et al. (103) showed that among Japanese males, the relative risk of 
developing hypertension was 1.9 times higher in the least fit compared with the most fit 
group even after adjusting for age, initial blood pressure, body fat, and other potential 
confounding variables. Although the mechanism responsible for the reduction in blood 
pressure associated with aerobic exercise is somewhat controversial, it may involve a 
reduction in sympathetic nervous system activity, thereby lowering resting heart rate, 
cardiac output and systolic blood pressure ( 4, 11 ). 
Moreau et al. (77) conducted a study in which 24 postmenopausal women with 
borderline to stage 1 hypertension (SBP 130-159 mm Hg and/or DBP 85-99 mm Hg) 
were randomized into either an exercise group or a control group for 24 weeks. Those in 
the exercise group were given an electronic pedometer and a target number of daily steps 
that would lead to a 3-km increase in daily walking which is consistent with the 
previously mentioned ACSM/CDC physical activity recommendation. After 12 weeks, . 
SBP decreased significantly from 142 to 136 mm Hg and was further reduced by 
5 mm Hg after 24 weeks in the exercise group who significantly increased daily walking 
by 4,300 steps while SBP and DBP remained unchanged in the control group who did not 
significantly change their walking volume. Diastolic blood pressure did not change 
significantly in either group over the course of the study. The authors did note that the 
reduction in blood pressure demonstrated in this study was unrelated to changes in body 
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mass, percent body fat, fasting plasma insulin, or dietary intake. Seals et al. ( I  07) also 
examined the effect of regular aerobic exercise for 12 weeks on blood pressure in high­
normal to stage 1 hypertensive, postmenopausal women. The aerobic exercise training 
consisted of walking at 50% of heart rate reserve (HRR) for 30 min·d- 1 , 3-4 days per 
week and progressed after about 2 ½ weeks to 40-45 min·d- 1 at 60-7Q% of HRR for 4-5 
days per week. After 12 weeks of exercise, SBP and DBP at rest decreased significantly 
by 10/7 and 12/5 mm Hg respectively in the sitting and standing positions. It was also 
noted that some decrease in blood pressure was observed in every subject and blood 
pressure changes occurred in the absence of changes in maximal aerobic capacity, body 
weight, or dietary intake. 
Iwane et al. (48) examined the effects of walking 10,000 steps/day or more on 
blood pressure in 30 mild essential hypertensive adult males. After 12 weeks, 
participants walked an average of 13,510 steps per day which lowered systolic blood 
pressure by 10 mm Hg suggesting that recommending 10,000 steps per day or more, 
without guidance on exercise intensity or duration was effective in lowering blood 
pressure in patients with mild essential hypertension. Similarly, Higashi et al. ( 40) 
assessed the impact of daily walking on blood pressure in Japanese men and women with 
essential hypertension. In response to 30 minutes per day of brisk walking, 5-7 times per 
week, participants lowered systolic blood pressure from 155 to 147 mm Hg and diastolic 
blood pressure from 96 to 92 mm Hg. Both these changes were significant decreases and 
were also significantly different from the inactive control group whose blood pressure 
remained essentially unchanged. 
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Several meta-analyses (53, 54, 106) have been conducted examining the impact of 
exercise training on blood pressure. Seals and Hagberg (106) conducted a meta-analysis 
examining the effect of exercise training on hypertension and found most studies report 
modest reductions in blood pressure ( <10 mm Hg) at rest and during submaximal 
exercise after training. Of the eleven studies reporting resting SBP and DBP values, 
seven showed a significant reduction in SBP and eight found a significant reduction in 
DBP. Among the eleven studies, the mean decrease in SBP was 9 mm Hg or 6% while 
DBP decreased by 7 mm Hg or 7% on average. However, it was noted that studies 
included in the analysis incorporated numerous methodological shortcomings and 
inadequate study design suggesting that interpretation of the findings should be done with 
caution. Kelley et al. (54) conducted a meta-analysis focus_ing specifically on walking 
and its effects on resting blood pressure and showed that systolic and diastolic blood 
pressures decreased significantly in response to walking interventions, independent of 
changes in body mass. Sixteen studies were included in this meta-analysis and training 
programs ranged in length from 4 to 52 weeks, frequency from 2 to 5 times per week, 
intensity from 45 to 86% of VOimax, and duration from 28 to 60 minutes. Interestingly, 
both systolic and diastolic blood pressure decreased about 2% in response to the 
intervention. However, some of the potential effects of walking on blood pressure may 
have been masked by the fact that several of the studies included in the meta-analysis 
examined the blood pressure response of normotensive individuals in response to 
exercise training. It is generally accepted that blood pressure changes following physical 
activity interventions are greatest in hypertensives and may be minimal in normotensive 
individuals (24, 52, 53, 79, 93). 
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Despite the fact that variations exist in regard to the degree that blood pressure 
changes in response to exercise training, it has been noted that even relatively small 
decreases in blood pressure can result in significant health improvements. Stamler et al . 
(114) estimated that a decrease of as little as 2 mm Hg in the average population SBP can 
reduce mortality from coronary heart disease, stroke, and all causes by 4, 6, and 3% 
respectively. Although differences exist in regard to the magnitude of blood pressure 
change in response to regular aerobic exercise, it is thought that the effects of exercise on 
blood pressure may be due differences in baseline blood pressures, demographic 
characteristics, characteristics of the training program, inadequate controls, and blood 
pressure assessment limitations (90). In regard to a gender comparison, meta-analytic 
studies limited to randomized controlled trials found no significant differences between 
resting blood pressure responses of normotensive and hypertensive men and women to 
endurance training (52, 53). 
Hyperlipidemia 
Elevated lipid and lipoprotein levels are known to be among the most significant 
risk factors for the development of cardiovascular disease. In addition, most efforts to 
improve lipid and lipoprotein profiles begin _with a multifaceted approach that includes 
increased levels of physical activity (28). Among the postulated benefits of physical 
activity in preventing heart disease is a favorable effect on blood lipids, particularly an 
increase in high-density lipoprotein cholesterol (HDL-C) (25, 26, 80, 82, 95, 105, 113). 
A review by Leon and Sanchez (67) presented evidence showing the relationship 
between physical activity and blood cholesterol levels from cross-sectional, longitudinal 
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epidemiologic observational, and experimental exercise training studies. Cross-sectional 
observational studies including both genders and all ages performing various aerobic 
activities have consistently shown what appears to be a positive dose-response 
association between the volume and intensity of aerobic activities and plasma HDL-C 
and an inverse relationship with triglyceride (TG) levels (67). Among endurance 
exercise training studies, the most commonly observed lipid change was an increase in 
HDL-C. It was also noted that aerobic exercise training helped to negate or attenuate the 
dietary-induced reduction in HDL-C, particularly in cases where substantial weight loss 
has occurred. Although significant reductions in total cholesterol (TC), low-density 
lipoprotein cholesterol (LDL-C), and TG occurred less frequently with exercise training 
than an increase in HDL-C, it was noted that men typically experienced greater 
reductions in TG than women in response to endurance exercise. 
To assess the impact of exercise intensity on lipid/lipoprotein changes, Duncan et 
al. (24) analyzed the effect of walking speed on cholesterol levels in 59 sedentary 
postmenopausal women. Participants were randomized into one of four treatment 
groups: aerobic walkers (8 kmh- 1 ), brisk walkers (6.4 kmH 1), strollers (4.8 k.m·h- 1 ), or 
sedentary controls. After 24 weeks of training, HDL-C increased significantly among the 
aerobic walkers and the strollers (6% increase in both groups), but not in the brisk 
walkers (4% increase) or controls (1 % increase). It was also noted that the TC:HDL ratio 
decreased significantly within the strollers (7% decrease) but not in any other group. 
Thus, this data suggests that vigorous exercise is not necessary for women to obtain 
significant improvements in blood lipid profile. Crouse et al. (18) also conducted a study 
examining the effect of exercise intensity on blood lipids. This study consisted of 26 
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hypercholesterolemic men who trained at either a high (80% V02max) or moderate (50% 
V02max) intensity, 3 days per week for durations calculated to result in 350 kcal of energy 
expenditure per session. After 24 weeks, training intensity did not significantly affect 
blood lipid profile when caloric expenditure was held constant. Suter et al . (1 18) 
compared the changes in lipid/lipoprotein levels in sedentary men in response to jogging 
or walking. Participants were randomized to one of two groups: jogging at 75% V02max, 
4 times per week for 30 minutes per session or walking at 50% V02max, 6 times per week 
for 30 minutes per session. After 6 months of exercise training, there were no significant 
differences in lipid/lipoprotein levels between the two groups. Although it is difficult to 
draw conclusions about the effect of exercise intensity on lipid/lipoproteins when other 
components of the exercise prescription vary, from the abovementioned studies, exercise 
intensity does not seem to affect lipid profile changes in men or women in response to 
aerobic exercise training. 
One question concerning the increase in HDL-C that may occur in response to 
exercise training is whether the increase is dependent upon changes in body weight. 
Higashi et al. ( 40) assessed the impact of daily aerobic exercise on lipoprotein levels in 
men and women. The aerobic exercise consisted of 30 minutes of brisk walking, 5-7 
times per week for 12 weeks. In this study, the exercise group noted significant 
improvements in both HDL-C and LDL-C, despite no change in body weight. However, 
there were no significant changes in TC or TG in response to the exercise intervention. 
No significant changes occurred in any of the lipoprotein values in the control group. 
Schwartz ( 105) determined the effect of dietary weight loss and aerobic training on HDL­
C in obese men. In this study, 26 participants were randomized to either a diet or aerobic 
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exercise group. The exercise consisted of a walk/jog program 3-5 days per week for 40 
minutes per day at 70-85% HRR. After 3 months, those in the diet group lost 
significantly more weight than those in the exercise group. In addition, TC, TG, and 
HDL-C improved significantly within the diet group while only the HDL-C improved 
significantly within the exercise group. However, in regard to the HDL-C subfractions, 
the more anti-atherogenic HDL2 subfraction increased significantly in the exercise group 
but not in the diet group. Thus, while diet and exercise can both impact HDL-C 
independent of body weight change, exercise appears to be more effective at increasing 
the more anti-atherogenic subfraction of HDL-C. 
Sopko et al. (113) designed a study to analyze the independent effects of exercise 
training and weight loss on blood lipids. Sedentary, obese men were stratified into one of 
four treatment groups: 1) inactive and constant weight (controls), 2) exercise training and 
constant weight, 3) inactive and weight loss, and 4) exercise training and weight loss. 
The exercise training consisted primarily of walking 5 days per week at a 5-10% grade 
with a total energy expenditure goal of 3 500 kcal/week. After 12 weeks, TC decreased in 
the exercise and weight loss group alone, LDL-C decreased only in the exercise and 
weight loss group while increasing in all other groups, and HDL-C increased 
significantly in all groups with the exception of the inactive and constant weight control 
group. Thus, both exercise training alone and dietary induced weight loss in obese men 
independently increased HDL-C similarly and the increase occurred independent of 
changes in body weight. 
Several studies that have examined the impact of walking alone on lipid and 
lipoprotein levels have reported conflicting results (24, 44, 62, 76, 81, 102, 117, 132). 
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Hinkelman and Nieman (44) examined the effects of walking five days per week for 45 
minutes per day at 62% V02max for 15 weeks in overweight women. Although the 
pattern of change in TG, TC, and LDL-C was not statistically different between the 
exercise and control groups, the interaction for HDL-C was significant with HDL-C 
actually increasing in the control group and decreasing slightly in the exercise group. 
The authors suggested that the surprising increase in HDL-C noted in the control group 
may have resulted from an increase in body weight. 
Santiago et al. ( 102) assessed the impact of 3 miles of brisk treadmill walking up 
a slight incline (5-7%) four times a week on blood lipid levels of sedentary women with a 
high baseline HDL-C. After 40 weeks, no significant change was noted in blood lipid 
variables despite a 22% increase in aerobic power. The authors concluded that the 
unchanged HDL-C following the walking intervention may be attributed to either a lack 
of change in body weight/percent body fat or to the favorable baseline blood lipoprotein 
values of the women in this study. 
Miyatake et al. (76) showed that daily walking can result in significant 
improvements in lipoprotein levels in obese Japanese males. Although subjects were 
instructed to walk 1000 steps more than their baseline steps per day value, the average 
increase in daily walking was over 1,800 steps per day more than their baseline value, 
which is roughly equivalent to an additional 1 mile of walking per day. After 12 months, 
in addition to a significant reduction in body weight, TC remained unchanged, TGa. 
decreased significantly and HDL-C increased significantly. Interestingly, both the 
average TG and HDL-C at baseline were within normal limits suggesting that lipoprotein 
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levels do not have to be abnormal initially to improve significantly in response to a 
regular exercise program. 
Woolf-May et al . (1 32) examined the efficacy of accumulated short vs. long bouts 
of brisk walking on blood lipid levels in men and women. Participants were allocated to 
one of four groups: long walkers (20-40 minutes/bout), intermediate walkers ( 1 0- 1 5  
minutes/bout), short walkers (5- 10  minutes/bouts), and a control group. All three 
walking groups were instructed to walk at an intensity equivalent to 70-75% V02max and 
all three groups performed the same total amount of walking for the duration of the study. 
After 1 8  weeks, all three walking groups showed similar improvements in fitness . 
However, only the long and intermediate walkers statistically decreased their LDL-C 
compared to the control group. No other significant changes in lipid/lipoprotein levels 
were noted. 
Nieman et al . (8 1 )  measured the impact of diet, exercise, and diet plus exercise on 
lipid and lipoprotein risk factors in moderately obese women. The exercise consisted of 
brisk walking for 45 minutes per day, 5 days per week at about 78% of maximal heart 
rate. Relative to the control group, TC and TG decreased significantly in both the diet 
and diet plus exercise groups, while LDL decreased significantly in the diet plus exercise 
group alone following the 1 2-week intervention. Although HDL changes were 
insignificant, HDL levels increased in the exercise group, decreased in the diet group and 
remained unchanged in the diet plus exercise group. The authors of this study noted that 
significant cholesterol improvements were most strongly related to weight loss. 
Kraus et al. (62) examined the impact of exercise intensity and frequency on 
changes in lipid/lipoprotein levels in sedentary overweight men and women. In this 
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study, participants were randomized into a high-amount, high intensity group; low­
amount, high-intensity group; low-amount, moderate intensity group; or a control group. 
Interestingly, subjects were encouraged to maintain their baseline body weight. After 
eight months, exercise training had no effect on the TC or LDL-C concentrations. 
However, HDL-C increased significantly in the high-amount, high-intensity group while 
increasing slightly in the low-amount, high intensity and low-amount, moderate intensity 
groups. Thus, it was concluded from this study that improvements in lipoproteins were 
related to the amount of activity and not to exercise intensity or the improvement in 
fitness. 
Sugiura et al. (117) also showed that daily walking can significantly improve 
lipoprotein levels in sedentary, middle-aged women. The women in the exercise group 
were asked to participate in a 90-minute physical education class consisting of walking, 
jogging, or rhythm dance at 40-60% ofVO2max once a week for 24 months in addition to 
increasing their steps per day by 2,000 to 3,000 more than their baseline average daily 
step count. Participants in the exercise group increased their daily steps from 6,800 to 
over 8,500 steps while the control group increased their daily step count from 5,700 to 
6,800 steps. In response to the intervention, TC, HDL-C, and the TC:HDL ratio 
improved significantly while all lipid/lipoprotein values remained unchanged in the 
control group. In addition, LDL-C also decreased nearly 20 mg/dL in the exercise group 
although this change was not significant. A multiple regression analysis showed that TC, 
HDL-C, and TC:HDL were significantly associated with daily steps, but were not 
associated with the modest change in BMI. Thus, the improvements in lipid profile in 
this study were attributed to the walking intervention and not the slight reduction in BMI. 
Kelley et al. (55) conducted a meta-analysis involving 25 randomized controlled 
studies that assessed the relationship between walking and lipid/lipoprotein levels. The 
studies assessed in this meta-analysis ranged in length from 10- 104 weeks, frequency 
from 3- 15 times per week, intensity from 50-86% V02max, duration from 10-75 minutes 
per session and compliance ( defined as the percentage of walking sessions attended) from 
50-100%. While all the changes in lipoproteins were in the direction favoring 
improvement, statistically significant changes were limited to LDL-C and TC:HDL. The 
average change for each lipid or lipoprotein level was as follows: TC (-3.4 mg/dL), HDL­
C (1.2 mg/dL), LDL-C (-5-5 mg/dL) and TG (.2 mg/dL). It was concluded that the lack 
of statistically significant improvements in TC, HDL-C, and TG may have to do with an 
actual lack of effect of walking on these factors and/or the generally acceptable mean 
baseline values of the subjects for these variables. 
In regard to a gender comparison, it has been suggested that women may be more 
resistant to physical activity induced changes in HDL-C and TG ( 44, 67). The most 
likely explanation for this is that women have higher initial HDL-C concentrations than 
men, thereby limiting the possibility of change (69). As with changes in blood pressure 
in response to an exercise regimen, differences in the extent of blood lipid changes in 
response to regular aerobic exercise and the differences in the magnitude of change 
between genders may be due to differences in baseline blood lipid/lipoprotein values and 
characteristics of the training program. 
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Obesity Epidemic 
In recent years, obesity has developed into a global epidemic. In 1998, the 
American Heart Association issued a Call to Action that reclassified obesity as a major, 
modifiable risk factor for coronary heart disease (27). In fact, the obesity epidemic may 
be progressing much faster than our understanding of the etiology and our ability to 
prevent and treat the disease (41). Recent evidence from the National Health and 
Nutrition Examination Survey (NHANES) indicates that the prevalence of overweight 
and obesity among adults in the United States is 64.5 and 30.5%, respectively (30). 
Compared with data from NHANES III (1988-1994), current NHANES data (1999-2000) 
showed that increases in the prevalence of overweight and obesity have been observed 
among males and females and across all ages and racial/ethnic groups (30). It has been 
estimated that by the year 2008, nearly 39% of the population will be considered obese 
(43). In regard to the risk associated with obesity, the Rand Institute recently reported 
that obese individuals have more overall health problems than smokers or drinkers (116). 
Overweight and Obesity 
In order to clarify the cause of weight change, it is necessary to understand the 
various energy balance equations. When energy intake is equal to energy expenditure, 
weight is maintained. In contrast when there is an imbalance between energy intake and 
energy expenditure, weight changes will likely occur. In consideration of the dynamic 
energy balance equation (122), if the rate of energy intake exceeds the rate of energy 
expenditure, a positive caloric balance results and consequently, weight gain occurs. In 
contrast, if the rate of energy expenditure exceeds the rate of energy intake, a negative 
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caloric balance results and therefore, weight loss occurs. Thus, from this information, it 
can be gathered that the two alternatives for promoting weight loss are to decrease the 
rate of energy intake and/ or increase the rate of energy expenditure. 
A meta-analysis by Miller et al. (75) examined the effectiveness of diet, exercise 
or diet plus exercise on weight loss and found diet and diet plus exercise to be more 
effective than exercise alone over the short-term. However, after one-year, diet plus 
exercise tended to be the superior program, although the weight lost maintained at one 
year did not significantly differ between the three conditions . Thus, it was concluded that 
while diet alone and diet plus exercise may be most beneficial over the short-term, an 
exercise component should be considered as part of the long-term intervention and/or 
follow-up. Similarly, Skender et al. (110) compared the effects of diet-only, exercise­
only and diet-plus-exercise on weight loss in 127 overweight men and women. The 
dietary intervention was adjusted to produce a weight loss of I kg/wk while the exercise 
component consisted of a home-based walking program, 3-5 days per week for up to 45 
minutes per session. In regard to intensity, subjects were instructed to walk at a level that 
felt "vigorous" but never "strenuous." Each of the three treatment conditions, which 
lasted I year, were accompanied by a total of 18 group instructional sessions that were 
conducted weekly for the first 12 weeks, followed by 3 biweekly sessions, followed by 3 
monthly sessions. After I year, there were no significant differences (p=.09) among the 
three groups. The diet-only group lost 6.8 kg, the exercise-only group lost 2.9 kg, and the 
diet plus-exercise-group lost 8.9 kg. One year after completing the treatment, the 
subjects were invited back for a follow-up examination. Interestingly, in the year 
following the intervention, only 6.7% of the diet-only group and 14.3% of the diet-plus-
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exercise group reported adhering "often" to dietary recommendations. In contrast, 44% 
of the exercise-only group reported exercising often during the year after treatment and 
74.3% of the exercise-only group considered exercise to be enjoyable. In regard to 
weight change after 2 years (1 year of intervention and 1 year of follow-up), the diet-only 
group was .9 kg above their baseline weight while the exercise-only and the diet-plus­
exercise groups were 2.7 and 2.2 kg below their baseline weights, respectively. 
Despite the fact that diet often produces more substantial weight loss than 
exercise over the short term, Ross et al. (99) demonstrated that diet-induced and exercise­
induced weight loss can be equivalent as long as the energy deficit is equal. In this study, 
obese men were randomly assigned to one of four groups: diet-induced weight loss, 
exercise-induced weight loss, exercise without weight loss or an inactive control group. 
Those in the diet-induced weight loss group were asked to reduce their isocaloric diet by 
700 kcal/day to achieve a weekly weight loss of 0.6 kg. To lose the same amount of 
weight, those in the exercise-induced weight loss group were asked to maintain their 
isocaloric diet while performing exercise that expended 700 kcal/day. Participants in the 
exercise without weight loss did the same amount of exercise each day as the exercise­
induced weight loss group but were told to consume enough calories to compensate for 
the energy expended during exercise (700 kcal/day). After 3 months, body weight 
decreased by 7 .5 kg in both weight loss groups while remaining unchanged in the 
exercise without weight loss and control groups. Thus, from this study it can be 
concluded that as long as the caloric deficit is equal, exercise and diet can result in an 
equally significant amount of weight loss. 
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The observation that dieting often produces greater weight loss than exercise over 
the short-term, and that exercise in combination with dieting often adds little to weight 
loss by dieting alone is not surprising (7 4 ). It is unrealistic to expect a sedentary person 
initiating an exercise program to achieve the same magnitude of energy deficit through 
exercise that could be achieved through an energy restricting diet (74). However, as a 
person trains, his/her ability to exercise for longer durations increases resulting in an 
increase in energy expenditure. An additional benefit of training is the ensuing increase 
in fat oxidation that may occur if training is of sufficient intensity and duration (7 4 ). 
The origin of obesity can be traced to a variety of causes including metabolic, 
genetic, behavioral, environmental, cultural and socioeconomic (1 28). Of these potential 
causes, behavioral and environmental factors appear to be the most impressionable. The 
current environment in the United States encourages consumption of energy and 
discourages energy expenditure (6, 42, 43). Thus, the solution to the obesity problem 
appears to lie in the identification of feasible ways or behaviors to cope with and to 
change the current environment (43). 
Walking 
Walking is the most common type of physical activity in the United States ( 1 27). 
It is the most natural form of activity and is the only sustained dynamic aerobic exercise 
common to everyone with the exception of the seriously disabled or very frail (78). 
Walking has the benefit of convenience, it may be accommodated in occupational and 
domestic routines and it is self-regulated in intensity, duration and frequency and, having 
a low ground impact; it is inherently safe (3 7, 78). 
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A recent study reported that approximately 34% of adults ages 18 and older 
participated in regular walking, defined as walking at least five times per week for at least 
30 minutes per session while an additional 46% reported walking occasionally, defined as 
walking for at least I O  minutes per time but did not meet the criteria for a regular walker 
(29). Walking is an activity that can be done independently as most adults prefer to walk 
on their own as opposed to in a supervised group setting (57). From a caloric expenditure 
standpoint, walking at any pace expends energy; about 4 kJ/kg of body weight for every 
kilometer walked (78). Thus, the cumulative effect of walking (like many other types of 
physical activity) has the potential to impact energy balance in a manner that may 
promote weight loss or weight maintenance. 
Walking is one of the few feasible exercise regimens in the treatment of 
overweight individuals because cardiovascular functional capacities are likely to be poor, 
and other exercise such as jogging and aerobics may be hazardous (78). Gwinup (34) 
suggested that walking would have to be recommended as the most practical form of 
exercise for obese subjects who wish to lose weight. The physiological. response during 
walking is determined by the intensity of the exercise in relation to the individual 's 
cardiovascular functional capacity (78). When walking at 4.8 km/hr (3.0 mph) on level 
ground, oxygen uptake is about 3.7 METs regardless of age, sex, or level of fitness. One 
MET is the energy requirement for resting. Therefore, the physiological stress of 
walking at this intensity is far less for an individual with a VO2max of I �.0 METs 
compared with an individual with a VO2max of 7.0 METs. 
Walking is familiar, convenient, safe, readily habit forming and it requires no 
special skills or equipment (45 , 78). The benefits of walking extend to improvements in 
physical, cognitive, and social function, all of which enhance the 'health-related quality 
of life' (98). While walking is generally considered to be a moderate intensity activity 
(93), physical activity on a high-intensity level is not always feasible for certain 
populations including the elderly, overweight, untrained, and individuals with 
cardiovascular disease (118). Thus, walking may be the ideal activity for such 
populations. Walking is a rhythmic, dynamic, aerobic activity of large skeletal muscles 
that confers the various benefits with minimal adverse effects. 
Walking and Weight Status 
Studies that have assessed the relationship between physical activity and body 
weight have generally reported that overweight people perform less physical activity. 
Chirico and Stunkard ( 1 7) showed that obese men and women walked significantly fewer 
miles per day than non-obese men and women. Similarly, Tyron et al. (126) reported a 
significant negative correlation between percentage overweight and physical activity. It 
was noted that as percentage overweight increased, physical activity reported as miles 
walked per hour decreased. Likewise, the prevalence of obesity has been shown to be 
lower in more active individuals. Tudor-Locke et al. (125) noted that the prevalence of 
obesity was only 10% among those taking more than 9,400 steps/day, compared to 40% 
among those taking less than 5,300 steps/day. Similarly, Thompson et al. (123) assessed 
the relationship between accumulated walking and body composition specifically in 
middle-aged women and noted significant negative correlations between steps per day 
and percent body fat (-.71), BMI (-.42), waist circumference (-.62), hip circumference 
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(-.28), and waist :hip ratio (-.65). In addition, when participants were stratified into 
activity tertiles, significant differences in body composition variables were noted among 
the activity groups. Although these studies demonstrate an association between physical 
activity and weight status/body composition, they are unable to establish a cause and 
effect relationship. However, whether a decrease in physical activity is a cause or an 
effect of obesity, inactivity contributes to a positive energy imbalance and thereby 
exacerbates the problem (126). 
Walking and Fitness 
Several studies have examined the relationship between walking and fitness (14, 
93, 102, 118). In 1994, Suter et al. (118) compared the effects of walking (50% V02max) 
and jogging (75% V02max) programs that elicited similar values for weekly energy 
expenditure in sedentary men. After 6 months of training, the walking and jogging 
groups increased V02max significantly by 2.5 and 2.9 ml/kg/min, respectively while the 
control group experienced a decrease in V02max by 1.2 ml/kg/min. The results of this 
study showed that the amount of training in terms of energy expenditure, which was 
about the same for both groups, rather than the intensity was the important criterion for 
improvement in cardiovascular fitness. 
Pollock et al. (93) assessed the effect of walking 4 times/week for approximately 
40 minutes for each training session for a total of 20 weeks on middle-aged men. 
Subjects in this study were encouraged to walk as far as possible in each 40-minute 
session. Walking distance increased from 2.5 miles during week 1 to 3.25 miles for the 
final 4 weeks of the study. As a result of training, V02max increased from 2.30 to 2.94 
L/min (28% increase), one-mile walk time decreased by over 1 ½ minutes ( 17% 
decrease), and heart rate response decreased significantly at each of the three stages of a 
standard treadmill walk and remained decreased up to 5 minutes into recovery, all factors 
indicating improved cardiovascular fitness. 
Lynch et al. (70) determined that visceral fat reduction following a weight loss 
intervention which included a reduced calorie diet and a walking program, was 
significantly related to improvements in V02max, The walking program in this 
intervention consisted 30-40 minutes of exercise, 3 days per week at a target heart rate of 
50-60% HRR. In comparing those that increased their aerobic fitness by an average of 
10% with those that showed no increase, those that increased their V02max experienced 
significant reductions in visceral adipose tissue area. 
In 1989, Blair et al. showed that significantly lower death rates may be related to 
moderate levels of physical fitness (14). In a prospective study involving over 3,000 
women and 10,000 men, there were significant differences in mortality between 
individuals in the least fit quintile and those in the next "moderately fit" quintile. The 
encouragement in this study lies in the fact that these differences in fitness represent a 
degree of improvement that should be achievable by brisk walking (13, 78). With an 
emphasis on the personal and public health gain associated with the shift from the 
inactive/unfit to the next higher level, walking is the ideal mode to serve the transition 
(87). 
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Physical Activity and Weight Management 
In 1999, Serdula et al. (108) reported that the prevalence those attempting to lose 
and maintain weight was 28 .8% and 35. 1 % among men and 43.6% and 34.4% among 
women, respectively. Several studies have examined the impact of regular walking on 
body composition variables. However, differences in exercise prescription, baseline 
characteristics, and measurement methods make direct comparisons among studies 
difficult. Nonetheless, it is possible to look at the effect of different components of the 
exercise prescription on changes in body composition. 
Continuous versus Intermittent Exercise 
The current ACSM/CDC physical activity recommendation suggests that 
accumulated physical activity (intermittent bouts of physical activity, as short as 8- 10 
minutes each, totaling 3 0 minutes or more) can provide equivalent health and fitness 
benefits as can continuous physical activity as long as the total amount of activity 
performed, expressed either in terms of caloric expenditure or minutes of activity, is the 
same (87). Several studies have examined the impact of continuous versus intermittent 
exercise on body weight change and have reported conflicting results. 
Donnelly et al. (23) investigated the effects of continuous vs. intermittent exercise 
on body composition in moderately obese females. Those randomized to the continuous 
group exercised for 30 minutes at 60-75% V02max, 3 times per week under direct 
supervision while those in the intermittent group were instructed to walk briskly, yet 
comfortably at approximately 50-65% HRR, 2 times per day, 15 minutes per session, 5 
days per week at their home or worksite. Although the volume of exercise differed 
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between the two groups with the continuous group expending 223 5 kJ per week 
compared to 3235 kJ per week in the intermittent group, only those in the continuous 
group noted significant reduction in body weight and percent body fat after 18 months. 
However, the fact that only the continuous group exercised under direct supervision may 
have influenced these results. 
Jakicic et al. (50) also examined the effects of continuous vs. intermittent 
exercise. In this study, the duration of exercise was set at 20 minutes per day for weeks 
1 -4, 30 minutes per day for weeks 5-8, and 40 minutes per day for weeks 9-20. 
Participants in the continuous group were told to walk the specified duration in one 
continuous bout while those in the intermittent group were told to perform the specified 
duration in multiple 10-minute bouts per day. Both groups were instructed to walk 5 
days per week at 70% of HRR. After 20 weeks, both body weight and BMI decreased 
significantly in both groups although the group by time interaction suggested that there 
was a trend for the intermittent group to have a greater magnitude of weight loss 
compared to the continuous group. This may be due to improved adherence as the 
intermittent group reported exercising significantly more days and for a greater total 
duration. 
Schmidt et al. ( 104) compared the effects of continuous versus intermittent 
exercise in overweight college aged females. Participants were assigned to one of four 
groups: a nonexercising control group, 30 minutes of continuous exercise group, 30 
minutes of accumulated exercise group (2, 15 minute bouts per day) and a second 30 
minutes of accumulated exercise group (3, 10 minute bouts per day). The exercising 
subjects participated in aerobic exercise training at 75% HRR, 3-5 days per week. In 
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addition, subjects were also asked to follow a self-monitored calorie restricted �iet (80% 
of resting energy expenditure) for the duration of the study. After 12 weeks, body 
weight, BMI, the sum of 7 skinfold sites, and the sum of 4 circumference measurements 
all decreased significantly in the three exercise groups while remaining unchanged in the 
control group. Unlike the findings of Jakicic et al. (50), exercise participation did not 
differ among the exercising groups with regard to the average number of days spent 
exercising per week. 
Murphy and Hardman (79) examined the effects of short and long bouts of 
physical activity in sedentary, middle-aged women. Participants in the short bouts group 
performed three 10-minute bouts of walking while those in the long bout group 
performed one 30-minute bout of walking. Both groups were instructed to walk briskly 
at 70-80% of their maximal heart rate, 5 days per week. In addition, subjects also agreed 
not to make any changes in their diet. After 10 weeks, body mass and waist 
circumference decreased significantly in the short bout group alone, while the sum of 4 
skinfolds decreased significantly in both exercise groups in comparison with the inactive 
control group. In this study, total time spent in brisk walking did not differ significantly 
between the two walking groups. 
Thus, although the data comparing continuous and intermittent exercise appear 
conflicting, three of the four studies mentioned suggest that exercise accumulated in 
bouts of at least 10 minutes each are at least as beneficial in reducing body weight as one 
· continuous bout as long as the total amount of activity performed is equal. However, it 
should be mentioned that although changes in body mass are noted in each study, 
changes in fat mass, which are more desirable, are not consistently reported. 
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Exercise Intensity and Weight Management 
Several studies have examined the effect of varying exercise intensities on body 
weight changes. Slenz et al. (111) compared eight months of varying amounts of 
exercise on body weight and body composition. In this study, sedentary, overweight men 
and women were randomized into one of four groups: a high amount/vigorous intensity 
group, a low amount/vigorous intensity group, a low amount/moderate intensity group, or 
an inactive control group. Despite being counseled to maintain baseline body weight, all 
three exercise groups lost a significant amount of body weight and fat mass compared 
with the inactive control group. In comparing those that did the same amount of exercise 
but at different intensities (low amount/moderate intensity vs. low amount/vigorous 
intensity), there was no significant difference in the decrease in body weight or fat mass. 
In fact, the authors noted that there were no variables for which the low-amount/vigorous 
intensity group was significantly better than the low-amount/moderate intensity group. 
Based on the fact that none of the four groups made any significant changes in mean 
caloric intake or in carbohydrate, fat, or protein intake, the changes noted are likely due 
to the increase in physical activity among these previously sedentary individuals. 
Suter et al. (118) compared the effects of walking vs. jogging on several body 
composition variables. In this study, sedentary, nonsmoking men were randomized into 
either a home-based unsupervised exercise program consisting of jogging at 75% V02max 
for 4 days per week for 30 minutes per day, walking at 50% V02max for 6 days per week 
for 30 minutes per day, or an inactive control group. After 6 months, there were no 
significant changes between either the joggers or walkers in body fat determined by 
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skinfold measurements or fat distribution as determined by waist:hip ratio. One likely 
explanation for a lack of change in body composition variables is that all three groups 
had a mean BMI of24.9 kg·m-2 suggesting that the groups were not overweight at the 
onset of the study. Interestingly, although there was no change in body fat on average in 
either exercising group, a significant association between the amount of training and a 
decrease in the sum of skinfolds and waist :hip ratio was observed only in the walkers. 
Similarly, Santiago et al. (101) compared the physiological responses of sedentary 
women to a conditioning program of walking or jogging. Participants consisted of 40 
slightly overweight, sedentary women randomized into either a walking group, jogging 
group or an inactive control group. The exercise prescription was standardized with 
respect to distance ( 4.8 km/session) and frequency ( 4 days/week). After 20 weeks, there 
were no significant changes in body weight, percentage of body fat, or the sum of five 
skinfolds for any of the three groups. As is the case in the Suter et al. study, there was no 
mention of a dietary analysis and thus, it is possible that in both studies, the walking and 
jogging groups had a compensatory increase in caloric intake that could have masked any 
potential changes in body weight that may have resulted from the increase in physical 
activity. 
A study by Duncan et al. (24) assessed the impact of the intensity of walking 
alone on body composition variables. Sedentary middle-aged women were randomized 
into one of four treatment groups: aerobic walkers (8 km/hr), brisk walkers (6.4 km/hr), 
strollers (4.8 km/hr) or sedentary controls. Each group was instructed to walk 4.8 km/day 
(3 miles), 5 days per week. Caloric intake, dietary fat, carbohydrate, and protein intake 
remained unchanged in all four groups over the course of the study. After 24 weeks, all 
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groups gained weight with the exception of the brisk walkers. The brisk walkers were the 
only group in which their change in body weight was significantly different from that of 
the control group. In regard to percent body fat, only the change among the strollers was 
significantly different from the controls. However, it is interesting to note that while 
none of the exercising groups lost body weight in response to the intervention, all three 
exercise groups decreased their body fat percentage on average while the control group 
increased their percent body fat. 
Likewise, Asikainen et al. ( 5) also looked at the effect of varying intensities of 
walking on body weight and body composition. In this study, sedentary, non-obese, 
postmenopausal women were randomized to one of five groups: walking at 55% V02max 
with a caloric goal of 1500 calories per week, walking at 45% V02max with a caloric goal 
of 1500 calories per week, walking at 55% V02max with a caloric goal of 1 000 calories 
per week, walking at 45% V02max with a caloric goal of 1000 calories per week, or an 
inactive control group. Each walking group was instructed to walk 5 days per week for 
24 weeks. In addition, while no significant differences were noted between body weight 
change in the walkers vs. the controls, there were significant differences between the 
walkers and the controls in respect to change in body fat percentage. Although there was 
no clear dose-response relation between exercise intensity, changes in body weight or fat 
weight, percent fat did decrease in each of the walking groups while increasing slightly in 
the control group, a finding similar to that of Duncan et al. (24). Thus, while walking did 
not produce a significant amount of weight loss in all three groups, it did limit the 
increase in percent fat that occurred in the control group. 
Although studies have made comparisons between the effects of walking at 
various intensities, it is difficult to weigh the impact of intensity alone when other 
variables of the exercise prescription such as frequency and duration vary. However, 
from the aforementioned studies that focused on walking alone, it appears that walking 
intensity does not significantly affect body weight or body composition changes. This is 
in agreement with Ball or and Keesey who have suggested that if weight regulation is the 
goal, it appears that walking pace is not as important as regularity and duration (6). In 
addition, Jakicic and Gallagher (49) noted that exercise prescribed at a relatively high 
intensity may increase the risk associated with exercise participation in sedentary, 
overweight adults, particularly when other cardiovascular disease risk factors are present. 
Walking and Weight Management 
In addition to the abovementioned studies that have looked at exercise of varying 
intensities in addition to continuous vs. intermittent exercise, other studies have examined 
the effect of walking for various durations and frequencies on body weight and body 
composition. However, the results from these studies are equivocal. Possible reasons for 
the lack of agreement may be due to the differences in subject characteristics, training 
protocols, and the durations of the interventions, which make it difficult to directly 
compare results between individual studies. 
In 1975, Gwinup (34) reported on the effect of exercise alone on the weight of 
obese women. In this study, eleven obese women progressively increased their amount 
of walking for one year or longer while on an ad libidum diet. Exercise time was divided 
into one, two, or occasionally three periods daily and subjects were advised to walk as 
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rapidly as could comfortably be tolerated. Weight loss over the I -year intervention 
averaged 10 kg and ranged from 4.5 to 17.3 kg. In general, the amount of weight loss 
paralleled the amount of exercise with the most active individuals losing the greatest 
amount of weight. Interestingly, it was noted that weight loss did not begin until walking 
exceeded 30 minutes daily, with the exception of two subjects who were somewhat active 
when they began the study. Thus, it was concluded that exercise alone can produce 
substantial and sustained weight loss in women who exercise for long durations on a 
daily basis. 
Moreau et al. (77) determined the impact of an increase in daily walking on body 
weight and body composition in postmenopausal women with borderline to stage 1 
hypertension. In being instructed to walk an additional 3 km per day, the women 
increased their daily walking from 5,400 steps/day to 9,700 steps/day. As a result, the 
women engaged in the walking intervention lost a statistically significant 1.3 kg of body 
mass after 24 weeks, despite the fact that body fat percentage remained essentially 
unchanged. 
Miyatake et al. (7 6) assessed the effect of daily walking on body composition in 
obese, Japanese men. In this study, participants were instructed to walk an additional 
1,000 steps per day above their baseline level. After 1 year, participants increased their 
daily walking significantly from 7,0 13 to 8,840 steps per day while reducing their caloric 
intake by a statistically insignificant 95 calories per day, which resulted in a significant 
reduction in body weight (-3.7 kg), body fat mass (-2.8 kg), waist circumference (-4 .6 
cm), hip circumference (- 1.6 cm), and body fat percentage (-2.5%). 
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Pollock et al . (93) determined the effect of a 20-week walking program of 
moderate- to high-intensity in sedentary middle-aged men. The training program 
consisted of walking 4 days/week for approximately 40 minutes per day. After the 20-
week intervention, body weight (-1.3 kg), percent body fat (-1.1%), abdominal (-0.7 in) 
and gluteal (-0.3 in) circumferences all decreased significantly. Percent body fat 
increased significantly in the control group while all other body composition and girth 
measurements remained unchanged. 
Leon et al. (66) examined the effects of a vigorous walking program on body 
composition of young, obese men. The walking program increased from one, 15-minute 
walk at 1.5 mph walk up a 10% grade each session for 5 days per week to three, 30-
minute walks at 3 .2 mph up a 10% grade each session for 5 days per week. After 16 
weeks, significant decreases were shown in body weight (-5.7 kg), BMI (- 1 .8 kg·m-2), and 
fat weight (-5.9 kg). In addition, significant decreases in 5 of the 7 skinfold 
measurements also occurred in response to 16 weeks of vigorous walking. 
A study by Parkkari et al. (86) assessed the impact of golfing 2-3 times per week 
on health outcomes in previously sedentary overweight, middle-aged men. It was found 
that low intensity walking equivalent to 15-20 km per week resulted in significant 
improvements in aerobic performance, body weight (-1.4 kg), waist circumference (-2.2 
cm), and abdominal skinfold thickness (-2.2 cm). 
Yamanouchi et al. (133) compared the effects of diet and diet plus exercise on 
insulin sensitivity and body weight in obese patients with non-insulin dependent diabetes 
mellitus. The diet consisted of a daily caloric intake equivalent to 1,000 kilocalories (54-
58% carbohydrates, 17-20% protein, and 25-26% fat) below their usual self-reported 
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intake. The diet plus exercise group was instructed to walk at least 1 0,000 steps/day. 
Over the course of the intervention the diet only group walked an average of 4,500 steps 
per day while the diet plus exercise group walked 1 9,200 steps/day. As a result, the diet 
plus exercise group lost significantly more body weight than the diet only group (7. 8  vs. 
4.2 kg). 
Hinkleman and Nieman ( 44) assessed the benefits of a walking program on body 
composition of overweight, sedentary women. The training program consisted of 
walking five days per week, for 45 minutes per day at an intensity equivalent to 62% 
V02max· After 1 5  weeks, there were no significant changes in body weight, body fat 
percentage, fat weight or lean weight in the walking group while body weight, fat weight, 
and lean weight all increased significantly in the inactive control group. Thus, while the 
walking intervention did not produce weight loss, it did help to prevent the weight gain 
( 1 .7 kg) that occurred in the control group. 
Similarly, Snyder et al . ( 1 1 2) found that a long-term, moderate intensity 
intermittent exercise program failed to improve body weight or body composition in 
overweight females . The intervention consisted of moderate intensity exercise 5 days per 
week for 30 minutes per day (3 , 1 0  minute bouts). After 32 weeks, body weight, percent 
body fat, and waist :hip ratio remained unchanged. Surprisingly, energy intake and 
nutrient composition estimated by 24-hour recall remained unchanged. Although body 
weight and body composition remained unchanged in the group as a whole, 7 of the 1 3  
participants experienced significant decreases in fat weight and waist:hip ratio while the 
remaining 6 subjects significantly increase fat weight over the course of the intervention. 
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Thus, it was suggested that among overweight, middle-aged females, there may be 
responders and non-responders to the same intervention. 
Swartz et al. ( 121) examined the impact of a I 0,000 step/day recommendation on 
glucose and insulin dynamics in overweight women. Subjects in this study increased 
their daily walking from 4,972 to 9,213 steps/day. Despite improvements in 2-hour 
plasma glucose levels and the area under the curve for glucose, body weight essentially 
remained unchanged, which is likely due to the relatively short duration of the study (8 
weeks). 
Gender Comparison 
Although several studies have assessed the impact of walking on body 
composition in men and women, very few have compared the gender effect in response to 
the same intervention. Although exercise has been shown to be an effective tool for 
weight management, its effects may be influenced by gender. A meta-analysis of 40 
studies by Bailor and Keesey provided evidence that males lost more body mass than 
females in response to run/walk exercise interventions ( 6). It was suggested that males 
participating in the studies were heavier and relatively more fat than the females resulting 
in increased energy expenditure per session which may have contributed to the greater 
body mass reduction observed in males. 
Kirk et al. (59) showed that both males and females significantly improved 
aerobic capacity in response to an exercise program of equal intensity and duration, but 
only the males lost a significant amount of body weight after the 16-month intervention. 
The exercise regimen progressed from 3 days per week for 30 minutes per session at 60% 
HRR for the first 4 months and was increased to 5 days per week for 4 5 minutes per 
session at 75% HRR and was maintained for the duration of the study. It was noted that 
energy intake was not restricted and remained unchanged throughout the duration of the 
study. After 9 months, males significantly decreased body weight (-5.3 kg) and fat 
weight (-5.0 kg) and maintained the weight loss throughout the remainder of the study. 
However, females did not significantly decrease their body weight or fat weight over the 
16-month intervention. Similarly, Snyder-Heelan et al. (1 12) found that only the males 
lost a significant amount of body weight in response to an exercise program with a goal 
energy expenditure of 420 kcal/session. In this study, moderately obese males and 
females were randomized to an exercise group (5 days per week for 45 minutes per 
session at 70-85% HRR) or an inactive control group. After 66 weeks, the males in the 
exercise group lost a significant amount of body weight (-5.1 kg) while the females in the 
exercise group increased body weight slightly (0.8 kg). Although this amount of exercise 
was not effective for weight loss in females, it did serve to limit weight gain that occurred 
in the female control group ( 4.e1 kg) over 66-week intervention. 
In 2003, Donnelly et al . (22) compared the long-term effects of supervised, 
moderate-intensity exercise on body weight and body composition in previously 
sedentary, overweight and moderately obese men and women. The training protocol 
consisted primarily of walking on a motor-driven treadmill 5 days per week and 
progressed in intensity from 60% of the HRR at baseline to 75% HRR at 6 months and 
duration from 20 minutes per session at baseline to 45 minutes per session at 6 months. 
The targeted minimum energy equivalent for exercise was approximately 400 kcal per 
session. After 16 months, the men averaged 668 kcal per exercise session and the women 
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averaged 439 kcal. In addition, the men experienced significant decreases in body weight 
(-5.2 kg), BMI (- 1 .6 kg/m-2), and fat mass (-4.9 kg) compared with men in the control 
group. Women who exercised maintained body weight, BMI, and fat mass while the 
women in the control group experienced significant increases in these three variables 
after 16 months. Although the women in this study did not lose weight, the exercise 
regimen did attenuate weight gain in the women who exercised compared with women in 
the control group. At 16 months, the women who exercised had significantly lower body 
weight, BMI, and fat mass compared with the controls. Interestingly, no significant 
differences were found either between or within groups across the 16-month intervention 
in total energy intake or macronutrient intake for men and women at any point in the 
study. It was concluded that 16 months of moderate-intensity exercise prevented weight 
gain in women and produced weight loss in men. Thus, it was suggested that 225 
minutes of moderate-intensity exercise per week may be a guideline for the amount of 
exercise necessary to prevent weight gain in young women and produce weight loss in 
young men. 
From studies directly comparing the male and female response to exercise 
training, it can be surmised that males are more likely to lose weight while females are 
more likely to maintain their weight following an exercise intervention. Interestingly, 
animal research supports these findings in that a gender specific response in regard to 
body mass and exercise training has consistently been noted with females conserving and 
males reducing body mass in response to exercise training ( 19, 83 ). 
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Summary 
Although the results regarding the effect that regular walking has on body 
composition are not in complete agreement, there is substantial evidence suggesting that 
that walking can positively influence body composition variables. As is the case with · 
changes in blood pressure and lipid/lipoprotein levels in response to a walking 
intervention, differences in baseline subject characteristics and training protocol likely 
contribute to some of the noted discrepancies. In addition, considering the impact that 
energy intake can have on body composition changes, the fact that several studies failed 
to account for this important factor makes it difficult to focus on physical activity alone 
as the factor influencing body composition changes. Nevertheless, there are plenty of 
reasons to believe that exercise can favorably alter body composition. Along with the 
increase in energy expenditure that accompanies physical activity, time spent exercising 
is also time spent away from food, which positively affects both sides of the energy 
balance equation. In addition to being a tool for promoting weight loss, walking can also 
be used as an activity to prevent weight regain following a physical activity intervention 
(3 1 ). In fact, data from the National Weight Control Registry has shown that the 
maintenance of exercise is one of the major factors associated with the maintenance of 
weight loss ( 60). 
It also well known that physical activity can affect variables other than body 
composition, blood pressure and blood cholesterol. It is generally agreed that increased 
physical activity can result in significant psychological benefits. Gwinup noted that 
although many of the subjects indicated that they did not enjoy the exercise periods, most 
were quite pleased about the results achieved and particularly about the general feeling of 
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wellbeing they experienced. They commented that weight loss through exercise, unlike 
that previously achieved through dieting, was not accompanied by feelings of weakness 
and increased nervousness, but rather by feelings of increased strength and relaxation 
(34). 
Given the vast potential for physical activity to alter a wide range of health related 
variables, it is essential to not only encourage the inactive to become more physically 
active but also to encourage those who are physically active to maintain it. It is important 
to note that regular exercise may elicit health benefits such as improved cardiorespiratory 
fitness (82), blood lipid profile (40), blood pressure ( 107), and blood sugar control ( 121), 
even in the absence of a weight reduction (130). As noted by Donnelly et al. (22) our 
challenge now is to develop means of achieving sustained increases in exercise ( or 
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Abstract 
Purpose: The purpose of this study was to determine the accuracy and reliability of the 
following electronic pedometers for measuring steps: Freestyle Pacer Pro (FR), Kenz 
Lifecorder (KZ), New Lifestyles NL-2000 (NL), Omron HJ-105 (OM), Oregon Scientific 
PE316CA (OR), Sportline 330 (SL330) and 345 (SL345), Walk4Life LS 2525 (WL), 
Yamax Skeletone EM-180 (SK), and the Yamax Digi-Walker SW-701 (DW). 
Methods: Ten males (34.7 ± 12.6 yrs), (meana± SD), and ten females (43.1 ± 19.9 yrs) 
ranging in BMI from 19.8 to 33.6 kg·m·2 walked 400-m around an outdoor track while 
wearing two pedometers of the same model (one on the right and left sides of the body) 
for each of ten models. Four pedometers of each model were assessed in this fashion. 
The actual steps taken were tallied by a researcher. Results : The KZ, NL, and DW were 
the most accurate in counting steps, displaying values that were within ± 3 % of the actual . 
steps taken, 95% of the time. The SL330 and OM were the least accurate, displaying 
values that were withina± 37% of the actual steps, 95% of the time. The reliability within 
a single model (Chronbach's alpha) was >0.80 for all pedometers with the exception of 
the SL330. The intra-model reliability was exceptionally high (>0.99) in the KZ, OM, 
NL, and the DW. Conclusion: Due to the variation that exists among models in regard 
to the internal mechanism and sensitivity, not all pedometers count steps accurately. 
Thus, it is important for researchers who use pedometers to assess physical activity to be 
aware of their accuracy and reliability. 
Key Words: steps, step counter, physical activity, motion sensor, walking 
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Introduction 
Prospective epidemiological studies support the belief that a physically active 
lifestyle can lower the risk of developing various chronic diseases such as coronary artery 
disease, Type 2 diabetes mellitus, hypertension, and obesity (1 ). With an emphasis on 
promoting a physically active lifestyle, numerous studies have examined the practicality 
and feasibility of using the pedometer as a tool for measuring physical activity levels 
( 10 , l  l , 17,22,23,28,29). Pedometers are devices that are typically worn at the waist and 
are capable of counting steps. Some models also calculate distance and estimate energy 
expenditure. Pedometers are a means of objectively measuring ubiquitous, ambulatory 
activity as well as many types of structured physical activities (24 ). 
The three main areas in which pedometer models may differ are cost, mechanism, 
and sensitivity of the device. There is considerable variation in the cost of a pedometer 
which can range anywhere from $10 to $200. Given the wide range of costs of various 
pedometers, a less expensive pedometer becomes an attractive option for those wanting 
to do large-scale studies. Thus, it would be of interest to determine if some of the less 
expensive pedometers are as accurate as some of the more costly versions. The internal 
mechanism is also a distinguishing point among the various brands and models of 
pedometers. There are three primary mechanisms by which pedometers function. The 
first type uses a spring-suspended horizontal lever arm that moves up and down in 
response to the hip's vertical accelerations. This movement opens and closes an 
electrical circuit; the lever arm makes an electrical contact (metal-on-metal contact) and a 
step is registered. The second type of mechanism is a magnetic reed proximity switch. 
With this mechanism, a magnet connected to a spring-suspended horizontal lever arm 
83 
within the pedometer moves up and down with each vertical acceleration of the hip. The 
magnetic field triggers a proximity switch encased in a glass cylinder and a step is 
counted. The third type uses an accelerometer-type mechanism consisting of a horizontal 
beam and a piezo-electric crystal. Pedometers using this particular mechanism can 
distinguish between differing intensities of exercise when estimating caloric expenditure. 
Finally, pedometers may also differ in their sensitivity, which is a function of the vertical 
acceleration "threshold" needed to trigger a step. Although this issue is related to the 
mechanism, the sensitivity of the internal mechanisms of different pedometers can vary 
as can the quality of the mechanism itself. 
In general, pedometers are most accurate in counting steps, less accurate in 
calculating distance, and even less accurate at estimating energy expenditure (2,4 ). Since 
steps are the most direct expression of what the pedometer actually measures (25), most 
researchers recommend reporting pedometer data as steps ( 4,25). A previous study 
conducted by Bassett et al. (2) assessed the accuracy of five electronic pedometers in 
measuring distance walked and steps taken on a sidewalk course and found that 
pedometers varied significantly in the pedometer-calculated distance over 4 .88 km. Due 
to the potential for such inaccuracies between pedometer models, it is essential that 
pedometers be tested for accuracy. 
In addition to the variation that exists between models, it is possible for 
discrepancies to exist within a particular pedometer model (intra-model reliability). 
Given the potential for differences in manufacturing tolerances and design specifications, 
it is conceivable for devices of the same model to differ significantly in steps counted. 
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Thus, it is evident that the reliability of pedometers within a particular model should be 
assessed. 
· Considering the fact that a great number of pedometer models have been 
introduced in recent years and that variability exists not only in the cost but also in the 
mechanism and sensitivity among pedometers, it would be beneficial to determine the 
accuracy of a variety of pedometers. In addition, the only multi-brand comparison was 
carried out in 1996 (2), and none of the pedometers that were assessed at that time are 
currently available. Therefore, the purpose of this study was to determine the accuracy 
and reliability of ten electronic pedometers for counting steps. 
Methods 
Pedometers 
Ten models of commercially available electronic pedometers were assessed in this 
study : Freestyle Pacer Pro (FR), Kenz Lifecorder (KZ), New Lifestyles NL-2000 (NL), 
Omron HJ-105 (OM), Oregon Scientific PE316CA (OR), Sportline 330 (SL330) and 345 
(SL345), Walk4Life LS 2525 (WL), Yamax Skeletone EM-180 (SK), and the Yamax 
Digi-Walker SW-701 (DW). Pedometer characteristics are presented in Table 1 .  
Subjects 
Ten male and ten female adults (22-69 yrs of age) volunteered to participate in the 
study. The procedures were reviewed and approved by the Institutional Review Board at 




$ 1 5  
$30 
Table 1 .  Pedometer characteristics 
Model Model Country of 
Manufng. 
Mechanism Features Approx. 
�Ost 
Freestyle Pacer Pro China M-M S, D, C $20 
Kenz Lifecorder Japan Accelerom. S,eC* $200 
New Lifestyles NL-2000 Japan Accelerom. S,eC* $50 
Omron HJ- 1 05 China Reed S,eD, C $27 
Oregon Scientific PE3e1 6CA China Reed S, D, C $20 
Sportline 330 Taiwan M-M s $ 1 3  
Sportline Taiwan M-M S, D, C 
Walk4Life LS 2525 Taiwan M-M S, D, C 
Yamax Skeletone Japan Reed s 
Yamax SW-70 1 Japan M-M S, D, C 
Mechanism: Metal-on-metal (M-M), Accelerometer (Accelerom.), Magnetic Reed 
Proximity Switch (MRPS) 
Features: Steps (S), Distance (D), Calories (C) 
* Indicates pedometers that estimate both gross and net caloric expenditure 
Approx. cost represents suggested retail cost ($) 
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Questionnaire (PAR-Q) (Appendix B) and signed a written informed consent (Appendix 
A) prior to participating in the study. Height was measured without shoes using a 
stadiometer and weight was also assessed without shoes in light clothing using a 
calibrated physician's  scale. In addition, each subject's stride length was determined 
prior to participation in the study. To determine stride length, subjects were asked to take 
20 strides at their normal walking pace on an outdoor track. The total distance was 
divided by 20, to calculate average stride length. Physical characteristics of the subjects 
are presented in Table 2. 
The subjects then took part in a series of walks around a 400-m outdoor track. 
Pedometer placement was standardized by placing it on the belt or waistband, in the mid­
line of the thigh, consistent with the manufacturers' recommendations. Pedometers with 
a variable sensitivity switch (OM, OR) were always placed in the middle setting. 
Devices of the same model were worn on both the right and left sides of the body while 
the subject walked a lap around the 400-m track. Then, two other devices of the same 
model were tested during a subsequent lap around the track to determine intra-model 
reliability. This procedure was repeated until 4 pedometers representing each of the 10 
models were tested. The actual steps taken were determined by a researcher using a 
hand-tally counter. The researcher walked behind the subject to avoid influencing the 
subject's pace. Each subject walked at his/her own normal walking speed and the 
amount of time it took to complete the lap was measured in order to calculate walking 
speed. The testing took place over the course of one to four days and the subjects wore 
the same pair of shoes for all trials. 
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Females 
Table 2. Physical characteristics of subjects 
. Males 
Age (yrs) 34.7±1 2.6 (22-55) 
Height (cm) 1 82.4±4,3 (1 75-1 88) 
Weight (kg) 92 .5±1 5 .0 (74 .5- 1 I 7.3) 
BMI (kg·m·2) 27.7±4,0 (22 .2-33 .6) 
Stride length (m) .79±,07 (.70-.90) 
Values are mean ± SD (range) 
BMI = Body Mass Index 
43 . 1±1 9.9 (22-69) 
1 65 .0±6 .6 (1 57.5- 1 78) 
69.3±1 2.5 (5 3 .2-90.9) 
25.5±4,9 ( 1 8 .6-32 . 1 )  
.7 1±.08 (.60-.85) 
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Statistical Analysis 
All analyses were performed using SPSS 1 1 .0. 1 for Windows (SPSS Inc., 
Chicago IL). For all analyses, an alpha of 0.05 was used to denote statistical 
significance. A 2-way repeated measures ANOV A (model x side) was used to assess 
differences between pedometers worn on the right and left sides of the body and to 
determine if significant differences existed between pedometer models. Paired t-tests 
were used to determine if the pedometer-estimated steps were significantly different from 
the actual steps taken. Cronbach's alpha was used to assess the intra-model reliability 
among pedometers of the same model. An alpha value of 0.80 was used to denote 
statistically significant intra-model reliability ( 12). 
Bland-Altman (5) plots were constructed to show the dispersion of the individual 
pedometer error scores around zero. This is a widely accepted technique to show the 
accuracy of biomedical devices (27). In this manner, the mean error score can be 
illustrated and the 95% prediction interval (i.e., 95% confidence interval for the 
individual observations) can also be shown. Individual error scores that have a tight 
prediction interval around zero signify a more accurate device. 
Results 
The average self-selected walking speed was 96.5 m-min- 1 and ranged from 77.3 
to 1 14.9 m-min-1 • There was no significant difference (P>0.05) between pedometers 
worn on the right and left sides of the body. However, there was a significant difference 
(P<0.05) among the 1 0  pedometer models. To determine accuracy, an error score (actual 
steps minus pedometer steps) was computed and compared to zero. Individual error 
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scores of zero would indicate that there was no difference between the estimated and 
actual steps taken, while negative scores represent overestimations and positive scores 
represent underestimations. Figure 1 displays the mean error scores between the actual 
steps taken and the pedometer-measured steps. The OR significantly overestimated the 
actual number of steps taken {P<0.05). The SL330 significantly underestimated the 
actual number of steps {P<0.05). The remaining pedometers had mean values that neither 
over- nor under-estimated the true number of steps taken. However, as we will show, 
three models {NL, DW, KZ) were clearly more accurate than the other models. 
Table 3 displays the mean error scores and the 95% prediction intervals. Figures 
2-4 show the Bland-Altman plots for various pedometer models. For convenience, theay­
axes are standardized to highlight the differences in accuracy between pedometers. The 
NL, DW, and KZ models were exceptionally accurate, having 95% prediction intervals 
that were within ± 17 steps (out of an average of 513) from zero. The WL, SK, SL345, 
FR, and OR were moderately accurate, having 95% prediction intervals that were within 
± 100 steps from zero. Finally, the OM and SL330 were the least accurate, having 95% 
prediction intervals that were within ± 1 88 steps from zero. 
As shown in Table 4, the intra-model reliability (among 4 pedometers of a single 
model) was >0.80 in all pedometers with the exception of the SL330. The intra-model 
reliability was exceptionally high (>0.99) in the KZ, OM, NL, and the DW. However, 




































































































































































Table 3 .  Error scores (Actual -Pedometer) in number of steps during a 400-m track 
walk at self-selected speeds.
Pedometer Mean SD 
FR 8.0 42 .6 
KZ -.2 1.5 
NL -.5 2.1 
OM 19.0 84.5 
OR -13 .3 * 27.6 
SL330 24.7* 70.5 
SL345 -6.0 37.2 
WL 2.6 40.0 
SK 4.8 31.5 
DW -.1 8.4 
SDe= Standard Deviation 
95% Prediction Interval 
(93.1, -77.2) 
(2.7, -3 .2) 








Negative scores correspond to overestimations and positive scores represent
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Figure 2. Representative Bland-Altman plot for the Yamax Digi-Walker SW-701 (DW) 
=which was one of the three most accurate pedometers. Solid horizontal line mean error 
score, dashed linesa= 95% prediction intervals (i.e., 95% Confidence Intervals of the 
individual observations). 
93 
- - - - - - - - - - - - -� - - - - - - - - - - - - - - -
- - - - - - - - -
300 
o ca 
D D D D D 


















DD D D 
- - - - - - - - - - - -� - - - - - - a 
- 1 00 D 
-200 
400 600 700 
(Actual Steps + Pedometer)/2 
Figure 3. Representative Bland-Altman plot for the Oregon Scientific PE3 16CA (OR) 
=which was among the four moderately accurate pedometers. Solid horizontal line mean 
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Figure 4. Representative Bland-Altman plot for the Sportline 330 (SL330) which was 
one of the two least accurate pedometers. Solid horizontal line = mean error score, 
dashed lines = 95% prediction intervals (i.e., 95% Confidence Intervals of the individual 
observations). 
Table 4. Intra-model reliability for each of the 10  different pedometer models. 
Pedometer 
Freestyle Pacer Pro 
Chronbach' s Alpha 
.90 
Kenz Lifecorder .998 
New Lifestyles NL-2000 .995 
Omron HJ- I 05 .991 
Oregon Scientific PE3 16CA .924 
Sportline 330 .76 
Sportline 345 .87 
Walk4Life LS2525 .885 
Y amasa Skeletone .935 
Yamax Digi-Walker SW-70 1 .992 
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Table 5 displays the mean difference in actual distance walked and the 
pedometer-calculated distance. Negative scores represent overestimations and positive 
scores indicate underestimations by the pedometer. There were significant differences 
(P<0.05) in five of the six pedometers that calculated distance, with the SL345 
approximating distance more closely than all other models. To determine accuracy in 
calculating distance, the estimated distance from the pedometer was subtracted from the 
actual distance walked and this difference score was compared to zero. 
Discussion 
. In the current study, eight of the ten pedometers tested yielded mean values that 
were not significantly different from the actual steps taken at self-selected walking 
speeds. However, the KZ, NL, and DW were the only pedometers accurate to withine± 
3% of the actual steps taken, 95% of the time. These three pedometers differed from the 
actual steps taken by less than 17 steps during a 400-m walk (totaling about 513 steps). 
Interestingly, these pedometers are all made in Japan, and they all met the Japanese 
Industrial Standard set by the Ministry of Industry and Trading regulations (7), which 
requires less than a three percent margin of error (3 steps out of 100). The intra-model 
reliability for the KZ, NL, and DW was also very high (>0.99), suggesting adequate 
quality control and tight manufacturing tolerances . These pedometers would appear to be 
suitable for use in research studies. 
Four of the other pedometers (WL, SK, SL345, FR) had moderate accuracy. 
They displayed values that were withine± 20% of the actual steps taken, 95% of the time. 





Table 5. Error scores (Actual 
Pedometer 
- Pedometer) in distance (m) during a 400-m track walk at 
Mean Std. Error 95% Confidence Intervals 
FR 29* 8 ( 11, 47) 
37* 16 (4, 70) 
75* 10 (55, 94) 
SL345 12 8 (-6, 30) 
WL 33* 8 ( 17, 50) 
DW 25* 6 (12, 37) 
Negative scores correspond to overestimations and positive scores represent 
underestimations of actual distance walked* P<0.05. 
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Three pedometer models were judged to be unacceptable under the conditions in which 
they were tested. The OR consistently tended to over-estimate the actual number of 
steps, possibly due to a high sensitivity for recording steps. As a result, the OR 
significantly over-estimated the mean number of steps (P<0.05). The SL330 and OM 
were the least accurate pedometers; they displayed values that were within ± 3 7% of the 
actual steps taken, 95% of the time. These two models predicted the actual steps to 
withina± 188 steps during a 400-m walk. Only the SL330 significantly under-estimated 
the mean number of steps taken. However, in both of these pedometers, there was a 
tendency to grossly underestimate steps, particularly in obese subjects (BMIa::::: 30 kg-m-2). 
Thus, these pedometers would be poor choices for use with obese individuals. 
There have been conflicting results regarding pedometer accuracy in obese 
individuals (BMI 2:30 kg·m-2). Shephard et al. (18) reported that the Sportline pedometer 
was less accurate in obese subjects compared with non-obese subjects as evidenced by 
greater mean absolute error scores in the obese. However, Swartz et al. (19) 
demonstrated that the Yamax SW-200 pedometer was accurate in lean, overweight, and 
obese subjects. Their results are consistent with those in the current study in showing 
that the Yamax SW-701 was accurate over a wide range of BMI's ( 18.6-33.6 kg·m-2). 
(These two models use the same internal mechanism for recording steps; they differ only 
in the functions that are displayed). Some other pedometers (OM and SL330) grossly 
underestimated steps taken by obese subjects. It should be noted, however, that the OM 
was accurate in individuals with both normal BMI's ( 18-24.9 kg·m-2) and those classified 
as overweight (25-29.9 kg-m-2). It is possible that in obese individuals, especially those 
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with a significant amount of abdominal fat, the angle of the pedometer when clipped to 
the belt or waistband compromises its ability to count steps accurately. 
Although the accuracy of pedometers for assessing distance was also examined, 
the results should be interpreted with caution. To calculate distance, the following 
formula is used : 
Distancea= steps x stride length 
Pedometer models differ in the precision with which stride length can be entered. For 
example, some pedometers allow the operator to input stride length to the nearest inch, 
while others only allow stride length to be input to the nearest 0.25 ft. Furthermore, only 
one stride length can be programmed into a pedometer, so if a subject changes his/her 
stride length after the calibration procedure, the distance estimated will be inaccurate. 
For most pedometers, distance was underestimated because the subjects had longer 
strides (and thus took fewer steps) during the 400-m track walk than in the 20-step 
calibration procedure. The SL345 was the only pedometer that did not significantly 
underestimate distance. However, this is because the SL345 overestimated the number of 
steps taken. Since most researchers choose to report pedometer data as steps, it would be 
inappropriate to conclude that the SL345 is the most accurate pedometer. 
Recent U.S. physical activity recommendations have encouraged Americans to 
accumulate at least 30 minutes of moderate physical activity on most, preferably all, days 
of the week (14,26). Dr. Hatano of Japan has proposed an alternative recommendation. 
He believes that taking I 0,000 steps per day would be effective for cardiovascular disease 
prevention (7). Hatano has found that increased ambulatory activity is associated with 
lower levels of blood pressure and subcutaneous fat (8). Hatano also estimated that a 60 
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kg Japanese male would expend at least 333 kcal/day in walking 10,000 steps per day. 
Previous research indicates that this amount (>2000 kcals/wk) appears to be protective 
against heart attacks (13). In addition, longitudinal studies have demonstrated that 
walking 10,000 steps per day results in improvements in cardiovascular disease risk 
factors in sedentary, at-risk populations (11,20). 
Electronic pedometers have gained widespread acceptance among physical 
activity researchers over the past decade (4) and the use of pedometers has become 
increasingly popular with the continued publicity of the 10,000 steps per day 
recommendation (9, 15). Thus, it is essential that the pedometer display accurate results. 
Wilde, et al. (28) showed that _by adding a 30-minute walk to their daily routine, subjects 
increased their step counts from 7,220 to 10,030 steps per day. This study indicates that 
for sedentary women, including a daily 30-minute walk in their schedule will generally 
allow them to meet both physical activity recommendations, suggesting that the two are 
roughly equivalent. However, pedometer accuracy can have a significant impact on the 
number of steps counted over the course of a day. A study conducted by Tudor-Locke et 
al. compared the Yamax SW-200 with the CSA model 7164 actigraph (a research grade 
accelerometer) and showed an 1,800 step/day difference between the two types of step 
counters (21 ). It was suggested that this difference is due to variations in the sensitivity 
of the two devices. Thus, since 1,800 steps may represent a relatively large portion of a 
person's daily step count and because it is possible for two step-counters to differ by this 
amount, it is essential that the pedometer accurately report steps taken. 
The electronic pedometer has limitations as a research tool ( 6) including its 
inability to provide information related to non-ambulatory activity (i.e., cycling, weight 
101 
training, and swimming). Neverthel�ss, it does have some distinguishing characteristics 
that make it useful as a motivational tool for promoting physical activity. First, the 
pedometer continuously monitors physical activity whether it is incidental or intentional. 
Studies have shown recall of ubiquitous, moderate activities ( e.g., walking) is less 
accurate than recall of structured, vigorous activities (3, 16). Thus, a device that is 
capable of continuously monitoring ambulatory activity would be beneficial for those 
interested in the assessment of physical activity. Second, the pedometer can serve as a 
feedback tool, providing immediate information on accumulated ambulatory activity and 
serving as a reminder to be physically active. While earlier criticisms of pedometers 
included their inability to store data ( 6), two of the pedometers assessed in this study, the 
NL and KZ pedometers are capable of storing up to 7 and 42 days worth of data, 
respectively, in one-day epochs. This makes these pedometers an appealing option for 
researchers who want to eliminate the potential bias of subjects recording their own data. 
This study is in agreement with the study conducted by Bassett et al. in 
demonstrating that considerable variation in accuracy exists among pedometers (2). 
Likewise, both studies indicated that a Yamax brand pedometer (DW-500 or SW-70 1 )  
was one of the best i n  regard to its accuracy and reliability. However, other pedometers 
that were unavailable at the time of the previous study have been shown to very accurate 
and reliable as well (NL and KZ). An ideal objective instrument is one that is low in 
·cost, easy to administer to large groups, unobtrusive to the subject, and accurate (6). 
While most pedometers displayed mean step scores that were not significantly different 
from the actual steps taken at self-selected walking speeds, some were distinctly better 
than ot�ers as indicated by individual error scores that had a tight prediction interval 
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around zero. Due to the variation that exists among pedometers in regard to the 
manufacturing specifications, mechanism and sensitivity of each device, not all 
pedometers count steps accurately. Thus, it is important for researchers who use 
pedometers to assess physical activity to know the accuracy and reliability of their 
instruments. 
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PARTeIV 
PEDOMETER MEASURES OF FREE-LIVING PHYSICAL ACTIVITY: 
COMPARISON OF 13 MODELS 
1 08 
Abstract 
Purpose : The purpose of this study was to compare the step values of multiple brands of 
pedometers over a 24-hour period. The following 13 electronic pedometers were 
assessed in the study: Accusplit Alliance 15o10 (AC), Freestyle Pacer Pro (FR), Colorado 
on the Move (CO), Kenz Lifecorder {KZ), New-Lifestyles NL-2000 (NL), Omron HJ-
I 05 (OM), Oregon Scientific PE3 16CA (OR), Sportline 330 (SL330) and 345 (SL345), 
Walk4Life LS 2525 (WL), Yamax Skeletone EM-180 (SK), Yamax Digi-Walker SW-
200 (YX200) and the Yamax Digi-Walker SW-70 1 (YX70 1). Methods: Ten males 
(39 .5 ± 16.6 yr), (mean ± SD), and ten females (43.3 ± 16.6 yr) ranging in BMI from 19 .8 
to 35 .4 kg·m·2 wore two pedometers for a 24-hour period. The criterion pedometer 
(YX200) was worn on the left side of the body and a comparison pedometer was worn on 
the right. Steps counted by each device were recorded at the end of the day for each of 
the thirteen pedometers. Results: Subjects took an average of 9,244 steps·d· 1 • The KZ, 
YX200, NL, YX70o1 and SL330 yielded mean values that were not significantly different 
from the criterion. The FR, AC, SK, CO, and SL345 significantly underestimated steps 
(P<0.05) and the WL, OM, and OR significantly overestimated steps (P<0.05) when 
compared to the criterion. In addition, some pedometers underestimated by 25% while 
others overestimated by 45%. Conclusion: The KZ, YX200, NL, and YX70o1 appear to 
be suitable for most research purposes. Given the potential for pedometers in physical 
activity research, it is necessary that there be consistency across studies in the 
measurement of "steps per day". 
Key Words: steps, step counter, 24-hours, motion sensor, walking 
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Introduction 
The objective quantification of physical activity is a challenge to those involved . 
in research and practice. Traditionally, physical activity has been assessed using 
questionnaires, but there are limitations in subjects' recall ability, especially for 
ubiquitous, light- or moderate-intensity activities (9). Thus, there has been interest in 
using objective monitors to record physical activity. 
Pedometers are a type of motion sensor that are low-cost, unobtrusive, accurate 
(1,4, 11), and their output (steps or distance) is easily comprehendible. Pedometers are 
typically worn on the belt or waistband and respond vertical accelerations of the hip 
during gait cycles. They provide data on steps and some models estimate distance 
traveled and energy expenditure. Although pedometers measure ambulatory activity, 
they do not capture all types of physical activity ( swimming, weight lifting, bicycling, 
etc.). Nevertheless, walking is one of the most common forms of activity and is readily 
captured by a pedometer. These devices are becoming increasingly popular in physical 
activity research on clinical interventions, community-wide interventions, surveillance, 
and international comparisons. A recent PubMed search revealed that the number of 
studies using pedometers nearly doubled (32 vs. 60) from 1993-1997 to 1998-2002. 
Pedometers have several practical applications. They can be used to: I )  
distinguish between individuals who vary based on steps·d-1 , 2) measure increases in 
physical activity with interventions, 3) conduct cross-study comparisons of different 
populations, 4) compare time trends in physical activity. In addition, members of the 
general public are interested in using pedometers to determine whether they are meeting 
step recommendations. However, if the differences in steps between pedometer brands 
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are large and a variety of brands are being used, then it becomes impossible to use 
pedometers for these purposes. 
Pedometer models differ in regard to cost ($10-200) and internal mechanisms. 
There are at least three basic types of mechanisms including the spring-suspended lever 
arm with metal-on-metal contact, magnetic reed proximity switch, and an accelerometer 
type ( 4, 1 1  ). The first mechanism uses a spring-suspended horizontal lever that moves up 
and down in response to the hip's vertical accelerations. This movement opens and 
closes an electrical circuit; the lever arm makes an electrical contact (metal-on-metal 
contact) and a step is registered. The second type of mechanism is a magnetic reed 
proximity switch. This type also uses a spring-suspended horizontal lever arm, however, 
with this mechanism a magnet is attached to the lever arm, and it is the magnetic field 
that causes two overlapping pieces of metal encased in a glass cylinder (magnetic reed 
proximity switch) to touch, resulting in a step being counted. The third type uses an 
accelerometer-type mechanism consisting of a horizontal beam and a piezo-electric 
crystal. The walking motion generates a sinusoidal curve when vertical acceleration is 
plotted against time. This mechanism uses zero crossings of the acceleration vs. time 
curve to detect steps. 
A second issue is sensitivity, which is related to the internal mechanism, and is a 
function of the vertical acceleration "threshold" needed to trigger a step. Previous studies 
(1,4, 1 1) have shown that these differences may translate into variations in accuracy 
among· pedometer models. Some models have been shown to be accurate over a fixed 
distance (1, 1 1) or at a variety of treadmill speeds ( 1,4) compared to direct observation of 
steps. However, no study has compared pedometer models under free-living conditions 
11 1 
over 24 hours. This is an important issue because pedometer output is often reported as 
"steps per day". 
One of the difficulties in assessing pedometer accuracy under free-living 
conditions is the lack of a "gold standard". Although pedometer accuracy can be 
assessed by counting steps in controlled laboratory experiments, it is not feasible to 
assess pedometer accuracy in this manner over 24 hours. Therefore, it was decided to use 
a single pedometer (Y amax SW-200) as the criterion. In controlled laboratory settings, · 
the Yamax SW series pedometers have been consistently shown to be one of the most 
accurate ( 4, 11 ). In addition, the Y amax pedometer is commonly used in applied research 
(7 ,8, 13 , 16). The purpose of this study was to compare the step values of multiple brands 
of pedometers over the course of a 24-hour period. 
Methods 
Pedometers 
The criterion pedometer selected for this study was the Yamax SW-200 (YX200). 
Th� SW series pedometer has performed very well in previous validation studies. The 
SW-701 (which has the same mechanism as the SW-200) consistently gave values within 
3% of actual steps taken during a self-paced walk, on an individual basis (10). Moreover, 
this pedometer gave mean step counts that were within 1 % of actual steps. At walking 
speeds ranging from 54 to 107 m-min· 1 , the SW-701 was the only one out of 10 models 
that did not differ significantly from actual steps taken ( 4). Finally the SW-200 
pedometer was found to have similar accuracy in normal weight, overweight, and 
moderately obese individuals (12). 
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Thirteen models of commercially available electronic pedometers were assessed 
in this study: Accusplit Alliance 1510 (AC), Freestyle Pacer Pro (FR), Colorado on the 
Move (CO), Kenz Lifecorder (KZ), New-Lifestyles NL-2000 (NL), Omron HJ-105 
(OM), C!regon Scientific PE316CA (OR), Sportline 330 (SL330) and 345 (SL345), 
Walk4Life LS 2525 (WL), Yamax Skeletone EM-180 (SK), Yamax Digi-Walker SW-
200 (YX200) and the Yamax Digi-Walker SW-701 (YX701). 
Participants 
Ten male (39 .5 ± 16.6 yr) and ten female adults (43 .3 ± 16.6 yr) ranging in BMI 
from 19.8 to 35.4 kg·m·2 volunteered to participate in the study. The procedures were 
reviewed and approved by the Institutional Review Board (IRB) at the University of 
Tennessee. Each subject completed a Physical Activity Readiness Questionnaire (PAR­
Q) (Appendix B) and signed a written informed consent (Appendix A) prior to 
participating in the study. Height was measured without shoes using a stadiometer and 
weight was also assessed without shoes in light clothing using a calibrated physician's 
scale. Physical characteristics of the participants are presented in Table 1. 
Protocol 
All participants wore the Yamax SW-200 (criterion) on the left side of the body 
and a comparison model on the right side for a 24-hour period, except when sleeping or 
showering. Each subject was tested over thirteen days, and the order of testing was 
randomized for the various pedometer models. (On one of these days the YX200 model 
was compared to a YX200 on the opposite side of the body to test for left vs . right side 
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(N=20) 
Table 1 .  Physical characteristics of participants. 
Men Women All Subjects 
Age (yr) 
(N=lO) (N=18) 






1 8 1 .6 ± 5 .6 
89.2 ± 1 7.3 
26.9 ± 4.6 
9525 ± 2349 
1 64.6 ± 7.3 
66.6 ± 8 .6 
24.6 ± 3 .2 
8963 ± 2466 
1 73 . 1  ± 1 0 .8 
77.9 ± 1 7.7 
25 .8 ± 4. 1 
9244 ± 3727 
Values are Mean ± Standard Deviation 
BMI = Body Mass Index 
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differences.) Previous studies using the same brand of pedometer have shown that there 
is no statistically significant difference between pedometers worn on the right and left 
sides of the body (1,4, 11 ). Among the 20 participants, five devices of each model were 
tested to provide a more representative sample. 
Pedometer placement was standardized by placing it on the belt or waistband, in 
the midline of the thigh, consistent with the manufacturers' recommendations. 
Pedometers with a variable sensitivity switch (OM, OR) were always placed in the 
middle setting. Subjects were instructed to put the pedometers on each morning and reset 
each device to zero, with the exception of two models (KZ, NL), which have internal 
clocks and reset on their own at midnight. Subjects then wore the pedometers over the 
course of the entire day and wrote the values down on a log sheet before going to bed 
each night. This procedure was repeated until all thirteen pedometers were compared to 
the criterion. The subjects were instructed not to wear the pedometers on Sundays due to 
the fact that significantly fewer steps are usually taken on Sundays compared with all 
other days of the week (2). 
Statistical Analysis 
All analyses were performed using SPSS 11.0.1 for Windows (SPSS, Inc., 
Chicago, IL). For all analyses, an alpha of 0.05 was used to denote st�tistical 
significance. A difference score ( comparison - criterion) was computed and compared to 
zero. Difference scores of zero would indicate that there was no difference between the 
criterion pedometer and the comparison pedometer. Positive difference scores represent 
overestimations and negative scores represent underestimations. A two-way repeated 
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measures ANOV A was used to determine if there was a significant difference between 
the mean difference scores of various pedometers and to determine if there was a 
significant difference in the mean difference scores between genders. Independent t-tests 
were used to determine if the comparison models were significantly different from the 
criterion. 
Bland-Altman (3) plots were constructed to show the distribution of the individual 
(criterioni- comparison) scores around zero. This is a standard method to show the 
accuracy of biomedical devices (18). In this manner, the mean difference (criterioni­
comparison) can be illustrated and the 95% prediction interval (i.e., 95% confidence 
interval for the individual observations) can also be shown. Pedometers that have a tight 
prediction interval around zero are more accurate. 
Results 
Subjects took an average of 9,244 steps·d- 1 according to the criterion pedometer. 
There was no significant interaction between pedometer model and gender and there were 
no significant gender differences (P>0.05). However, there were significant differences 
(P<0.05) among the 13 pedometer models. Figure 1 displays the mean difference scores 
expressed as a percentage of the steps counted by the criterion pedometer. Table 2 
displays mean difference scores, standard deviations, and 95% confidence intervals for 
each pedometer model. The FR, AC, SK, CO, SL345 significantly underestimated steps 
while the WL, OM and the OR significantly overestimated (P<0.05). Figures 2-4 show 


























































































































































































































































































Table 2. Difference scores ( comparison - criterion pedometer) in number of steps over a 
24-hour period. 
PEDOMETER MEAN SD 95% CI 95% PI 
*FR - 2445 2 1 57 -3454, - 1436 -6672, 1 782 
* AC - 2 1 89 2697 -345 1 ,  -926 -7475, 3098 
* SK - 1 1 61  2279 -2228, -94 -5629, 3307 
* co - 1042 2 1 46 -2407, -38 -5249, 3 1 64 
* SL345 - 997 1 872 -1 873 , - 1 2 1  -4666, 2673 
KZ - 703 1 537 - 1 422, 1 7  -37 1 6, 23 1 1 
YX200 # - 372 1 685 - 1 1 61 ,  4 1 7  -3675, 293 1 
NL 206 1 539 -5 14, 926 -2809, 3222 
YX701 426 1 547 -298, 1 1 49 -2606, 3457 
SL330 443 1 885 -439, 1 325 -325 1 ,  4 1 3 7  
WL t 1 099 1 833 241 ,  1 957 -2493, 4691 
OM t 2266 301 9  853,  3679 -3652, 8 1 83 
OR t 3636 2662 2390, 4882 - 1 583, 8854 
SD = Standard Deviation 
CI = Confidence Interval 
PI = Prediction Interval 
* Significantly lower than the criterion (P<0.05) 
t Significantly higher than the criterion (P<0.05) 
# This pedometer is also sold under the names Accusplit AE1 20 and Walk4Life LS2000 
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Figure 2. Representative Bland-Altman plot for the New Lifestyles NL-2000 (NL) which 
was one of the five most accurate pedometers. Solid horizontal line = mean error score, 
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Figure 3. Representative Bland-Altman plot for the Freestyle Pacer Pro (FR) which was 
among the five pedometers that significantly underestimated steps (P<0.05) compared 
with the criterion (P<0.05). Solid horizontal linea= mean error score, dashed linesa= 95% 
prediction intervals (i.e., 95% Confidence Intervals of the individual observations). 
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Figure 4. Representative Bland-Altman plot for the Oregon Scientific PE3 1 6CA (OR) 
which was one of three pedometers that significantly overestimated steps compared with 
=the criterion (P<0.05). Solid horizontal line = mean error score, dashed linese 95% 
prediction intervals (i.e., 95% Confidence Intervals of the individual observations). 
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appeared to overestimate steps to a greater extent at higher step counts. However, this 
was an isolated case as other models did not show this type of systematic error. 
Discussion 
In the current study, five (KZ, YX200 , NL, YX70 1, SL330) of the thirteen 
pedometers tested yielded mean values that were not significantly different from the 
criterion. Five (FR, AC, SK, CO, SL345) pedometers significantly underestimated steps 
and three (WL, OM, OR) significantly overestimated steps, compared to the criterion 
(YX200). 
The statistical power in the present study was adequate to detect a 10% difference 
among pedometer brands. This roughly coincided with what we considered to be a 
meaningful difference. For research purposes, we suggest using one of the models that 
did not significantly differ from the criterion. The pedometers that met this standard are 
the KZ, YX200, NL, YX70 1, and SL330. However, given the fact that statistical 
significance is a function of sample size (15), some emphasis should be placed on 
practical significance. Thus, we suggest that the CO and SL345, which were 
significantly different from the criterion but had mean values within 10% of the criterion 
would be suitable choices for physical activity promotion purposes. 
The following pedometer determined steps per day activity classifications have 
been proposed: <5,000 sedentary, 5000-7,499 inactive, 7500-9,999 somewhat active, 
�10,000 active (17). Having standardization among pedometer brands is necessary to 
ensure that such a classification scheme for activity status is meaningful. If a pedometer 
yields mean scores that are not within ±10% of the criterion, the risk of misclassification 
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increases, making it difficult to compare results across studies. In addition, given that the 
same pedometer model on the right and left hip can differ by 5%, this suggests that an 
acceptable difference of less than 10% may be too strict. It is important to note that an 
acceptable difference of 10% applies only to free-living conditions. Laboratory type 
validations must be held to a higher standard as suggested in previous publications ( 4, 11 ). 
Schneider et al. ( 11) previously showed that the KZ, NL, and YX701 were the 
most accurate pedometers at counting steps during a 400-m track walk at a self-selected 
pace. These three pedometers are all made in Japan and they all met the Japanese 
Industrial Standard set by the Ministry of Industry and Trading regulations ( 5) which 
requires less than a three percent margin of error (3 steps out of 100). Interestingly, these 
same three devices (KZ, NL, and YX701) were among the five pedometers that were not 
significantly different from the criterion (YX200) in the present study. 
Crouter et al. ( 4) also showed that the KZ, NL, and YX701 were among the most 
accurate pedometers at counting steps on the treadmill at speeds ranging from 54 to 107 
mmin-1 • These three pedometers, along with the WL, showed acceptable accuracy 
(recording at least 88% of actual steps) at a slow speed (54 mmin- 1 ) and thus were 
considered a good choice for research studies. In that study, these same three pedometers 
were among six that gave mean values within ±1 % of the actual steps taken at 80 mmin· 1 
and above. 
There are four plausible explanations for the step counting discrepancy that exists 
among pedometer models. First, models may differ in their vertical acceleration 
threshold required to trigger a step. This feature is related to the internal mechanism of 
the device, which has been described in a previous publication ( 1 1). Those devices that 
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are highly sensitive compared to the criterion model are prone to overestimate steps while 
those that are less sensitive would likely underestimate steps. The Yamax SW-200 
requires an acceleration :::0.35 g to register a step (16). Tudor-Locke et al. ( 16) compared 
a pedometer (YX200) and the CSA model 7164 accelerometer/step counter over a 24-
hour period and found a significant difference in mean step counts with the YX200 
counting 1,845 fewer steps per day than the CSA. This difference was attributed to the 
CSA' s lower vertical acceleration threshold required to record a step compared with the 
YX200 (0.30 g vs. 0.35 g). Although the lower threshold of the CSA makes it more 
likely to capture steps at slower walking speeds, it is also apt to detect non-ambulatory 
activity such as twisting, fidgeting, and bending as well as mechanical vibration ( e.g., 
motor vehicle travel) (7). Second, some pedometers (FR, AC, SL345) are programmed 
to only begin recording steps after four consecutive steps have been taken. For example, 
if an individual took just four steps and then stopped, the steps would not be counted. 
However, if he took five or more consecutive steps, each step would be counted (the first 
four steps do not appear on the output screen but the fifth step registers as _a five and 
every step is counted individually thereafter). This feature would logically result in an 
underestimation in steps when compared with a device that counts every step regardless 
of whether or not they were taken in succession. Third, some devices may be more 
accurate than others in overweight or obese subjects. In an individual with a significant 
amount of abdominal obesity, the pedometer may not be vertically aligned resulting in 
decreased accuracy (11) .  Finally, one device (OR) has been shown to frequently double­
count steps (1 1), which explains the overestimation in this study. 
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Previous studies have shown that waist-mounted pedometers gave mean values 
within ±12% at speedso� 80 mmin-1 (1 ,4) although they tend to underestimate steps taken 
at slower walking speeds. A gait laboratory study found that the self-selected walking 
speed of 200 healthy adults averaged 84 m·min- 1 (14). Taken together, this might lead 
one to conclude that most pedometers would yield fairly similar values (steps per day) in 
free-living adults. However, the present study found large mean error scores between 
pedometers, ranging from an underestimation of 25% to an overestimation of 45%, for 
24-hour data. This suggests that a large percentage of steps taken throughout the day 
might be accumulated at slower speeds or in light activity. For future studies, we 
recommend the selection of a pedometer model that compares closely with the criterion 
model used in the current study. This would help to ensure standardization of free-living 
pedometer data. 
Hatano (5) has proposed that taking 10,000 steps per day would be effective for 
cardiovascular disease prevention. He estimates that a 60 kg Japanese male would 
expend at least 333 kcal per day in walking 10,000 steps. Earlier research indicates that 
this amount (>2000 kcals per wk) appears to be protective against heart attacks (9). 
Alternatively, Hill has proposed that weight gain could be eliminated by some 
combination of increasing energy expenditure and decreasing energy intake by 100 kcal 
per day ( 6). He notes that energy expenditure can be increased by 100 kcal per day by 
walking an extra mile each day. Hill states that "Walking a mile, whether done all at 
once or divided up across the day, burns about 100 kcal, which would theoretically 
completely abolish the energy gap and hence weight gain for most of the population. A 
mile of walking for most people is only about 2,000 to 2,500 extra steps . . .  " (6). Whether 
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one's goal is to take 10,000 steps per day or to increase normal daily walking by 2,000 
steps per day, it is essential that the pedometer counts are standardized. In this study, 
there were several individual occasions where the comparison pedometer gave values that 
under or overestimated steps by 35 to 60%, respectively. These inconsistencies in 
pedometer-estimated steps would make it difficult to measure progress towards meeting 
various daily step goals. 
In conclusion, the present study shows that there are differences between models 
in pedometer measures of free-living physical activity. Five pedometers appear to give 
similar values for steps per day compared to the criterion (YX200). However, one of 
these (SL330) was shown to be unreliable in a previous study (11), and therefore cannot 
be recommended. The remaining four pedometers (KZ, YX200, NL, and YX701) seem 
to be suitable for applied physical activity research. In order to standardize results across 
studies, researchers should use one of these pedometers or demonstrate the equivalence 
of a different pedometer using a similar research design. Given the increasing use of 
pedometers in physical activity research, it is imperative that there be consistency across 
studies in the measurement of "steps per day". 
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PARTeV 
EFFECTS OF A 10,000 STEPS PER DAY GOAL 
IN OVERWEIGHT MEN VS. WOMEN 
1 30 
Abstract 
Purpose: The purpose of this study was to compare the effects of a 10,000 steps per day 
exercise prescription on body composition, cardiovascular risk factors and adherence in 
overweight men vs. women. Methods: 20 men (48 ± 6 yrs) (meane± SD) and 37 women 
(46 ± 8 yrs) who were overweight or obese participated in a 10,000 steps per day 
intervention. Body weight, body mass index (BMI), percent body fat, fat mass, fat-free 
mass, waist circumference, hip circumference, systolic blood pressure, diastolic blood 
pressure, and heart rate were determined at baseline, after 20 weeks and again after 36 
weeks. A blood lipid profile was assessed at baseline and after 36 weeks. Participants 
were not given any instruction regarding dietary intake. Results : 15 men and 24 women 
(68%) completed the 36-week intervention. In response to a 10,000 steps per day 
exercise prescription, they increased daily walking from 5,232 to 9,159 steps per day. 
Men and women experienced similarly significant improvements in body weight, BMI, 
percent body fat, fat mass, waist and hip circumferences, and HDL-C. When the effects 
of adherence to the exercise prescription were examined, the adherers significantly 
reduced body weight, BMI, percent body fat, fat mass, and waist and hip circumferences 
after 36 weeks, whereas the non-adherers experienced little or no change in these 
variables. Conclusion: The 10,000 steps per day exercise prescription was effective at 
producing weight loss in overweight, middle-aged men and women. These results 
suggest that this amount of activity is an effective strategy for weight management in this 
population. 
Key Words: intervention, pedometer, walking, weight loss, adherence 
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Introduction 
It is well established that obesity is a major public health problem in the United 
States and other developed countries. Current data indicate that the prevalence of 
overweight and obesity among U.S. adults is 65.7 and 30.6%, respectively ( 15). The 
prevalence of obesity has increased in males and females and across all ages from 
NHANES II ( 1976-1980), NHANES III (1988-1994) and the continuous NHANES 
(1999-2000) (10). Due to the negative health consequences associated with obesity (38) 
and the high annual healthcare costs associated with its treatment ( 5), it is essential to 
develop programs designed to prevent and treat this disease. 
Excess body weight and physical inactivity are risk factors for chronic disease and 
coronary heart disease mortality (20). It is likely that a decline in physical activity ( 12) 
resulting from labor-saving devices (27) has contributed to the obesity epidemic in the 
United States. Despite the abundance of literature supporting the health benefits 
associated with leading a physical activity lifestyle, 55% of Americans remain either 
inactive or insufficiently active ( 4 ). As a result, Healthy People 20 10 has placed physical 
activity among its leading health indicators which reflect the major public health 
concerns of the United States (52). However, debate exists regarding the amount of 
activity needed to provide optimal health benefits. This has led to the emergence of 
numerous exercise prescriptions and recommendations that encourage participation in 
various amounts of activity. 
Among the more popular is the 10,000 steps per day goal described by Hatano 
(14). It originated in Japan and it is becoming increasingly popular in the United States 
(16, 53). However, despite the popularity of this exercise prescription, few longitudinal 
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studies have attempted to determine the potential health benefits associated with doing 
this amount of activity (36, 48) and none have compared its effects on body weight and 
body composition in overweight men vs. women. In addition, it is not yet established 
whether 10,000 steps per day is a feasible goal for sedentary, overweight adults. 
It is well known that two aspects of energy balance can affect body weight: 
energy intake and energy expenditure. A reduction in energy intake is typically more 
effective than an increase in energy expenditure at producing short term ( <6 months) 
weight loss (19, 44, 34). However, obesity treatments utilizing a reduction in energy 
intake alone have poor long-term effects, as most dieters regain all of the weight loss 
within 2 to 3 years (25, 44). An increase in energy expenditure is another option for 
producing weight loss. Studies have shown that exercise interventions without dietary 
restriction can result in significant reductions in body weight (36, 39, 41) and this 
approach has been shown to be important in long-term maintenance of weight loss (24, 
44). 
Some studies have indicated that exercise-induced changes in body weight differ 
in men vs. women (7, 23, 46). Whether exercise is prescribed with a minimum level of 
energy expenditure per session or for a specific time and intensity, men often experience 
greater changes in body weight than women following an exercise intervention (7, 18, 23, 
46). One study found that 225 minutes of moderate-to-vigorous intensity exercise 
consisting of primarily walking was ineffective at producing weight loss in women, but 
resulted in a 5 .2 kg reduction in body weight in men after 16 months (8). Another study 
of similar length found that 2000 kcal of energy expenditure per week, although 
inadequate for weight loss in women, resulted in a 5 . 1  kg weight loss in men ( 46). 
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Interestingly, in both of these studies, women actually experienced slight, nonsignificant 
increases in body weight in response to the exercise intervention. 
Despite the presence of an apparent gender effect regarding exercise-induced 
weight loss, other studies have shown that exercise can be effective at producing a 
significant amount of weight loss in men (29, 39) and women (1 3, 36) in the absence of 
caloric restriction. However, given the potential for a gender effect in response to 
exercise along with the paucity of studies examining the 10,000 steps per day goal, it 
would be valuable to compare the responses of men and women to this popular exercise 
prescription. Therefore, the purpose of this study was to determine the effects of a 
1 0,000 steps per day exercise prescription on body composition, cardiovascular risk 
factors and adherence in overweight men vs. women. 
Methods 
Participants 
Fifty-seven sedentary, overweight or obese, middle-aged men and women 
between 30-55 years of age volunteered to participate in the study. Participants were not 
dieting for weight loss and were relatively weight stable (within 4% of their current body 
weight) for the three months prior to the intervention. Inclusion criteria for the 
participants were : age between 30-60 years, body mass index (BMI) between 
25-45 kgm·2, the ability to follow instructions and record data, and the ability to walk 1 
mile without pain or discomfort. The exclusion criteria were: history of myocardial 
infarction, angina, stroke, heart failure, or uncontrolled cardiac arrhythmias; resting blood 
pressure greater than 1 80 mm Hg systolic and 1 00 mm Hg diastolic; current cigarette 
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smoking; exercise exceeding 7,300 steps per day or 90 minutes of moderate intensity 
activity per week; currently taking weight loss medications or prescription medication 
that may impair physical performance. Volunteers were recruited by flyers posted in 
public buildings, newspaper advertisements, community presentations and word of 
mouth. Prior to their participation, the study was verbally explained, and each participant 
read and signed an informed consent form (Appendix C). The informed consent -form 
was approved by the University of Tennessee and the University of Tennessee Medical 
Center Institutional Review Boards and included sufficient information to ensure their 
knowledgeable consent. A health history questionnaire was completed by all participants 
prior to the study to screen for any contraindications to exercise (Appendix D). 
The intervention lasted 36 weeks. The two weeks prior to the intervention served 
as a baseline period and data from this phase were used to screen participants to confom 
that they were inactive (�7 ,300 steps per day). Participants were instructed not to 
change their normal activities during the two-week baseline period. All participants were 
given a waist-mounted Digi-Walker SW-200 electronic pedometer (Yamax, Inc., Tokyo, 
Japan) along with instructions on the proper use of the pedometer. The Digi-Walker SW 
series pedometers have consistently scored among the most accurate in previous 
validation studies (6, 42, 28) and are reported to have similar accuracy in normal weight, 
overweight and moderately obese individuals ( 4 7). Prior to the two-week baseline 
period, pedometer accuracy was verified by having each participant take 20 steps down a 




confinn pedometer accuracy. The participants were instructed to wear the pedometer 
each day during all waking hours, except when taking a shower or swimming. All 
participants were asked to record the number of steps per day along with the time the 
pedometer was put on and the time it was taken off. 
After the baseline period, preliminary measures were obtained. At this point, all 
participants were given a physical activity prescription that led up to a goal of 
accumulating at least 10,000 steps per day. The first week they were encouraged to take 
7,000 steps per day, the second week 8,000 steps per day, the third week 9,000 steps per 
day, and by the fourth week they were instructed to walk at least 10,000 steps per day. 
Protocol 
The study protocol required four visits to the laboratory. The first visit included 
an introduction to the study, reading and signing the infonned consent form; completing a 
health history questionnaire; and pedometer/activity log distribution and instruction. 
Participants were also given a three-day dietary record fonn and instructions for use 
(Appendix E). Each participant was asked to complete the dietary record during the 
week prior to the second visit. The second visit included anthropometric measurements 
(i.e., body composition, girth measurements, body weight and height); resting heart rate 
and blood pressure assessment; and a blood lipid profile. The third visit occurred 20 
weeks after the start of the intervention. Anthropometric measurements and resting heart 
rate and blood pressures measurements were repeated at this time point. A dietary record 
fonn with instructions was provided at the third visit and participants were asked to 
complete the record and return it for subsequent analysis. The fourth visit occurred at the 
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end of the 36-week intervention and included a repeat of all the preliminary 
measurements. A dietary record form was mailed out two weeks prior to the fourth visit 
with instructions for completion. Blood samples were drawn at the outpatient laboratory 
at the University of Tennessee Medical Center and analyzed for �lood lipid content by 
Dynacare Tennessee (Knoxville, 1N). All other laboratory measurements were made in 
the Applied Physiology Laboratory at the University of Tennessee. 
Resting Heart Rate and Blood Pressure 
Each participant was asked to sit quietly for five to ten minutes after which resting 
heart rate and blood pressure was measured. Heart rate was taken at the radial pulse for 
15 seconds and then multiplied by four to determine beats per minute. The heart rate was 
taken in triplicate. Blood pressure was measured by the same investigator using a 
sphygmomanometer and a stethoscope in accordance with the guidelines provided by the 
American Society of Hypertension (1  ). The average of the two closest heart rate and 
blood pressure measurements served as the resting values. 
Blood Lipid Profile 
A 1 O ml blood sample was collected from the antecubital vein following a 12  hour 
overnight fast. Following centrifugation, the serum was removed and analyzed by the 
colorimetric method (2 reagent format) using the Abbott Aeroset chemistry analyzer 
(Abbott Laboratories, Abbot Park, IL). Controls were run daily for all tests and used to 
verify system performance and to monitor accuracy and precision. 
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Anthropometric Measures 
Anthropometric measures included body composition, girth, weight, and height. 
Body composition was assessed using whole body plethysmography (BOD POD ® Body 
Composition System, Life Measurement Instruments, Concord, CA). The BOD POD 
utilizes the inverse relationship between volume and pressure to determine body volume, 
which is then used to calculate body density. Using the Siri equation (43), body density 
was used to calculate percent body fat. The primary advantage of the BOD POD is that it 
determines body density based on air displacement rather than on water immersion and is 
therefore, simpler and quicker than hydrostatic weighing (33). In addition, studies have 
shown that BOD POD estimates of body composition are not significantly different from 
those determined by hydrostatic weighing, which is a widely accepted criterion method 
(32). The participants sat inside a sealed chamber wearing a lycra/nylon swimsuit and 
swim cap. Body volume was corrected for thoracic gas volume using a prediction 
equation based on age, gender, and height (33). Girth measurements were assessed at the 
waist (narrowest part of the torso) and the hips (maximal circumference at the buttocks 
above the gluteal fold) in accordance with the Anthropometric Standardization Reference 
Manual by Lohman, Roche, and Martorell (3). Body weight (kg) was measured using a 
calibrated physician's scale (Health-o-meter, Bridgeview, IL), and height (cm) was 
measured using a stadiometer (Seca Corp., Columbia, MD), also in accordance with 
standard practices (11 ). Every attempt was made to measure body weight at 
approximately the same time of day each time subjects were tested. 
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Physical Activity Log 
During the screening and intervention periods, participants were instructed to 
record the time the pedometer was put on, the time it was taken off, and the total number 
of daily steps in a physical activity log each day. Physical activity logs were returned to 
the Principal Investigator every other week either by fax or mail. 
Dietary Assessment 
All participants completed a three-day dietary record at baseline, 20 weeks, and 
36 weeks. The dietary record was explained to each participant in detail including how to 
properly describe the food item, the amount eaten, and how it was prepared. All items 
consumed within the three-day period were recorded by the participant and analyzed 
using Nutritionist Pro software (First Data Bank Inc., San Bruno, CA). Analyses were 
examined to determine if the participants changed their dietary habits over the 
intervention period. 
Investigator/Participant Contact 
Participants were asked to attend an informational session every other week for 
the first two months and then monthly thereafter. The purpose of the informational 
session was to confirm that the participant was completing the task asked of them, to 
address any questions or comments the participant may have had, and to provide an 
educational session on a variety of topics. Participants were also given pamphlets 
(HealthPartners, Inc. Minneapolis, MN) that included a description of the health benefits 
of walking, motivational tips, and ideas for accumulating steps. Participants were 
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encouraged to contact the Principal Investigator by phone or e-mail with questions or 
comments regarding the walking program. 
Data Analysis 
An on-treatment analysis was performed on all participants who completed the 
intervention, irrespective of adherence. In clinical settings, the on-treatment analysis is 
used to assess change in health variables in response to being given a behavioral or 
pharmaceutical prescription. In addition, to determine the physiological efficacy of 
taking 10,000 steps per day, a separate analysis was also performed on those participants 
who successfully adhered to the exercise prescription. In order to maintain clear 
separation of those who adhered to the exercise prescription and those who did not, 
acceptable adherence was defined as taking an average of 9,500 steps per day or more 
from week 4 to week 36. Most studies assessing this variable typically define acceptable 
adherence as attending a large percentage of the exercise sessions (26). 
All statistical analyses were performed using SPSS 1 1.5 for Windows (SPSS Inc., 
Chicago IL). For all analyses, an alpha of 0.05 was used to denote statistical 
significance. Independent samples t-tests were used to compare the baseline 
characteristics between genders. Repeated mea�ures analyses of variance (ANOVA's) 
were used to compare the effects of gender and adherence on body weight, body 
composition, girth measurements, blood pressure, heart rate, and blood lipid profile in 
response to taking 10,000 steps per day for 36 weeks. Correlational analyses were used 
to assess relationships between the change in daily step counts (steps·d- 1) and the changes 
in dependent variables. Paired t-tests were used to assess changes within groups over the 
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course of the intervention. A 2 x 2 Chi-Square analysis was used to assess adherence to 
the intervention. 
Results 
One hundred nineteen individuals met the initial criteria based on a telephone 
interview. Of these, 57 participants (20 men, 37 women) met all study criteria and 
initiated the intervention and 39 (15 men, 24 women) participated for the duration of the 
study (Figure 1 ). Among the 3 9 participants who completed the study, 10 men and 
10 women were able to adhere to the exercise prescription defined a priori as averaging 
9,500 steps per day or more. Participants wore the pedometer for more than 15 hours per 
day on average over the course of the intervention. The baseline characteristics of the 
participants who completed the first half of the study are presented in Table 1 .  
Significant baseline differences between men and women were found for height, percent 
body fat, fat mass, fat-free mass, hip circumference, and HDL-C. A chi-square analysis 
showed that adherence to the exercise prescription was not significantly different 
between men and women. 
Analyses of variance (ANOVA's) were used to examine the effect of gender and 
adherence over time. Due to the absence of any significant 3-way interactions (gender x 
adherence x time), separate models were run to look at the effects of gender (gender x 
time) and adherence ( adherence x time) in response to the intervention. For both men 
and women, significant improvements were noted for body weight, BMI, percent body 
fat, fat mass, waist circumference, hip circumference, and HDL-C (Tables 2 and 3). 
14 1 
57 met initial criteria and 
initiated the intervention 
20emen 37ewomen 
17 men participated through 25 women participated through 
first 20 weeks first 20 weeks 
JJ 
15 men completed the 24 women completed the 
36-week intervention 36-week intervention 
10 adhered to the 10 adhered to the 
exercise prescription exercise prescription 
(2:9,500 steps·d- 1) (2:9,500 steps·d- 1) 
Figure 1. Participation Flowchart. 
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=Table 1 .  Baseline characteristics of men (ne l 7) and women (n=25) who 
completed at least 20 weeks. 
Variable Men Women 
Age, yrs 45 ± 7 47 ± 6 
Steps·d- 1 5218 ± 1484 5276 ± 1089 
Height, cm* 178.7 ± 6.6 166.5 ± 5.9 
Weight, kg 105.4 ± 19.3 94.9 ± 16. l 
BMI, kg·m·2 32.9 ± 5.0 34.2 ± 5.0 
Body fat,e%* 34.8 ± 6.5 48.3 ± 5.2 
Fat mass, kg* 37.7 ± 13 .2 46.4 ± 1 1 .9 
Fat-free mass, kg* 68.0 ± 7.9 48 .6 ± 6.3 
Waist Circumference, cm 108.6 ± IO . I  102 .6 ± 12 .8 
Hip Circumference, cm* 1 13 .0 ± 10.5 123 . 1 e±e13 ,3 
SBP,emmeHg 127 ± 12 12 1 ± 12 
DBP,emmeHg 85 ± 5  83 ± 7  
HR, beats·min·1 70 ± 10 73 ± 1 1  
TC, mg·dr 1 182 ± 34 19 1 ± 3 1  
Triglycerides, mg·dr
1 147 ± 56 122 ± 64 
HDL-C, mg·dr1 * 39e± 9  54 ± 14 
LDL-C, mg·dr 1 1 1 3 ± 30 1 13 ± 26 
Data are given as meane± SD. 
* Significant difference between men and women (P<0.05)
M (Men), W (Women), BMI (body mass index), SBP (systolic blood pressure), 
DBP ( diastolic blood pressure), HR (heart rate), TC (total cholesterol), 
HDL-C (high-density lipoprotein), LDL-C (low-density lipoprotein) 
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Table 2. Dependent variables measured at baseline, 20 weeks, and 36 weeks for 
men (n= l 5) and women (n=24) who completed the intervention. 
Variable Gender Baseline 
Weight Men 106.8 ± 1 9.2 
(kg) Women 94.3 ± 1 6 . 1  
Total 99. 1 + 1 8.2a 
BMI Men 33 . 1  ± 5. 1 
(kg·m-2) Women 33 .9 ± 4.9 
Total 33 .6 + 4.9a 
Body fat Men 34.8 ± 6.4 
(%) Women 48. 1 ± 5.2 
Total 42.9 + 8.6a 
Fat mass Men 38 . 1  ± 1 3 .2 
(kg) Women 45.9 ± 1 1 .9 
Total 42 .9 + 12 .9a 
Fat-free mass Men 69.0 ± 7.7 
(kg) Women 48.5 ± 6.4 
Total 56.6 + 12 .2a 
Waist Circ. Men 109.2 ± 10  
(cm) Women 1 02.5 ± 1 3 . 1  
Total 1 05.2 + 1 2.3a 
Hip Circ. Men 1 1 3 .8 ± 1 0.6 
(cm) Women 1 22.7 ± 1 3 .4 
Total 1 1 9.2 + 1 3 .0a 
SBP Men 127 ± 1 2  
(mm Hg) Women 120 ± 1 2  
Total 123 + 1 2  
DBP Men 85 ± 5 
(mm Hg) Women 83 ± 7  
Total 84 + 7  
HR Men 70 ± 9  
(beats·min · 1) Women 73 ± 1 1  
Total 72 + 10  
20 weeks 
1 03.4 ± 19.6 
92.8 + 1 5 .2 
96.8 + 1 7.5b 
3 1 .9 ± 5 .0 
33 .4 + 4.7 
32.8 +4.8b 
32.6 ± 6.7 
46.3 + 5 .6 
4 1 . 1  +9.0b 
34.8 ± 1 3 .6 
43 .5 + 1 0.8  
40.2 + 1 2.5b 
69.0 ± 7.7 
49.6 + 6.9 -
b56.9 + 1 1  .9 
1 06.2 ± 1 0.5 
1 0 1 .5 + 1 3 . 1  
1 03 .3 + 12 .3b 
1 1 0.7 ± 1 0.3 
120.4 + 1 2.9 
1 1 6.7 + 1 2.8b 
123 ± 1 2  
1 25 ± 1 4  
124 + 1 3  
84 ± 5  
82 ± 8  
83 + 7  
71  ± 1 0  
73 ± 1 1  
73 + 1 1  
36 weeks 
1 02.6 ± 20.6 
92.6 + 1 5 . 1  
96 .4 + 1 7.8b 
3 1 .6 ± 5 .3 
33 .3 + 4 .6 
32 .7 +4.9b 
3 1 .7 ± 7.2 
46.7 + 5 .2 
4 1 .0 +9.4b 
33 .8 ± 1 3 .9 
43.9 + 10.8 
40. 1 + 1 2 .9b 
69.2 ± 8.0 
49 .2 + 6.4* 
56.8 +1 2 . 1  ab 
1 06.4 ± 1 2.3 
1 0 1  .0 + 1 2. 1  
1 03 . 1  + 1 2.4b 
1 1 1  . 1  ± 1 2.6 
1 20.7 + 1 2.9 
1 1 7. 1 + 1 3 .Sb 
1 26 ± 1 5  
1 1  9 ±  1 4  
122 + 1 4  
82  ± 6  
82 ± 9  
82 + 8 
7 1  ± 1 1  
72 ± 9  
72 + 1 0  
Values with different superscripts indicate significant differences within groups 
(P<0.05). Pairwise comparisons were done only on total values. 
*Indicates a significant difference in the way men and women responded over the 
course of the intervention. 
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Table 3. Blood lipid profiles measured at baseline and 36 weeks 
for men (n=13) and women (n=23) who completed the intervention. 






181 ± 36 
190 ± 31 
187 + 33 
174 ± 38 
193 ± 29 
186 + 33 
Triglycerides




140 ± 52 
125 ± 63 
130 + 59 
135 ± 76 
110 ± 59 






40i± 9  
53 ± 14 
48 + 13a 
42 ± 10 
56i+ 10 
51 + 12b 
LDL-C 




113 ± 30 
112 ± 27 
113 + 28 
105 ± 32 
115 ± 25 
111 + 27 
Values with different superscripts indicate significant differences from baseline to 
36 weeks (P<0.05). Pairwise comparisons were done only on total values. 
Two men and one woman were excluded from the lipid profile analysis due to 
changes in cholesterol-altering medication. 
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Only the change in fat-free mass differed significantly between men and women in 
response to the intervention with the women experiencing a slight but significant increase 
in this variable. Figures 2 and 3 show the changes in daily step counts and body weight 
among men and women in response to the intervention. Two men and two women were 
excluded from the blood pressure and heart rate measurements due to changes in 
medications that may alter these variables. Two men and one woman were excluded 
from the lipid profile analysis due to changes in cholesterol-altering medication. 
A repeated measures ANOV A was also done on all men and women who adhered 
to the exercise prescription for the full 36 weeks (data not presented). Again, fat-free 
mass was the only variable that responded differently between men and �omen. 
Significant improvements were noted for body weight, BMI, percent body fat, fat mass, 
waist circumference, and hip circumference. 
Due to the lack of significant differences between men and women in the 
response to the intervention (except for fat-free mass), an analysis was performed on the 
combined group to compare those who adhered to the exercise prescription and those 
who did not. At baseline, there were no significant differences between any variables 
when comparing the adherers with the non-adherers. A repeated measures ANOVA 
showed that the adherers experienced significant improvements in body weight, BMI, 
percent body fat, fat mass, waist circumference and hip circumference (Tables 4 and 5). 
Little or no changes were seen in the non-adherers, although they did significantly 
increase their daily step counts by 2500 steps·d- 1 • Figures 4 and 5 show the changes in 
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Figure 2: A comparison of changes in daily step counts among men and women 
in response to a 10,000 steps per day intervention. 
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Figure 3 :  A comparison of changes in body weight among men and women in 
response to a 10,000 steps per day intervention. 
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Table 4. Dependent variables measured at baseline, 20 weeks, and 36 weeks in 
adherers (n=20) and non-adherers (n= l 9). 
Variable Baseline 20 weeks 36 weeks 
Weight, kg 
Adherers 99.8 ± 2 1 . 1  a 97.0 ± 20.5b 95.3 ± 20.7b 
Non-adherers 95 .2 + 1 4.9 94.6 + 1 3 .6 95.5 + 1 3 .5 
BMI, kg·m·2 
Adherers 33 .5 ± 5 .3a 
Non-adherers 32.4 + 4.0 
32.5 ± 5 . l b 
32.2 + 3 .8 
3 1 .9 ± 5 , 1 b 
32.5 + 3 .8 
Body fat,e% 
Adherers 40.6 ± 8.7a 
Non-adherers 44.8 + 8 .8a 
38 .3 + 8 .5b 
43.5 + 9.2b 
37.4 + 9.2b 
44.3 +8.7ab 
Fat mass, kg 
Adherers 4 1 .0 ± 1 3 .7a 
Non-adherers 43 .0 + 12.5a 
37.8 + 1 3 . l b 
41e.5 + 1 1 e.8b 
36.3 ± 1 3 .5b 
42.6 + 1 1 .5a 
Fat-free mass, kg 
Adherers 59. 1 ± 12 .9 
Non-adherers 52.6 + 1 0. 8a 
59.5 + 12.2 
53 .4 + 1 0.8b 
59.4 + 12.5 
53 .4 + 1 0.7b 
Waist Circ, cm 
Adherers 1 06.7 ± 1 1 .4a 1 04. 7 ± 1 1 .Sb 1 03 .6 ± 12.2b 
Non-adherers 1 00.2 + 1 1 .3 
Hip Circ, cm 
99.7 + 1 1 .9 1 00.2 + 1 1 .3 
Adherers 1 1 7.0 ± 1 3 .0a 
Non-adherers 1 1 8.7  + 12.sa 
SBP,emmeHg 
1 14.4 + 1 2.7b 
1 1 7.2 + 1 2.0b 
1 1 4 . 1 + 1 3 .7b 
1 1 7. 8  + 1 2.2ab 
Adherers 1 26 ± 1 4  1 26 ± 1 5  1 26 ± 1 7  
Non-adherers 1 1 8  + 1 0  1 22 + 1 2  1 1 7 + e1 1  
DBP,emmeHg 
Adherers 85 ± 7  84e± 8  83 ± 9  
Non-adherers 82e+ 6  
HR, beats·min·1 
82e+ 6  8 1  + 7 
Adherers 75 ± 1 2  74e± 1 2  74 ± 1 1  
Non-adherers 70 + 1 0  72 + 1 0  70e+ 8 
Values with different superscripts indicate significant differences (P<0.05) within 
groups. 
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Table 5. Blood lipid profiles measured at baseline and 36 weeks in 
adherers (n=16) and non-adherers (n= l 7). 
Variable Baseline 36 weeks 
TC, mg·dr 1 
Adherers 192 ± 37 187 ± 38 
Non-adherers 182 + 30 187 + 32 
Triglycerides, mg·dr1 
Adherers 143 ± 67 131 ± 86 





48 + l l a 
50 + 14b 
52 + 10b 
LDL-C, mg·dr1 
Adherers 117 ± 29 111 ± 28 
Non-adherers 109 + 28 113 + 30 
Values with different superscripts indicate significant differences (P<0.05) within 
groups. 
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Figure 4 :  A comparison of changes in daily step counts among the adherers and 
non-adherers in response to a 10,000 steps per day intervention. 
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Figure 5: A comparison of changes in body weight among the adherers and 
non-adherers in response to a 10,000 steps per day intervention. 
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Partial correlations were used to assess the relationship between the increase in 
daily walking over 36 weeks and the change in dependent variables while controlling for 
changes in energy intake and initial body weight. There were significant correlations 
noted between the increase in daily step counts (steps·d-1 ) and the changes in body weight 
(r = -.42) ,  BMI (-.42) ,  hip circumference (-.41), percent body fat (-.44) ,  and fat mass 
(-.45). A marginal partial correlation (P<0.10) was found between the increase in daily 
step counts and the change in waist circumference (-.35) .  Pearson correlations were used 
to assess the relationship between the increase in daily walking and the change in 
dependent variables over the course of the intervention. A significant correlation was 
found between the increases in daily step counts and HDL-C (.45). 
No statistically significant differences were found between men (2498, 2315, 
271 1  kcal at baseline, 20 weeks, and 36 weeks) and women (2 194, 209 1, and 1993 kcal at 
baseline, 20 weeks, and 36 weeks) for total energy intake or macronutrient composition 
( carbohydrate, protein, and fat) across the 36-week intervention. In addition, no 
significant within gender changes were noted in any of these dietary variables. Likewise, 
no statistically significant differences were noted between the adherers and non-adherers, 
nor did either group significantly change any of the abovementioned dietary variables 




The on-treatment analysis showed that overweight men and women given a 
10,000 steps per day exercise prescription experienced significant improvements in body 
weight, BMI, percent body fat, fat mass, waist and hip circumferences, and HDL-C. 
The only factor that responded differently between genders was fat-free mass. However, 
the change in fat-free mass in both genders was very small (<1 kg) and is unlikely to be 
considered clinically significant. These findings suggest that a 1 0,000 steps per day 
program is effective at improving body weight and body composition in previously 
sedentary, overweight adults. 
We ·recognize that statistical significance is largely a _function of sample size ( 49). 
Based on the difference in weight loss between men and women, it would have taken 104 
individuals (52 men and 52 women) to detect a significant difference in this variable 
(80% power). Nonetheless, this study indicates that the gender difference in response to 
this exercise intervention was not as large as what some previous studies have found 
since men and women responded to a 1 0,000 steps per day goal in a similar manner. 
To determine if there was a dose-response relationship between the change in 
daily step counts and the dependent variables, a partial correlation was used to compare 
the increase in daily walking with the change in all dependent variables after controlling 
for baseline body weight along with any change in energy intake over the course of the 
intervention. Significant correlations were found between the increase in daily step 
counts and the changes in body weight, BMI, percent body fat, fat mass and hip 
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circumference. This suggests that the greater the increase in daily walking, the greater 
the improvement in body weight and body composition variables. 
Adherers vs. Non-adherers 
In comparing men who adhered to the exercise prescription to women who 
adhered, once again little effect of gender was seen. This suggests that walking 10,000 
steps per day is equally efficacious for weight loss in sedentary, overweight men and 
women. 
Given that men and women responded similarly, a comparison was made between 
those who adhered to the exercise prescription with those who did not. Both adherers and 
non-adherers significantly increased daily walking (by 5,275 and 2,472 steps·d- 1 , 
respectively). Although the increase in daily walking was significant for both groups, 
only the adherers showed significant improvements in body weight, BMI, percent body 
fat, fat mass, waist circumference, and hip circumference after 36 weeks. In contrast, 
those who did not adhere to the exercise prescription had little or no change in these 
variables. 
Although no significant differences were apparent in regard to body weight or fat 
mass change between men and women in response to the intervention, men tended to lose 
a little more weight and fat mass than women. This is partly due to the fact that the men 
were heavier than the women, and heavier individuals expend more calories per step. 
Thus, for a given increase in daily walking the men would have expended more calories, 
which favored the tendency to lose more weight. In addition, men showed a trend 
155 
towards greater adherence to the 10,000 steps per day exercise prescription which could 
also have been a contributing factor. 
Comparison to Literature 
An increase in physical activity has long been considered a potential tool for 
weight management. Several studies have assessed the effect of walking on body weight 
in men or women. Pollock et al. ( 40) found that a 20-week, moderate-to-high intensity 
walking program for 160 minutes per week in middle-aged men resulted in a statistically 
significant 1 .3 kg of weight loss. Similarly, Moreau et al. (36) showed that adding a 
3-km daily walk to the normal activity (4,300 steps·d-1 increase) of postmenopausal 
women also resulted in a significant weight loss of 1 .3 kg after 24 weeks. Other walking 
studies have also noted weight loss in both genders ( 1 3 ,  29, 35, 37). However, not all 
studies have found walking to be effective at producing weight loss. Hinkleman and 
Nieman ( 17) showed that a 15-week, moderate intensity walking program, 5 days per 
week for 45 minutes per session did not result in significant reductions in body weight or 
fat mass in overweight women. Snyder et al. ( 45) also found that a 32-week walking 
program for 150 minutes per week was not sufficient to produce significant changes in 
body weight or body composition in overweight females. 
Studies that have evaluated the gender effect have shown that men lose more 
weight than women in response to an exercise intervention (2, 7, 23 , 46). Donnelly et al. 
(7) showed that after 16  months of moderate-intensity exercise that progressed up to 
225 minutes per week, only men lost a significant amount of body weight and fat mass. 
Men lost 5.3 kg of body weight and 5.0 kg of fat mass after 9 months, at which point 
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weight loss leveled off and did not change significantly for the remainder of the study. In 
contrast, women showed a trend towards an increase in body weight (0.6 kg) and 
decrease in fat mass (-0.2 kg). Snyder-Heelan et al. (46) also found that men were more 
successful in regard to weight loss than women following a 66-week intervention. In this 
study, exercise was adjusted to result in 400 kcal of energy expenditure per session, 5 
days per week. Similar to the findings of Donnelly et al. (7) ,  men in this study lost 5 .1 kg 
of body weight while women had a slight but statistically insignificant increase in body 
weight (0.8 kg) . 
The current study shows close agreement with the findings of both Donnelly et al. 
and Snyder-Heelan et al. in regard to the change in body weight in men, but differs with 
regard to the changes in body weight in women. However, the current study is in 
agreement with the findings of Moreau et al. (36) concerning the amount of weight loss 
in women. The current study found that both sedentary, overweight men and women lose 
weight if they walk 10,000 steps per day. It is unclear why some previous exercise 
interventions failed to produce weight loss in women. Possible explanations are that, in 
some studies, women expended less energy ( due to lower adherence or smaller body 
size), increased their energy intake to compensate for the increase in exercise energy 
expenditure, or they unintentionally decreased their habitual physical activity. 
Lipid Profile and Blood Pressure 
High-density lipoprotein values increased similarly in both men and women and 
in the adherers and non-,adherers. In addition, there was a significant correlation between 
the increase in daily walking and the increase in HDL-C. Consistent with other findings 
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(31 ), the women in this study had significantly higher baseline HDL-C levels than the 
men. However, unlike other studies, women were not more resistant than men to 
exercise-induced changes in HDL-C ( 17, 30). 
There were no significant changes in blood pressure or heart rate among men and 
women or among the adherers and non-adherers. This is due to the fact that most of the 
participants had initial resting blood pressure values that were in the normal range. Thus, 
a lack of change in these variables is consistent with finding that blood pressure changes 
are likely to be minimal in normotensive individuals (9, 2 1 ,  22, 40). 
Summary 
The 10,000 steps per day exercise prescription was effective at increasing daily 
walking and resulted in significant improvements in .body weight, BMI, percent body fat, 
fat mass, waist circumference, hip circumference, and HDL-C in overweight, middle­
aged men and women. In addition, those who adhered to the exercise prescription 
experienced significantly greater improvements in body weight and body composition 
when compared with those who did not adhere. These results suggest that the 10,000 
steps per day exercise prescription is an effective tool for weight management and should 
be considered as a strategy for dealing with the current obesity epidemic. 
158 
Acknowledgements 
The authors would like to thank Cary Springer of the UT Statistical Consulting 
Services for supporting the data analysis in this study. This research was supported by 
the James D. Moran and Monica Moran Dissertation Award and the Charlie and Mai 
Coffey Endowment in Exercise Science. 
1 59 
References 
1. American Society of Hypertension - Public Policy Committee. Recommendations 
for routine blood pressure measurement by indirect cuff sphygmomanometry. Am. 
J. Hypertens. 5:207-209, 1992. 
2. Ballor, D. L. and R. E. Keesey. A meta-analysis of the factors affecting exercise­
induced changes in body mass, fat mass and fat-free mass in males and females. 
Int. J. Obes. 15:717-726, 199 1. 
3. Callaway, C. W., W. C. Chumlea, C. Bouchard, et al. Circumferences. In: 
Anthropometric Standardization Reference Manual. T. G. Lohman, A. F. Roche, 
and R. Martorell (Eds.) Champaign, IL: Human Kinetics Books, 1988, pp. 44-47. 
4. Centers for Disease Control and Prevention - Morbidity and Mortality Weekly 
Report. Prevalence of Physical Activity, Including Lifestyle Activities Among 
Adults - United States, 2000-2001 , 2003, pp. 764-769. 
5. Colditz, G. A. Economic costs of obesity and inactivity. Med. Sci. Sports Exerc. 
31:S515-S52 1, 1999. 
6. Crouter, S. E., P. L. Schneider, M. Karabulut, and D.aR. Bassett. Validity of 10 
electronic pedometers for measuring steps, distance, and energy cost. Med. Sci. 
Sports Exerc. 35: 1455-1460, 2003. 
7. Donnelly, J.aE., J. 0. Hill, D. J. Jacobsen, et al. Effects of a 16-month randomized 
controlled exercise trial on body weight and composition in young, overweight 
men and women. Arch. Intern. Med. 163: 1343- 13 50, 2003. 
160 
8. Donnelly, J. E., D. J. Jacobsen, K. Snyder-Heelan, R. Seip, and S. Smith. The 
effects of 18 months of intermittent vs continuous exercise on aerobic capacity, 
body weight and composition, and metabolic fitness in previously sedentary, 
moderately obese females. Int. J. Obes. 24:566-572, 2000. 
9. Duncan, J. J., N. F. Gordon, and C. B. Scott. Women walking for health and 
fitness.JAMA. 266:3295-3299, 199 1. 
10. Flegal, K. M., M. D. Carroll, C. L. Ogden, and C. L. Johnson. Prevalence and 
Trends in Obesity Among U.S. Adults, 1999-2000. JAMA. 288: 1723- 1727, 2002. 
1 1. Gordon, C. C., W. C. Chumlea, and A. F. Roche. Stature, Recumbent Length, and 
Weight. In: Anthropometric Standardization Reference Manual. T. G. Lohman, 
A. F. Roche, and R. Martorell (Eds.) Champaign, IL: Human Kinetics Books, 
1988, pp. 3-8. 
12. Grundy, S. M., G. Blackburn, M. Higgins, R. Lauer, M. G. Perri, and D. Ryan. 
Physical activity in the prevention and treatment of obesity and its comorbidities: 
evidence report of independent panel to assess the role of physical activity in the 
treatment of obesity and its comorbidities. Med Sci. Sports Exerc. 31  :S502-S508, 
1999. 
13. Gwinup, G. Effect of exercise alone on the weight of obese women. Arch. Intern. 
Med 135:676-680, 1975. 
14. Hatano, Y. Use of the pedometer for promoting daily walking exercise. JCHPER 
J. 29:4-8, 1993. 
16 1 
15. Hedley, A. A., C. L. Ogden, C. L. Johnson, M. D. Carroll, L. R. Curtin, and K. M. 
Flegal. Prevalence of overweight and obesity among US children, adolescents, 
and adults, 1999-2002. JAMA. 291 :2847-2850, 2004. 
16. Heimrich, N. Journey to better fitness starts with 10,000 steps. USA Today. June 
29, 1999. 
17. Hinkleman, L. L. and D. C. Nieman. The effects of a walking program on body 
composition and serum lipids and lipoproteins in overweight women. J. Sports 
Med Phys. Fitness. 33:49-58, 1993. 
18. Jakicic, J. M., K. Clark, E. Coleman, et al. Appropriate intervention strategies for 
weight loss and prevention of weight regain for adults. Med. Sci. Sports Exerc. 
33:2 145-2156, 2001. 
19. Jakicic, J.aM. and K. I. Gallagher. Exercise considerations for the sedentary, 
overweight adult. Exerc. Sports Sci. Rev. 31 :9 1-95, 2003. 
20. Katzmarzyk, P. T., I. Janssen, and C. I. Ardem. Physical inactivity, excess 
adiposity and premature mortality. Obes. Rev. 4:257-290, 2003. 
2 1 .  Kelley, D. A., K. A. Kelley, and Z. V .  Tran. Aerobic exercise and resting blood 
pressure: A meta-analytic review of randomized, controlled trials. Prev. Cardiol. 
4:73-80, 2001. 
22. Kelley, G. A. Effects of aerobic exercise in normotensive adults: a brief meta­
analytic review of controlled clinical trials. South Med. J. 88 :42-46, 1995. 
162 
23. Kirk, E. P., J.iE. Donnelly, D. J. Jacobsen, and C. Gibson. Time-course and 
gender effects in aerobic capacity and body composition for overweight 
individuals: Midwest exercise trial (MET). Med Sci. Sports Exerc. 34:S120 
[abstract], 2002. 
24. Klem, M. L., R. R. Wing, M. T. McGuire, H. M. Seagle, and J. 0. Hill. A 
descriptive study of individuals successful at long-term maintenance of 
substantial weight loss. Am. J. Clin. Nutr. 66:239-246, 1997. 
25. Kramer, F. M., R. W. Jeffery, and J. L. Forster. Long-term follow-up of 
behavioral treatement for obesity: patterns of weight regain among men and 
women. Int. J. Obes. 13:123-136, 1989. 
26. Kraus, W. E., J. A. Houmard, B. D. Duscha, et al. Effects of the amount and 
intensity of exercise on plasma lipoproteins. New Engl. J. Med 347:1483-1492, 
2002. 
27. Lanningham-Foster, L., L. J. Nysse, and J. A. Levine. Labor saved, calories lost: 
The energetic impact of domestic labor-saving devices. Obes. Res. 11 :1179-1181, 
2003. 
28. Le Masurier, G. C., S. M. Lee, and C. Tudor-Locke. Motion sensor accuracy 
under controlled and free-living conditions. Med. Sci. Sports Exerc. 36:905-910, 
2004. 
29. Leon, A. S., J. Conrad, D. B. Hunninghake, and R. Serfass. Effects of a vigorous 
walking program on body composition, and carbohydrate and lipid metabolism of 
obese young men. Am. J. Clin. Nutr. 33:1776-1787, 1979. 
163 
30. Leon, A. S. and 0. A. Sanchez. Response of blood lipids to exercise training 
alone or in combination with dietary intervention. Med. Sci. Sports Exerc. 
33 :S502-S5 l 5, 2001. 
31. Lokey, E. A. and Z. V. Tran. Effects of exercsie training on serum lipid and 
lipoprotein concentrations in women: A meta-analysis. Int. J. Sports Med. l 0:424-
429, 1989. 
32. McCrory, M. A., T. D. Gomez, E. M. Bemauer, and P. A. Mole. Evaluation of 
new air displacement plethysmograph for measuring human body composition. 
Med. Sci. Sports Exerc. 27:1686-1691, 1995. 
33. McCrory, M.iA., P.iA. Mole, T. D. Gomez, K. G. Dewey, and E. M. Bemauer. 
Body composition by air-displacement plethysmography by using predicted and 
measured thoracic gas volumes. J. Appl. Physiol. 84:1475-1479, 1998. 
34. Miller, W. C., D. M. Koceja, and E. J. Hamilton. A meta-analysis of the past 25 
years of weight loss research using diet, exercise, or diet plus exercise 
intervention. Int. J. Obes. 21 :941-94 7, 1997. 
35 .  Miyatake, N., H. Nishidawa, A. Morishita, et al. Daily walking reduces visceral 
adipose tissue areas and improves insulin resistance in Japanese obese adults. 
Diabetes Res. Clin. Pract. 58 :101-107, 2002. 
36. Moreau, K. L., R. Degarmo, J. Langley, et al. Increasing daily walking lowers 
blood pressure in postmenopausal women. Med. Sci. Sports Exerc. 33:1825-1831, 
2001. 
37. Parkkari, J., A. Natri, P. Kannus, et al. A controlled trial of the health benefits of 
regular walking on a golf course. Am. J. Med. l 09 :102-108, 2000. 
164 
38. Pi-Sunyer, F. X. Medical hazards of obesity. Ann. Intern. Med. 1 19 :655-660, 
1993. 
39. Pollock, M. L. Prescribing exercise for fitness and adherence. In: Exercsie 
adherence: It 's impact on public health. R. K. Dishman (Ed.) Champaign, IL: 
Human Kinetics, 1988, pp. 259-277. 
40. Pollock, M. L., H. S. Miller, R. Janeway, A. C. Linnerud, B. Robertson, and V. R. 
Effects of walking on body composition and cardiovascular function of middle­
aged men . .I. Appl. Physiol. 30 : 126- 130, 1971 .  
4 1 .  Ross, R., D. Dagnone, P. J. H. Jones, et al. Reduction in obesity and related 
comorbid conditions after diet-induced weight loss or exercise-induced weight 
loss in men. Ann. Epidemiol. 133 :92- 103, 2000 . 
42. Schneider, P. L., S. E. Crouter, and D. R. Bassett. Pedometer measures of free­
living physical activity: Comparison of 13 models. Med. Sci. Sports Exerc. 
36:33 1 -335, 2004. 
43. Siri, N. E. Body compostion from fluid spaces and density. In: Techniques for 
Measuring Body Composition. J. Brozek and A. Henschel (Eds.) Washington, 
D.C. : National Academy of Science, 1961 , pp. 223-224. 
44. Skender, M. L., G. K. Goodrick, D. J. DelJunco, et al. Comparison of2-year 
weight loss trends in behavioral treatments of obesity: Diet, exercise and 
combination interventions . .I. Am. Diet. Assoc. 96:342-346, 1996. 
165 
45. Snyder, K. A., J.oE. Donnelly, D. J. Jacobsen, G. Hertner, and J.oM. Jakicic. The 
effects of long-term, moderate intensity, intermittent exercise on aerobic capacity, 
body composition, blood lipids, insulin and glucose in overweight females. Int. J. 
Obes. 2 1 : 1 180- 1 189, 1997. 
46. Snyder-Heelan, K. A., D. J. Jacobsen, J. 0. Hill, S. Johnson, and J. E. Donnelly. 
Differences in body weight changes between males and females in response to 
exercise. Med. Sci. Sports Exerc. 33:S138 [abstract], 200 1. 
47. Swartz, A. M., D.oR. Bassett, J.oB. Moore, D. L. Thompson, and S. J. Strath. 
Effects of body mass index on the accuracy of an electronic pedometer. Int. J. 
Sports Med. 24:588-592, 2003. 
48. Swartz, A. M. and D. L. Thompson. Increasing daily walking improves glucose 
tolerance in overweight women. Prev. Med. 37 :356-362, 2003. 
49. Thomas, J. R. and J. K. Nelson. Becoming Acquainted with Statistical Concepts. 
In: Research Methods in Physical Activity Champaign, IL : Human Kinetics, 1996, 
p. 1 10. 
50. Tudor-Locke, C. Talcing steps toward increased physical activity: Using 
pedometers to measure and motivate. Research Digest. 3 :  1-8, 2002. 
5 1. Tudor-Locke, C. and A. M. Myers. Methodological considerations for researchers 
and practitioners using pedometers to measure physical (ambulatory) activity. 
Res. Q. Exerc. Sport 72: 1- 12, 200 1. 
166 
52. U.S. Department of Health and Human Services. Understanding and Improving 
Health. In: Healthy People 2010 Washington, DC: U.S. Government Printing 
Office, 2000. 






PARTS III, IV 
INFORMED CONSENT FORM 
1 69 
INFORMED CONSENT FORM 
The Validation of Electronic Pedometers 
Investigator: Patrick L. Schneider 
Address: 
The University of Tennessee 
Department of Health, Safety, and Exercise Science 
1914 Andy Holt Ave. 
Knoxville, TN 3 7919 
Telephone: 865-974-5091 
Purpose 
You are invited to participate in a research study. The purpose of this study is to examine 
the use of electronic pedometers to measure steps taken, distance walked, and caloric 
expenditure. If you give your consent, you will be asked to participate in one part of the 
study. The section checked below is the part of the study you are volunteering for. 
Before exercising, you will be given a brief questionnaire to determine your health status 
and you will be measured for height and weight in the laboratory. 
Procedures 
Part 1. Course validation - You will take 20 strides and the total distance covered 
will be divided by 20 to determine stride length. You will then be asked to walk 
around a 400 meter outdoor track a total of 2 times for each pedometer of the 
same brand. A total of 12 different brands of pedometers will be tested. 
Therefore, you will be asked to walk around the 400 meter track a total of 24 
times which is equivalent to 6 miles. A researcher will accompany you on each 
walk, manually counting each step. The testing will take place over the course of 
1-5 days and will require a total of about 2-4 hours of your time. 
__ Part 2. Effects of walking speed - You will be asked to walk on the treadmill at 
2.0, 2.5, 3.0, 3.5, and 4.0 mph (5 minutes per stage). The effects of walking speed 
on the accuracy of each of the 10 brands of pedometers being tested will be 
examined. The testing will take place over the course of 3-5 days and will require 
about 4-5 hours of your time. You will be asked to wear a nose-clip and 
mouthpiece, and breathe into a device to measure oxygen uptake for each of the 
five 25 minute trials you will be asked to complete. The liters of oxygen actually 
consumed will be compared against the estimated value from the pedometer. You 
will also have your resting metabolic rate measured using the nose-clip and 
mouthpiece for 40 minutes on a separate day from the walking trials. 
__ Part 3. 24-hour comparisoni- You will be asked to wear a Yamax SW-200 
pedometer on one hip and another model on the other for 24 hours and record the 
number of steps registered on both pedometers at the end of each day. A 
comparison will then be made between the Yamax SW-200 and the comparative 
model. A total of 12 pedometers will be compared to the Yamax SW-200, 
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which will require a total of 12 days of testing. You will not be asked to do any 
activities beyond which you would normally do on any other day. You will be 
given instructions on how to use each pedometer and will not be asked to return to 
the laboratory until all 12 pedometers have been compared. 
Risks and Benefits 
There are very few risks associated with moderate exercise. The risks include abnormal 
blood pressure responses and heart rhythm disturbances. These risks of participating in 
this study are equivalent to the risks of activities requiring moderate exertion (yard work, 
light sport activities, etc.) that you engage in during everyday activities. The benefits to 
participation include knowledge of your stride length, and exposure to a device that may 
provide accurate information about "steps taken" and "distance walked;" You will also 
be given information on your resting metabolic rate. 
Confidentiality 
The information obtained from these tests will be treated as privileged and confidential 
and will consequently not be released to any person without your consent. However, the 
information will be used in research reports or presentations, but your name and other 
identity will not be disclosed. 
Right to Ask Questions and to Withdraw 
You are free to decide whether or not to participate in this study and are free to withdraw 
from the study at any time. 
Before you sign this form, please ask questions about any aspects of the study which are 
unclear to you. 
Consent 
By signing this paper, I am indicating that I understand and agree to take part in this 
research study. 
Your signature Date 
Researcher's signature Date 
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Physical Activity Readiness Questionnaire (P AR-Q) 
Regular physical activity is fun and healthy, and increasingly more people are starting to 
become more active every day. Being more active is very safe for most people. 
However, people should check with their doctor before they start becoming much more 
physically active. 
If you are planning to become much more physically active than you are now, start by 
answering the seven questions in the box below. If you are between the ages of 15 and 
69, the PAR-Q will tell you if you should check with your doctor before you start. If you 
are over 69 years of age, and you are not used to being very active, check with your 
doctor. 
Common sense is your best guide when you answer these questions. Please read the 
questions carefully and answer each one honestly: check YES or NO. 
YES NO 1.  Has your doctor ever said that you have a heart condition and that 
you should only do physical activity recommended by a doctor? 
YES ·No 2. Do you feel pain in your chest when you do physical activity? 
YES NO 3 .  In the past month, have you had chest pain when you were not 
doing physical activity? 
YES NO 4. Do you lose your balance because of dizziness or do you ever lose 
consciousness? 
YES NO 5. Do you have a bone or joint problem that could be made worse by 
a change in your physical activity? 
YES NO 6. Do you know of any other reason why you should not be doing 
physical activity? 
I have read, understood and completed this questionnaire. Any questions I had were 
answered to my full satisfaction. 
Name _______________ _ 
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INFORMED CONSENT FORM 
TITLE OF STUDY: A comparison of the 1 0,000 steps per day recommendation in 
overweight men vs. women: the effects on cardiovascular risk factors and adherence 
Investigator: Patrick L. Schneider, M.S. 
Address: The University of Tennessee 
Department of Health and Exercise Science 
19 14  Andy Holt Ave. 
Knoxville, TN 3 7996 
Telephone: 865-974-5091 
Co-Investigators: David Bassett, Ph.D. 
Kenneth Bielak, M.D. 
PURPOSE 
You are invited to participate in a research study examining the effects of a 36-
week walking program on adherence, weight loss and cardiovascular risk factors. This 
study will provide information on the relationship between walking 1 0,000 steps per day 
and specific health benefits. The research will take place at both the University of 
Tennessee and the University of Tennessee Medical Center. This study will begin in the 
Summer of 2003 and will conclude in the Spring of 2004 and will involve 100 
participants. 
PROCEDURES 
If you choose to participate in this study, you will report to the Applied 
Physiology Laboratory, Room 310 in the Health, Physical Education and Recreation 
(HPER) building at the University of Tennessee on four separate occasions: prior to the 
study to complete necessary paperwork described below (this visit), at baseline, 1 8  
weeks, and 3 6 weeks for the measurement of a variety of health related variables. Each 
occasion is expected to last about 1 hour. Prior to any testing, you will complete a 
questionnaire regarding your health history, exercise training habits, and your readiness 
to adopt a physical activity program. The health history form will be used to ensure that 
the testing is safe for you. You will be asked to report to the laboratory in a rested 
condition not having consumed food 12  hours prior to testing. Your will also be asked to 
refrain from alcohol consumption and exercise for 12  hours prior to the test. On two 
occasions, you will be asked to report to the outpatient laboratory at the University of 
Tennessee Medical Center for a blood cholesterol test. 
On each of your visits, you will report to the laboratory between 6 :00 and 
10 :00 a.m. after a 12-hour overnight fast. Your blood pressure and heart rate will be 
measured three times while you are sitting in a chair after you have rested quietly for five 
minutes. Your body composition will be determined by measuring your height, weight, 
waist and hip circumferences, and body fat percentage. Two different techniques 
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(Tanita® and Bod Pod®) will be used to assess body fat percentage. The Tanita®, is a 
device that is similar in appearance to a bathroom scale. You will be asked to stand on 
the "scale" with bare feet, dressed in a swimsuit for approximately one minute. This 
device estimates your body fatness by measuring the resistance to a small electrical 
current that is passed from the scale through your body. You will not be able to feel the 
current and this test is harmless. The Bod Pod®, is a whole body chamber that uses 
changes in air pressure within the chamber to determine body volume. Your body 
volume will be measured as you sit for approximately 3 minutes in a sealed chamber 
wearing a lycra swimsuit. During this time you will be able to breathe normally and .view 
your surroundings. Along with your body weight, body volume is used to estimate body 
fatness. When you report to the outpatient laboratory at the University of Tennessee 
Medical Center, a needle will be inserted into your forearm and a small blood sample (7 
cc, about 1 ½ teaspoons) will be taken to be later analyzed for blood cholesterol levels. 
The blood will be disposed of immediately after the blood cholesterol measurement is 
complete. 
You will be given an electronic pedometer to wear throughout the day during the 
entire study. You will be asked to record the number of steps shown on the pedometer at 
the end of the day for two weeks. This information will allow us to determine your 
current average weekly walking distance. You will also be given a three-day dietary 
record form and will be asked to record the food and drink that you consume for three 
days. 
WALKING PROGRAM 
After completion of all the baseline measures, you will then be given a 
recommendation that leads up to taking at least 10,000 steps per day for 36 weeks. The 
first week you will be asked to take 7,000 steps per day. The second, 8,000 steps per day. 
The third, 9,000 steps per day. And on the fourth week you will be asked to take at least 
10,000 steps per day. You will be asked to walk at a self-selected, comfortable pace. In 
order to get at least 10,000 steps per day, you will have to do some walking beyond that 
required by your normal daily routine. This additional walking can be accumulated in 
several short bouts or can be done all at once. Your walking steps, along with the time 
that you put the pedometer on in the morning and the time that you take it off in the 
evening will be recorded on a daily log sheet. You will also be asked to attend a one­
hour informational session every other week for the first two months and then monthly 
thereafter. The informational sessions are intended to allow you to ask questions or make 
comments about the walking program and to provide you with educational information 
on a variety of health related topics. 
RISKS ASSOCIATED WITH PARTICIPATION 
The potential risks that may occur while participating in this study are those 
associated with any type of exercise: injury to muscles and/or joints, dizziness, headache, 
and in very rare instances heart attack. However, these risks are minimal in healthy 
individuals, and the investigators are trained to conduct these types of experiments. In 
addition to the pain and/or discomfort associated with taking a small blood sample to 
determine your blood lipid profile ( cholesterol), you may experience some local bruising, 
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tenderness and/or an area of infection where blood samples were taken. Trained 
technicians will perform the blood sampling technique and sterile procedures will be used 
to minimize this risk. In regard to the walking program, you will be walking at a self­
selected pace. 
BENEFITS ASSOCIATED WITH PARTICIPATION 
This study will provide information on the relationship between taking 10,000 
steps per day for 36 weeks and specific health benefits in males vs. females. You will 
benefit by acquiring valuable information on your current health status including: blood 
lipid profile, body composition, and resting heart rate and blood pressure. If you 
participate in the walking program, you may obtain some health and fitness benefits by 
participating in the walking program and developing a positive exercise habit. You will 
also get experience with the pedometer that will provide information on steps taken over 
the course of a day. 
ALTERNATIVES TO PARTICIPATION 
As an alternative to participating in this study, you may choose to not participate. 
CONFIDENTIALITY 
The information obtained from the tests will be treated as privileged and 
confidential and will consequently not be released to any person without your consent. 
All the information collected will be coded by a subject number rather than by name and 
will be kept in a locked file cabinet by Patrick Schneider. However, the information will 
be used in research reports or presentations, but your name and other identity will not be 
disclosed. 
COMPENSATION AND TREATMENT FOR INJURY 
I understand that I am not waiving any legal rights or releasing the University of 
Tennessee or its agents from liability for negligence. I understand that, in the event of 
physical injury resulting from research procedures the University of Tennessee does not 
have funds budgeted for compensation either for lost wages or for medical treatment. In 
the unlikely event that physical injury occurs as a result of participating in this study, 
financial compensation is not automatically available and medical treatment will not be 
provided free of charge. If a physical injury should occur over the course of the study, 
immediately notify the primary investigator, Patrick Schneider (see below for phone and 
office numbers). 
QUESTIONS 
If you have questions or concerns at any time during the course of this 
investigation or after you complete the study, you may contact Patrick Schneider at (865) 
974-5091. Patrick Schneider's office is located in the HPER Building in Room 303. If at 
any time during this study, events occur that will impact your ability to participate (i.e., 
you sustain a training injury, you are ill, etc.), you should inform Patrick Schneider 
immediately. You may also contact the chairman of the University of Tennessee 
Graduate School of Medicine Institutional Review Board at (865) 544-9781 if you have 
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any questions about your rights as a participant in this study or your rights as a research 
subject. 
PAYMENT FOR PARTICIPATION 
As a volunteer in this study, you will not receive any payment in exchange for 
your participation. 
COSTS OF PARTIPATION 
There will not be any additional costs to you as a result from participating in this 
study. 
VOLUNTARY PARTICIPATION 
As a volunteer in this study, it is your right to withdraw from this investigation at 
any time. If you decide to withdraw from this study, you will in no way be penalized. If 
you are unable to adhere to the walking program, you will be asked to continue wearing 
the pedometer and continue completing the physical activity log. In addition, you will 
also be asked to attend the 18-week and 36-week measurement sessions. 
CONSENT 
I have read or have had read to me the description of the research study as 
outlined above. The investigator or his representative has explained the study to me and 
has answered all of the questions I have at this time. I have been told of the potential 
risks, discomforts, side effects and adverse reactions as well as the possible benefits of 
the study. I freely volunteer to participate in the study. I understand that I do not have to 
take part in this study and that my refusal to participate will involve no penalty or loss of 
rights to which I am entitled. I further understand that I am free to later withdraw my 
consent and discontinue participation in this study at any time. I understand that refusing 
to participate later or withdrawing from the study will not adversely affect my subsequent 
medical care. 
Signature of Research Subject or Legally Authorized Representative Date 
Signature of Witness Date 




HEALTH HISTORY QUESTIONNAIRE 
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HEALTH HISTORY QUESTIONNAIRE 
NAME _____________ DATE _______ 
DATE OF BIRTH _________ AGE _____ 
ADDRESS _______________ 
PHONE NUMBERS (HOME) _____ (WORK) ______ 
e-mail address: --------------
When is the best time to contact you? __________________ 
When is the best time for you to attend a one-hour informational session to be held every 
other week for the first two months of the program and then monthly thereafter? 
Weekdays: am __ pm __ Weekends: am __ pm __ 
Please list specific days or times if necessary __________________ 
Please answer the following questions. This information will only be used for research purposes 
and will not be made public. Please answer these questions based on physical exercise in which 
you regularly engage. This should not include daily work activities such as walking from one 
office to another. 
1 .  Do you regularly engage in exercise? Yes/No Ifyes, please describe. 
2. On average, how many times per week do you engage in exercise training? 
o __ __ 2 __ 3 __ 4 __ s __ 6 __ 1 __ 
3. On average, how long do you exercise each time? 
0- 1 9  minutes ___ 20-40 minutes ___ more than 40 __ _ 
4. How long have you been exercising at this level? 
Less than 6 months 
6 - 12  months 
1 - 2 years 




( ) ( ) 
( ) ( ) 
Past History: 
MEDICAL HISTORY 
Have you ever been diagnosed with the following conditions? Please check the appropriate 
column. 









High Blood Pressure 
Any heart problem ( ) 
( ) ( )
( ) ( )
( ) ( )Lung Disease 
Seizures ( ) ( ) ( )
Irregular heart beat ( ) ( ) ( )
Bronchitis ( ) ( ) ( )
Emphysema




Kidney Disease ( )
Liver Disease ( )
Severe Allergies ( )
Orthopedic problems ( )
Hyper- or Hypothyroidism ( )
AIDS ( )
Heparin Sensitivity ( ) 
( ) ( )
( ) ( )
( ) ( )







Present Symptoms Review: 
Have you recently had any of the following symptoms? Please check if so. 
Chest Pain ( ) Frequent Urination ( )
Shorbless of breath ( ) Blood in urine ( )
Heart palpitations ( ) Burning sensations ( )
Leg or ankle swelling ( ) Severe headache ( )
Coughing up blood ( ) Blurred vision ( )
Low blood sugar ( ) Difficulty walking ( )
Feeling faint or dizzy ( ) Weakness in arm ( )
Leg numbness ( ) Significant emotional problem ( ) 
Do you smoke? Yes/No If yes, how many per day? _____ 
Are you currently trying to lose weight (through diet, exercise, and/or medication)? Yes/No 
Are you taking any medications? Yes/No 
If yes, please describe: _______ _______________ 
On average, how many alcoholic drinks do you consume per week? _______ 
Can you walk I continuous mile without pain or discomfort? _______ 
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I have been given the opportunity to ask questions about any of the above items that were unclear, 
and I have answered all questions completely and truthfully to the best of my knowledge. 




DIETARY RECORD INSTRUCTIONS 
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2. 
Dietary Record Instructions 
1. Use the Dietary Record Forms provided to record everything you eat or drink for 
3 consecutive days - two weekdays and one weekend day. 
Indicate the name of the FOOD ITEM, the AMOUNT eaten, how it was 
PREPARED (fried, boiled, broiled, etc.), and the TIME the food was eaten. If the 
item was a brand name product, please include the name. Try to be accurate 
about the amounts eaten. Measuring with measuring cups and spoons is best, but 
if you must make estimates, use the following guidelines: 
Fist is about 1 cup 
Tip of Thumb is about 1 teaspoon 
Palm of the hand is about 3 ounces of meat ( about the size of a deck of 
cards)
Tip of Thumb is about 1 ounce of cheese 
3. Try to eat what you normally eat and record everything. The project will only be 
useful if you are HONEST about what you eat. The information you provide is 
confidential. 
4. MILK: Indicate whether milk is whole, low fat (1 or 2% ), or skim. Include 
flavoring if one is used. 
5. VEGETABLES and FRUITS: One average serving of cooked or canned fruits 
and vegetables is about a half cup. Fresh whole fruits and vegetables should be 
listed as small, medium or large. Be sure to indicate if sugar or syrup is added to 
fruit and list if any margarine, butter, cheese sauce, or cream sauce are added to 
vegetables. When recording salad, list items comprising the salad separately and 
be sure to include salad dressing used. 
6. EGGS: Indicate method of preparation (scrambled, fried, poached, etc.) and 
number eaten. 
7. MEAT I POULTRY / FISH: Indicate approximate size or weight in ounces of the 
serving. Be sure to include any gravy, sauce or breading added. 
8. CHEESE: Indicate kind, number of ounces or slices, and whether it is made from 
whole milk, part skim, or is low calorie. 
9. CEREAL: Specify kind, whether cooked or dry, and measure in terms or cups or 
ounces. Remember that consuming 8 oz. of cereal is not the same as consuming 
one cup of cereal. 1 cup of cereal generally weighs about 1 ounce. 
10. BREAD and ROLLS: Specify kind (whole wheat, enriched wheat, rye, etc.) and 
number of slices. 
11. BEVERAGES: Include every item you drink excluding water. Be sure to record 
cream and sugar used in tea and coffee, whether juices are sweetened or 
unsweetened and whether soft drinks are diet or regular. 
12. FATS: Remember to record all butter, margarine, oil and other fats used in 
cooking or on food. 
13. MIXED DISHESi/ CASSEROLES: List the main ingredients and approximate 
amount of each ingredient to the best of your ability. 




Dietary Record Form 
Name: 
Date: _______ (Please use a new copy for each day) 
Food Item Amount Time 
Express approximate measures in cups ( c ), Tablespoons (T), teaspoons (t), grams (g), 
ounces (oz), pieces, etc. 
185 
Dietary Record Form 
Name: ------------
Date: _______ (Please use a new copy for each day) 
Food Item Amount Time 
Express approximate measures in cups (c), Tablespoons (n, teaspoons (t), grams (g), 
ounces ( oz), pieces, etc. 
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------------
Dietary Record Form 
Name: 
Date: _______ (Please use a new copy for each day) 
Food Item Amount Time 
Express approximate measures in cups ( c ), Tablespoons (T), teaspoons ( t ), grams (g), 
ounces (oz), pieces, etc. 
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VITA 
Patrick L. Schneider was born and raised in Sparta, Wisconsin. He attended 
Winona State University in Winona, Minnesota where he received his Bachelor of 
Science degree in Exercise Science. Patrick then entered the graduate program in Adult 
Fitness/Cardiac Rehabilitation at the University of Wisconsin-La Crosse. In 1999, 
Patrick received his Master of Science degree and became certified as an ACSM Exercise 
Specialist. Upon graduation, Patrick worked for two years as a Clinical Exercise 
Physiologist at Franciscan Skemp Healthcare in La Crosse, Wisconsin. In 2001, he 
began the graduate program in Exercise Science at the University of Tennessee where he 
served as a Graduate Teaching Associate. Following the completion of the Doctor of 
Philosophy degree in Education in 2004, Patrick assumed a faculty position at Ball State 
University in Muncie, Indiana. 
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